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DNA adenine methylation plays a role in several core bacterial processes, including 
DNA  mismatch  repair,  the  timing  of  DNA  replication  and  gene  expression.  The 
dependence of bacterial virulence on the activity of Dam, an adenine methyltransferase, 
makes it an attractive target for novel antibiotics. Dam from Yersinia pestis, the plague 
causing  bacteria,  was  expressed  and  purified  by  nickel  affinity  chromatography.  A 
plasmid containing the methylation sensitive restriction endonuclease dpnI gene was 
assembled.  DpnI  was  expressed  and  purified  by  nickel  affinity  chromatography.  A 
Y. pestis  Dam  activity  assay,  which  relied  on  the  sensitivity  of  DpnI  to  DNA 
methylation,  was  developed.  This  continuous  fluorescence  based  assay  was  used  to 
determine several kinetic parameters of the enzyme. The assay was validated for use in 
a  high  throughput  96 well  format  and  used  to  screen  a  library  of  one  thousand 
compounds for Y. pestis Dam inhibitors. Several compounds of interest were identified. 
These  compounds  were  synthesised,  re tested  for  activity  against  Dam,  counter 
screened against the restriction endonuclease DpnI and assayed for an ability to bind 
DNA. A plasmid encoding Dam from the hyperthermophile Pyrococcus horikoshii was 
assembled. Wild type P. horikoshii Dam was expressed and purified by nickel affinity 
chromatography. The resultant Dam was contaminated by a product of mis initiation of 
translation at an internal methionine codon. Site directed mutagenesis was undertaken to 
replace  the  problematic  codon  in  the  dam  gene.  Mutant  P.  horikoshii  Dam  was 
expressed  and  purified  by  nickel  affinity  chromatography.  This  hyperthermophilic 
enzyme was used in the development of a direct and continuous fluorescence based 
assay  for  Dam  activity.  Several  kinetic  parameters  of  P.  horikoshii  Dam  were 
determined with the direct assay. 
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MTase        Methyltransferase   
NEB         New England Biolabs 
PCR         Polymerase chain reaction 
Pfu         Pyrococcus furiosus 
P. horikoshii       Pyrococcus horikoshii 
PMSF        Phenylmethylsulfonyl fluoride 
PVDF        Polyvinylidene fluoride   
REase        Restriction endonuclease 
Rf         Retention factor     
RFU         Relative fluorescence unit 
R/M         Restriction / modification   xix
SDS PAGE       Sodium dodecyl sulphate polyacrylamide gel                                 
                            electrophoresis 
S. typhimuirium     Salmonella typhimurium 
Taq         Thermus aquaticus 
TEMED       N,N,N’,N’ Tetramethylethylenediamine 
Tris         Tris(hydroxymethyl)aminomethane 
UDG         Uracil DNA glycosylase 
UV         Ultraviolet 
V. cholerae       Vibrio cholerae 
Xantphos       4,5 bis(diphenylphosphino) 9,9 dimethylxanthene 
Y. enterocolitica     Yersinia enterocolitica 
Ype         Yersinia pestis 
Y. pestis       Yersinia pestis 
Y. pseudotuberculosis    Yersinia pseudotuberculosis 
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1  Chapter 1 
 
Chapter 1:   Introduction 
 
1.1 DNA methylation and the role of the Dam MTase in bacteria 
 
DNA methyltransferases add extra epigenetic information to DNA by catalysing the 
transfer of a methyl group from S adenosyl L methionine to adenine or cytosine bases. 
Three  modifications  can  be  carried  out  by  these  methyltransferases  (Figure  1.1). 




















Figure 1.1 The three bases found in DNA which result from methyltransferase activity. 
N6 methyladenine, N4 methylcytosine and C5 methylcytosine are shown respectively. 
 
All of these sites are in the major groove of B form DNA, the region where enzymes 
can most effectively use hydrogen bonding and hydrophobic interactions to recognise 


















Figure 1.2 An A T base pair with major and minor groove positions displayed. Chapter 1 
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Adenine methylation also destabilises DNA and resultant conformational changes to the 
double helix are recognised by some enzymes (4,5).  
 
DNA adenine methylation is used by some organisms within each of the domains of 
life, bacteria, archaea and eukaryotes. Within the kingdom animalia, a subdivision of the 
eukaryotic domain, adenine methylation is absent. Animals instead use methylation of 
the C5 position of cytosine (1,3,6 8).  
 
Many  known  adenine  MTases  form  part  of  a  R/M  system  that  allows  bacteria  to 
differentiate between self and foreign DNA, whilst others belonging to phage are used 
to counter this bacterial defence (9). The bacterial ‘Dam’ MTases, which have similar 
biochemical properties to the type II MTases from R/M systems, do not have a partner 
restriction  enzyme  (1,10).  The  majority    of    adenine  methyltransferases  can  be 
categorised as α, β or γ according to the arrangement of their structural domains (Table 
1.1) (11 15). The Dam MTases of E. coli and Y. pestis are in the α family and methylate 
adenine in the palindromic sequence  GATC (Figure 1.3). The AdoMet binding and 
catalytic  regions  contain  the  conserved  amino  acid  motifs  FXGXG  and  DPPY 
respectively. 
 
Family  Arrangement of structural domains (N to C terminus) 
       
α  AdoMet binding region  Target recognition region   Catalytic region 
       
β  Catalytic region  Target recognition region   AdoMet binding region 
       
γ  AdoMet binding region  Catalytic region  Target recognition region 
       
Table 1.1 Arrangements of domains for the major groups of N6 adenine MTases. 
 
Adenine methylation is thought to require distortion of the double helix with rotation of 
the target base about the phosphodiester backbone into the enzyme active site. DNA 
base flipping has been  demonstrated for the HhaI cytosine  and M.EcoDam adenine 
methyltransferases  and  is  also  used  by  other  types  of  DNA manipulating  enzyme Chapter 1 
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(Figure 1.3) (13,16,17). It has been proposed that base flipping may provide a universal 
mechanism by which DNA methyltransferases access their target bases (13). 
 
 
Figure 1.3 X ray crystal structure of E. coli Dam bound to DNA and AdoHcy (purple) 
shown from two different angles (17). The AdoMet binding region (yellow) can be seen 
in the centre, harbouring AdoHcy. The target recognition region (blue) can be seen on 
the right, in close contact with the DNA. The target adenine base (orange) in the DNA is 
flipped out towards the catalytic region (red). 
 
The lifetime of a DNA base pair is typically in the range of 1 500 ms (1). For an A T 
base pair there will be natural periods when the adenine base is partially flipped out of Chapter 1 
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the double helix. It is believed that M.EcoDam encourages this flipping through the 
contacts  it  makes  with  the  DNA  backbone  and  the  stabilisation  it  provides  to  the 
adenine base in the flipped conformation via its conserved DPPY motif. Base flipping is 
therefore promoted by a combination of active and passive means (18). 
 
Methyl  transfer  to  the  exocyclic  nitrogen  of  adenine  proceeds  directly,  in  an  SN2 
reaction without a covalently bound enzyme substrate intermediate (Figure 1.4) (19). 
The DPPY motif, conserved in the catalytic region of the E. coli and Y. pestis Dam 
MTases,  helps  to  negatively  polarise  the  N6  position  of  the  target  adenine  base, 
facilitating the nucleophilic attack. Specifically, it is the side chain of the aspartic acid 
residue and the main chain carbonyl of the first proline residue in the motif which 
accomplish this via their hydrogen bonds to the amino group. The tyrosine residue of 
the  DPPY  motif  packs  against  the  target  adenine  constraining  its  mobility.  It  also 
provides some stabilisation of the cationic transition state through interaction with its π 
electrons (1,3). Once released from the enzyme, the methylated adenine can form a 




















































Figure 1.4 Methyl transfer from AdoMet to the exocyclic nitrogen of adenine. The 
target base is flipped out of the double helix into the enzyme active site. Transfer of the 
methyl group proceeds via an SN2 reaction in which AdoMet is converted into AdoHcy. Chapter 1 
  5
The order of substrate binding by E. coli Dam appears dependant upon experimental 
conditions. There are literature reports which provide evidence for a DNA first and an 
AdoMet first order of binding (20,21). Likewise some experiments have shown Dam to 
be  processive  whilst  others  have  pointed  to  a  distributive  mode  of  action  (20 22). 
Differences  in  measured  processivity  are  attributable  to  the  2 3  bp  adjacent  to  the 
GATC recognition sequences used in the studies, which affect Dam behaviour (23). In 
order to effectively participate in DNA repair and gene regulation Dam is required to act 
both processively and distributively. To efficiently methylate the majority of the 20,000 
GATC sites in the E. coli genome enzyme processivity is thought to be essential (24). It 
has been shown that E. coli Dam will meet a GATC site ~3000 times following binding 
to λ DNA before it dissociates. Since this is a one dimensional random walk along the 
DNA  many  GATC  sites  will  be  visited  on  more  than  one  occasion  and  so  this 
corresponds to methylation of 55 sites prior to dissociation (20). It is likely that in vivo 
the number of sites processively methylated will be lower than this due to displacement 
of Dam by other DNA binding proteins. By contrast, GATC sites in the pap promoter 
are  flanked  by  sequences  which  ensure  low  processivity.  This  allows  differential 
methylation  of  the  sites  which  forms  the  basis  of  the  control  mechanism  for  pilus 
expression (25). CcrM and M.SssI are two other solitary MTases and have both been 
shown to act processively (26,27). In contrast, MTases which are part of a R/M system 
act distributively since this confers maximum protection against invading phage DNA 
(28,29). 
 
Dam  methylation  plays  a  role  in  several  core  bacterial  processes,  including  DNA 
mismatch repair, the timing of DNA replication and gene expression (30 38). Several 
important E. coli genes, the Yersinia outer proteins and at least 20 genes in Salmonella 
typhimurium are under its control (39 41). These are described in more detail in the 
‘Dam and bacterial pathogenesis’ section. 
 
During DNA replication the status of GATC sites in the E. coli genome changes from 
fully to hemi methylated. This is because replication is semi conservative and adenine 
introduced into the new DNA strand is unmethylated. In E. coli there are an estimated 
130 molecules of Dam which re methylate the hemi methylated DNA (42). Plasmid 
DNA can be re methylated within two to four seconds but chromosomal DNA in slow 
growing cells requires about a minute (42 44). During this short interval, replication Chapter 1 
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errors in the nascent strand are repaired. Methylation, or its absence, is the marker 
which  allows  the  cell’s  repair  apparatus  to  differentiate  between  the  template  and 
nascent  strand.  Alteration  of  Dam  activity  in  bacteria  causes  an  increased  rate  of 
spontaneous mutation (45,46). Mutants lacking dam and some other genes encoding 
enzymes involved in DNA repair, for example recA, B, C, J, ruv and lexA, are not viable 
(47). 
 
One region of the DNA which keeps its hemi methylated status for longer is the origin 
of replication, which has an abundance of GATC sites. Control of the methylation status 
of these sites is central to the bacterial mechanism for timing DNA replication. The 
regulatory  protein  SeqA  binds  to  the  hemi methylated  origin  of  replication  and 
sequesters it, delaying re methylation. Since hemi methylated origins of replication are 
inactive this limits DNA replication to once per cell cycle (48). 
 
Control  of  genes  coding  for  the  Pap  pilus  proteins  in  E.  coli  is  an  example  of 
transcriptional  regulation  associated  with  Dam  methylation  (39,48 50).  Conditions 
within the cell just after DNA replication determine if Dam is able to methylate GATC 
sites  proximal  to  or  distal  from  the  promoter  region  of  the  gene  operon.  The 
establishment of a methylation pattern locks pap operon transcription in the on or off 
position until the DNA is again replicated. Expression of these E. coli pyelonephritis 
associated pilus  proteins  is  an  important  virulence  determinant  in  urinary  tract 
infections (51).  
 
1.2 Dam and bacterial pathogenesis 
 
Evidence for a relationship between microbial virulence and Dam activity exists for 
several  disease  causing  bacteria  (Table  1.2).    In  some,  including  certain  Y. 
pseudotuberculosis strains, Y. enterocolitica and V. cholerae, the dam gene is essential 
for viability (40,52). In others, including Y. pseudotuberculosis strains, S. typhimurium 
and Y. pestis, dam deficient bacteria are viable but show reductions in virulence of 1 
million fold,  10,000 fold  and  >  2300 fold  respectively  (41,53,54).  Attenuation  was 
determined for these mutants by comparing the median lethal dose in mice to that of the 
wild type bacteria. Chapter 1 
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Altered  Dam  activity  is  not  universally  linked  to  bacterial  attenuation  as  there  are 
literature  examples  where  this  is  not  the  case  (55,56).  In  E.  coli,  whilst  there  is  a 
demonstrated link between Dam activity and the regulation of pap genes known to be 
required for virulence, there have been no in vivo demonstrations of this link. There is 
however a report that a dam deficient mutant of enterohaemorrhagic E. coli showed 
increased adherence to mammalian cells in vitro and was capable of colonisation of the 
mammalian intestine (56).  
 
Alteration of Dam activity in bacteria can also have other problematic consequences. 
Reduction  of  Dam  activity  in  enterohaemorrhagic  E.  coli  can  lead  to  induction  of 
prophages and an accompanied production of Shiga toxin (57). Shiga toxin invades 
mammalian cells and attacks ribosomal RNA in a manner similar to ricin toxin (58,59). 
Both  toxins  possess  RNA  N glycosidase  activity  and  remove  an  adenine  base  from 
position  4324  in  the  28S  ribosomal  RNA  of  eukaryotes,  thus  inhibiting  protein 
synthesis. 
 
Where there is a link between Dam activity and bacterial virulence there are several 
possible mechanisms by which the attenuation may be brought about.  
 
In Salmonella, many genes with a possible role in virulence are under the control of 
Dam. It has been shown that 20 genes which are preferentially expressed by Salmonella 
in vivo (mouse) are repressed by active Dam (41). These included four genes, spvB, 
pmrB, mgtA and entF, which have been implicated in virulence. The spvB gene encodes 
an  ADP ribosyltransferase  and  facilitates  growth  at  sites  of  systemic  infection  (60). 
Gene pmrB is involved in resistance of antibacterial peptides and mgtA and entF are 
involved in magnesium and iron transport respectively. In their recent review, Marinus 
and Casadesus list five defects which have been observed in Salmonella dam mutants 
and  trace  the  underlying  causes  (34).  Firstly,  murine  studies  have  shown  that  dam 
mutants have a reduced ability to interact with intestinal epithelial cells (61). The cause 
is believed to be the inefficient activation of genes, including hilA, hilC, invF, sipB, 
sipC, sicA and prgH, in S. enterica pathogenicity island I (SPI I)  (34,62). SPI I is not 
activated because of lower levels of transcriptional activator HilD. Expression of this 
protein appears to be posttranscriptionally and therefore indirectly regulated by Dam Chapter 1 
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(34).  A  possible  mechanism  for  this  regulation  is  through  the  effect  of  adenine 
methylation on the production of small non coding RNA or antisense RNA molecules 
(34).   Secondly, Salmonella dam mutants have reduced motility. This is thought to be 
because of altered expression of flagellar proteins such as fliC and fliD which interferes 
with the orderly process of flagellar assembly (62). Thirdly, Salmonella dam mutants 
have an unstable envelope which allows proteins to leak from the cells (63). Envelope 
instability has been linked to impaired binding of Tol and PAL envelope proteins to the 
peptidoglycan  cell  wall  and  decreased  transcription  of  the  gene  encoding  Braun 
lipoprotein. The exact mechanism by which the Tol / PAL to peptidoglycan binding 
process  is  impaired  is  not  known.    Fourthly,  fimbrial  proteins  such  as  StdA  are 
ectopically  expressed  in  dam  mutants  of  Salmonella  which  may  stimulate  a  host 
immune response (34,64,65). Fifthly, dam mutants are more susceptible to bile salts 
(66). Since bile salts have a detergent activity this property of dam mutants is likely 
linked to their envelope instability (34). Prieto and co workers have also shown that bile 
salts induce the SOS response and increase the rate of DNA mutation in Salmonella 
(67). These observations are consistent with a view that bile salts damage Salmonella 
DNA. It has been found that dam mutants also lacking the MutHLS methyl directed 
mismatch repair system are less sensitive to bile salts. It is thought that in dam negative 
strains, the damage done by bile salts can lead to MutHLS induced strand breaks as the 
DNA has no methyl groups to direct the repair process (67).  
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Pathogenic Bacterium  Resultant Disease 
Section A   
Actinobacillus actinomycetecomitans (68)  Periodontal infection 
Aeromonas hydrophila (69)  Gastrointestinal infection 
Bordetella pertussis (70)  Respiratory infection (whooping cough) 
‡Escherichia coli (51)  Gastrointestinal / urinary tract infections 
Klebsiella pneumoniae (71)  Pneumonia 
Haemophilus influenzae (72)  Bacteraemia, pneumonia, meningitis 
Neisseria meningitides (73)  Meningitis 
Pasteurella multocida (46)  Cutaneous infection 
Salmonella typhimurium (41,74)  Gastrointestinal infection 
Vibrio cholerae (40)  Gastrointestinal infection (cholera) 
Yersinia pestis (53,54)  Bubonic and pneumonic plague 
Yersinia enterocolitica (52)  Gastrointestinal infection 
Yersinia pseudotuberculosis (40) (75)  Gastrointestinal infection 
Section B   
# Shigella flexneri (55)  Gastrointestinal infection 
† Brucella abortus (76)  Brucellosis 
Table 1.2 Section A: Bacteria whose pathogenicity is linked to Dam activity. Section B: 
Other  pathogenic  bacteria  of  interest. 
#  Shigella  flexneri  showed  no  significant  link 
between virulence and Dam activity. 
† Brucella abortus virulence is linked to the CcrM 
adenine  methyltransferase.
  ‡  E.  coli  dam  mutants  may  or  may  not  be  attenuated  in 
urinary tract infections, in gastrointestinal infection no attenuation was observed. 
 
In an attenuated Yersinia pestis dam mutant it was found that 129 genes had altered 
expression when compared to the wild type strain. There were 53 genes with reduced 
expression, none of which were known virulence determinants. Attenuation of Y. pestis 
dam  mutants  has  therefore  been  attributed  to  an  increased  visibility  to  the  immune 
system caused by the altered gene expression patterns (54).  
 
The precise effects of deleting the dam gene vary between bacteria, but the frequent link 
between its activity and bacterial virulence, coupled with the fact that mammalian cells Chapter 1 
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exploit cytosine  and not adenine methylation,  make it an attractive target for novel 
antibacterial compounds (41,77). 
 
1.3 Yersinia pestis and the need for novel antibiotics 
 
Plague  has  afflicted  humans  for  thousands  of  years,  the  earliest  record  may  be  the 
outbreak of ‘tumours’ amongst the Philistines described in the Old Testament book of 
Samuel. Three pandemics have occurred since then. First was the Justinian Plague of 
A.D. 542 which originated in the Egyptian port of Pelusium and spread throughout 
Europe  and  the  Middle  East.  Second  was  the  14
th  century  ‘Black  Death’  or  ‘Great 
Mortality’, originating in Asia, it spread throughout the entirety of Eurasia. Between 
1347 and 1351 a third of the European population, an estimated 24 million people, were 
killed by the disease (78). The causative agent of plague was identified as the bacillus 
Yersinia pestis by Alexander Yersin during the third pandemic which began in Hong 
Kong at the end of the 19
th century (Figure 1.5) (79). Yersinia pseudotuberculosis, a 
genetically  similar  bacteria  of  the  same  genus  had  been  identified  a  decade  earlier 
(80,81). Some have argued that the 14
th century outbreak was not due to Y. pestis but 
this minority view is undermined by the presence of Y. pestis DNA in the tooth pulp of 
bodies from 14
th century ‘catastrophe graves’ in southern France (78,82,83). 
 
 
Figure 1.5 A scanning electron micrograph of Y. pestis bacteria (84).  
 
Bubonic plague is the most common form of the disease and causes swollen lymph 
glands, fever, headache and extreme exhaustion. If untreated 50 60 % of bubonic plague 
victims will die whilst the pneumonic and septacaemic forms are almost always fatal Chapter 1 
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(85).  Standard  treatments  include  the  use  of  streptomycin  or  gentamicin  and  have 
brought this mortality rate down to below 14 % (86).  
 
Plague has not been eradicated in modern times and each year thousands of cases are 
reported to the World Health Organization (85). Under the right conditions large plague 
outbreaks still occur. An example is the spike in the number of cases in Asia at the time 
of the Vietnam War (Figure 1.6). 
Year


















Figure 1.6 Cases of plague reported to the World Health Organisation between 1954 
and 1998. 
 
Y. pestis isolates from sufferers are normally susceptible to the antibiotics commonly 
used  against  gram negative  bacteria.  However,  in  1995  Y.  pestis  from  a  patient  in 
Madagascar was observed to be multi drug resistant, with decreased susceptibility to 
chloramphenicol, streptomycin, tetracycline, ampicillin, kanamycin, spectinomycin and 
minocycline (87). A second strain with resistance to streptomycin was isolated from a 
patient  in  another  Madagascan  district  the  same  year  (88).  Resistance  genes  in  the 
MDR Y. pestis were present on a plasmid which could be transferred between bacteria 
by conjugation (87). Worryingly, there is a large reservoir of such plasmids distributed 
in MDR zoonotic pathogens associated with agriculture. This increases the chance that 
such  plasmids  will  again  be  spread  to  Y.  pestis  in  the  future  (89).  It  is  the  use  of 
antibiotics in animal feed that has made livestock a fertile arena for the selection and 
maintenance of antibiotic resistance genes (90,91). Chapter 1 
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The naturally occurring drug resistant plague cases highlight the need to develop new 
antibacterial agents against Y. pestis, but there is another equally strong motivation. 
Y. pestis,  possibly  modified  with  antibiotic  resistance  genes,  could  be  released 
deliberately as a biological warfare agent (92). This happened during World War II 
when the Japanese army dropped Y. pestis harbouring fleas in China with the aim of 
causing a plague outbreak. More recently, in the 1970s, the Soviet Union is believed to 
have weaponised the bacterium (86,93). Today, as a result of internationally accepted 
conventions  banning  the  use  of  biological  weapons,  it  seems  to  be  assumed  that  a 
deliberate release of plague would most likely be by bio terrorists (94). Several factors 
make Y. pestis a good candidate for such purposes. Firstly, it is prevalent in nature 
throughout the world and so could be isolated and grown in a laboratory (82). Secondly, 
aerosol dispersion could cause the more deadly pneumonic plague, which could then be 
spread  from  person  to  person  (86).  Thirdly,  the  dose  of  Y.  pestis  needed  to  cause 
infection is low, between 100 and 500 bacteria (95).  
 
Besides plague a number of other important diseases could potentially be treated with 
Dam  inhibitors  and  some  are  worth  exploring  in  greater  detail  (Table  1.2).  Vibrio 
cholerae is responsible for cholera, a disease currently in its seventh pandemic. In 1992 
a new epidemic strain, O139, emerged and more recently MDR forms of this strain have 
been  identified  (85).  Interestingly,  this  resistance  was  mediated  by  a  plasmid  very 
similar to the one responsible for the 1995 MDR Y. pestis case in Madagascar (96). 
Problematic levels of drug resistance have also been observed in uropathogenic E. coli 
and MDR Salmonella typhimurium DT104, which is widespread in cattle throughout 
the UK and has spread to humans through the food chain (97 99). 
 
1.4 Existent DNA adenine methyltransferase assays 
 
To  identify  and  study  Dam  inhibitors  a  good  assay,  which  can  be  used  for  high 
throughput screening and kinetic analysis, is required.  
 
Common assay strategies, suitable for measuring turnover by adenine MTases, can be 
broadly divided into three types: 1) measurement of the addition of radiolabelled methyl 
groups onto DNA from [methyl 
3H/
14C] AdoMet, 2) measurement of the conversion of Chapter 1 
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AdoMet  to  AdoHcy,  3)  measurement  of  the  susceptibility  of  a  DNA  substrate  to 
cleavage by a restriction enzyme (Figure 1.7). 
 
MTase activity has also been measured by MALDI TOF mass spectrometry in a multi 
step assay (100). A common method used to study MTase DNA interaction, but not 
turnover, involves 2 aminopurine, a base analogue displaying increased fluorescence 
when removed from the stacking environment of double helical DNA (101 104). Other 
methods, used solely for studying C5 cytosine MTases and their products include those 
based on bisulfite treatment or trapping of the covalent MTase DNA intermediate (105 
108). Under certain conditions sodium bisulfite reacts with unmethylated cytosine bases 
and causes their deamination, thus converting them into uracil bases (105 107). DNA 
can then be amplified by PCR and sequenced. Only cytosines methylated in the original 
DNA strand will still appear as cytosines in the sequenced strand. 
 
The first strategy is frequently used to study both adenine and cytosine MTase activity. 
Methyl groups are transferred by the MTase from [methyl 
3H/
14C] AdoMet onto DNA 
which is the separated from unreacted [methyl 
3H/
14C] AdoMet in a purification step. 
The incorporation of radioactive methyl groups can then be quantitatively determined. 
Purification procedures vary and can involve binding and washing the DNA on a filter 
paper (10,109), TLC (110), column chromatography (111) or an affinity tag on the 
DNA substrate (112). Such assay methods can be time consuming, insensitive to low 
levels of methylation and do not give real time data. M.EcoRV adenine MTase activity 
has been measured with this strategy, employed in a microplate format that exploits 
biotin avidin binding (112). Samples containing biotinylated oligonucleotide substrate 
were taken from MTase assays and added to avidin coated wells. The wells were then 
washed,  the  bound  DNA  released  by  enzymatic  degradation  and  the  radioactivity 
analysed  by  liquid  scintillation  counting.  This  format  does  overcome  some 
disadvantages, for example allowing higher throughput, improved sensitivity and the 
potential for automation. Despite this it is still a multi step, discontinuous assay with the 
inherent risks of radioactive materials. 

































































Detection of fluorescent DNA  
 
Figure  1.7  Common  assay  strategies  suitable  for  measurement  of  adenine  MTase 
activity: 1) measurement of the addition of radioactive methyl groups onto DNA. 2) 
measurement of the formation of AdoHcy. 3) measurement of the susceptibility of a 
DNA substrate to cleavage by a REase.  
 
The second strategy, measuring AdoHcy production, was developed as a general way to 
assay AdoMet dependent MTases.  One such assay, demonstrated with salicylic acid 
carboxyl MTase, relies on two additional enzymes in solution to convert AdoHcy to Chapter 1 
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homocysteine. This thiol containing molecule is then quantified colourimetrically with 
Ellman’s reagent (Figure 1.8) (113). Radioactive substrates are dispensed with and end 
product  inhibition  by  AdoHcy  prevented.  The  assay  is  however  discontinuous  and 
complex,  with  two  enzymatic  and  one  chemical  step  needed  for  signal  generation. 
Sensitivity is also low, it has been estimated that only changes in AdoHcy concentration 
of over 4  M could be resolved with the assay. This value is based on the typical 
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Figure 1.8 The principle of Hendrick’s assay for methyltransferase activity. AdoHcy 
nucleosidase converts Adohcy into S ribosylhomocysteine. Homocysteine is produced 
from  S ribosylhomocysteine  by  the  enzyme  LuxS.  Homocysteine  reacts  with  5,  5’ 
dithiobis (2 nitrobenzoic acid) (Ellman’s reagent) to yield 2 nitro 5 thiobenzoate which 
can be quantified spectrophotometrically. 
 
Subsequent improvements have simplified the assay to need just one coupling enzyme, 
S adenosylhomocysteine hydrolase, and increased the sensitivity four fold with the use 















Figure 1.9 A thiol activated reporter molecule containing a FRET pair, fluorescein and 
methyl red, linked by a disulfide bond. Reaction with AdoHcy breaks the disulfide bond 
and leads to an increase in fluorescein fluorescence. 
 
A continuous variant of this strategy has also been developed in which two enzymes 
convert the adenine in AdoHcy into hypoxanthine, a process associated with a decrease 
in absorbance at 265 nm (Figure 1.7) (115). This assay suffers from low sensitivity 
which  would  be  accentuated  against  a  background  containing  DNA  which  absorbs 
strongly at ~265 nm. A similar absorbance based assay has been used to measure the 
conversion of AdoHcy into S inosylhomocysteine by a non specific deaminase from 
Aspergillus oryzae (116). In this assay a decrease in absorbance of 0.1, over a path 
length  of  1  cm,  required  a  change  in  AdoHcy  concentration  of  11.6   M.  This 
concentration of a short oligonucleotide substrate would have produced a background 
absorbance  of  approximately  1.  Such  absorbance  based  assays  therefore  produce  a 
signal which is approximately 10 % of the background. A different variation of the 
strategy relies on competition between AdoHcy produced by the MTase and a tracer 
AdoHcy fluorescein  conjugate  for  AdoHcy  specific  antibodies.  MTase  generated 
AdoHcy  displaces  the  tracer  AdoHcy fluorescein  conjugate  from  the  antibodies, 
resulting in a measurable decrease in fluorescence polarisation (117). This antibody 
method  improves  sensitivity  and  can  still  be  carried  out  in  microplate  format.  It  is 
however  discontinuous  and  a  way  to  terminate  MTase  activity,  without  affecting 
subsequent  AdoHcy  antibody  interactions,  is  required.  High  AdoMet  concentrations 
have also been shown to interfere with results. This interference is due to the slight 
affinity of AdoMet, which is structurally similar to AdoHcy, for the antibodies. 
 Chapter 1 
  17
Strategy  three  often  involves  an  oligonucleotide,  labelled  with  a  fluorphore  and 
quencher, that is rendered susceptible to or protected from a restriction endonuclease by 
the action of a DNA MTase (118). Cleavage by the REase separates the fluorophore and 
quencher giving rise to a fluorescence increase. This protection assay format has been 
used to screen large compound libraries for Dam inhibitors and an ELISA based variant 
to study cytosine and other adenine MTases (77,119). Such methods are discontinuous, 
involving multiple steps but do avoid radioactive substrates, are highly sensitive and can 
be used for a variety of methyltransferases, even without cognate restriction enzymes. 
More  recently,  methylation  induced  REase  susceptibility  has  formed  the  basis  of  a 
sensitive, continuous, coupled enzyme assay for Dam activity (120). This relied on the 
ability of DpnI to preferentially cut the Dam recognition sequence GATC when fully 
methylated (121,122). REases specific for m6A / m4C / m5C containing DNA are rarer 
than those whose activity is blocked by methylation. Consequentially, whilst being good 
for  studying  Dam,  such  continuous  assays  may  be  unsuitable  for  other  important 
MTases.  Despite  this,  as  REases  with  new  recognition  sequences  and  methylation 
sensitivities are found, the scope of these continuous assays will increase. A recently 
introduced methylation sensitive restriction enzyme is GlaI. This enzyme has permitted 
the development of a robust continuous assay for the important cytosine MTase Dnmt1 
(123,124).  In  the  assay  Dnmt1  adds  one  extra  methyl  group  to  an  oligonucleotide 
producing a tetramethylated sequence that is recognised and cleaved by GlaI. 
 
1.5 DNA adenine methyltransferase inhibitors 
 
As  with  all  antibiotics  the  current  adenine  MTase  inhibitors,  none  of  which  are  in 
clinical use, can be divided into two types, natural and synthetic.  
 
Known  natural  adenine  MTase  inhibitors  include  the  by product  of  methylation 
S adenosylhomocysteine  and  sinefungin,  a  molecule  isolated  from  Streptomyces 
griseolus (Figure 1.10, Figure 1.11) (125).The Ki for these two molecules measured 
with the EcoRI adenine MTase was 10  M and 9 nM respectively (109). Both of the 
compounds are analogues of the S adenosylmethionine substrate and target its binding 
pocket. As a consequence they inhibit a broad range of MTases. Sinefungin in particular 





Figure 1.10 A composite of three X ray crystal structures showing the orientation of 
AdoMet (green), AdoHcy (red) and sinefungin (blue) in the active site of the M.TaqI 
adenine  methyltransferase  (126).  The  whole  enzyme  and  a  close  up  of  the  Adomet 
binding pocket are shown in the upper and lower panels respectively. 
 
There  are  reports  of  other  synthetic  S adenosylhomocysteine  analogues  which  can 
inhibit and activate DNA MTases but they too appear to be non specific (127) (Figure 








































































Figure 1.11 Compounds which interact with adenine methyltransferases: AdoMet, the 
natural substrate; 1, (AdoHcy) the by product of methylation and a known inhibitor; 2, 
(sinefungin)  a  known  inhibitor;  3,  (5’ S (Propionic  acid)5’ deoxy 9 (1’ β D 
ribofuranosyl)1,3 dideaza adenine) an apparent MTase activator (127); 4, one of the bi 
substrate inhibitors with a preference for adenine MTases designed by Benkovic and co 
workers (128); 5, core structure of the borinic ester, adenine MTase specific, inhibitors 
developed by Benkovic and co workers (129). 
 
To  try  and  achieve  selectivity,  Benkovic  and  co workers  produced  a  number  of 
rationally  designed  bi substrate  mimics.  These  incorporated  a  deoxyadenosine 
nucleotide with amino and carboxylic acid groups tethered onto the N6 position via a 
sulphur atom (compound 4, Figure 1.11). The deoxyadenosine was designed to mimic Chapter 1 
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the  target  adenine  base  in  DNA  whilst  the  amino  and  carboxylic  groups  sat  in  the 
AdoMet binding pocket. Such molecules were selective for the adenine MTase CcrM 
over the cytosine MTase HhaI (128). Benkovic’s group went on to create and screen a 
combinatorial library of molecules based on this lead structure and identified borinic 
esters as potent Dam inhibitors (129) (compound 5, Figure 1.11). 
 
Using a high throughput screening approach on a diverse compound library Mashoon 
and  co workers  identified  five  novel  classes  of  Dam  inhibitor  (Figure  1.12).  These 
classes displayed a variety of inhibition modalities and several examples from each 


































Figure 1.12 The five classes of Dam inhibitor identified by Mashoon and co workers. 
 
1.6 Summary and conclusions 
 
Novel  antibacterials  effective  against  Y.  pestis  are  required.  Thousands  of  cases  of 
plague occur annually and multi drug resistant strains have been observed. Y. pestis 
could potentially be used as a biological weapon due to its availability, infectivity and 
high fatality rate.  
 
Dam is an adenine methyltransferase with a key regulatory role in bacteria. Y. pestis 
Dam represents an attractive target for novel antibiotics because of its proven link to Chapter 1 
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virulence, absence in humans and wider distribution in other pathogenic gram negative 
bacteria. 
 
There exist a number of assays which could be used to monitor Dam activity but many 
rely on radioactivity and none are truly real time. To facilitate the identification and 
characterisation of Y. pestis Dam inhibitors, the first requirement is a new Dam assay, 
amenable to high throughput screening and in depth kinetic analysis. The development 
of this assay and its application to finding and characterising new Dam inhibitors has 
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2  Chapter 2 
 




Hairpin oligonucleotides possessing adjacent fluorophore and quencher pairs have been 
used  to  assay  the  activity  of  restriction  enzymes  such  as  BamHI  (1).  When  the 
fluorophore and quencher are attached to an oligonucleotide the pair are held in close 
proximity. Overlap of the fluorophore emission and quencher absorbance spectra allows 
Förster resonance energy transfer (FRET) to occur, decreasing the observed fluorophore 
fluorescence (Figure 2.1). Since the efficiency of this process is inversely proportional 
to the sixth power with respect to distance, restriction enzyme activity separating the 
FRET pair restores the fluorophore fluorescence (2,3).  
 
Restriction  enzyme  DpnI  is  often  used  to  identify  the  methylation  status  of  DNA 
because it recognises and cuts palindromic GATC sequences only when the adenine on 
both of the strands is methylated (4,5). The aim was to combine the discriminatory 
ability  of  DpnI  with  the  use  of  a  hairpin  oligonucleotide  to  produce  a  continuous 
coupled enzyme assay for Dam activity. Methylation of a fluorescently labelled hairpin 
oligonucleotide by Y. pestis Dam would result in its recognition and restriction by DpnI, 
with an associated fluorescence increase. At the time development of our assay began, 
Li and co workers had yet to publish their work on a similar assay and our research took 
no  intellectual  inspiration  from  theirs  (6).  As  will  be  demonstrated  in  this  and 
subsequent chapters the assay which we developed was actually superior to Li’s because 
of one small but crucial difference. 
 


















Fluorophore Quencher  
Figure  2.1  Förster  Resonance  Energy  Transfer:  The  fluorophore  absorbs 
electromagnetic  radiation  and  is  taken  into  an  excited  electronic  state.  The  excited 
molecule loses energy through collisions with surrounding molecules and descends to 
the lowest vibrational level of the excited electronic state. The fluorophore returns to the 
lower electronic state, emitting excess energy as electromagnetic radiation. A nearby 
quencher molecule absorbs this radiation and is taken into an excited electronic state. 
The quencher returns to the ground electronic state, transferring the excess energy into 
the surrounding molecules in a radiationless manner. 
 
Plasmid pRJW421307, which contained the Y. pestis Dam gene under the control of an 
arabinose inducible promoter, had been created by Dr R. J. Wood and used to express 
active  Y.  pestis  Dam.  It  was  considered  worthwhile  to  re test  expression  in  several 
different E. coli strains harbouring the plasmid. DpnI from a commercial source was 
used  for  initial  assay  development  but  later  it  was  more  economical  to  prepare 
recombinant  DpnI  from  an  expression  system.  Construction  of  a  DpnI  expression 
plasmid, identification of a good expression strain and optimisation of the purification 
were therefore undertaken. Chapter 2 
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This  chapter  describes  the  cloning,  expression  and  purification  of  the  two  enzymes 
Y. pestis Dam and DpnI, and the stages in the development of a fluorescent real time 
coupled enzyme assay for Dam activity. Maps of the expression plasmids, including 
pRJW421307 produced by Dr. R. Wood, may be found in appendix A. 
 
2.2 Cloning, expression and purification of enzymes for use in the assay 
 
2.2.1 Expression of Y. pestis Dam 
 
The  expression  of  N terminally His6 tagged  Y.  pestis  Dam,  abbreviated  His6 
M.YpeDam (7), from pRJW421307 was investigated in E. coli strains BL21 (DE3), 
JM110 and GM215 (Table 2.1). Cultures of each strain were grown in 100 ml of 2YT 
media and the absorbance at 600 nm monitored over time. When the absorbance at 
600 nm reached 0.6, protein expression was induced with arabinose and the protein 
content of cells analysed by SDS PAGE every hour for four hours thereafter. 
 
The cultures of BL21 (DE3) and GM215 grew unremarkably up to an absorbance of 0.6 
at 600 nm in approximately 2 hours (Figure 2.2, upper and lower graphs). Strain JM110 
took longer, with three hours passing before an absorbance of 0.6 was reached (Figure 
2.2, middle graph). Induction of Dam expression in strain BL21 (DE3) curtailed growth 
significantly. Strain GM215 showed some reduction in growth, but only 2 hours after 




Table 2.1 E. coli strain genotypes. Strains beginning ‘GM’ were originally produced by Professor Martin. G. Marinus. 
 
Strain  Genotype  Comments 
BL21 (DE3) (8),(9)  F , ompT, hsdSB(rB , mB ), dcm, gal, λ(DE3)  Dcm –ve. Generally used as an expression 
host. Deficient in lon and ompT proteases 
GM33 (10),(11)  F , LAM , IN(rrnD rrnE)1, dam 3, sup 85  Dam –ve strain. Colonies and cell pellet 
greasy in appearance. Difficult to collect by 
centrifugation. 
GM48 (10)  F , thr 1, araC14, leuB6(Am), fhuA31, lacY1, tsx 78, glnV44(AS), 
galK2(Oc), galT22, LAM , dcm 6, dam 3, thi 1 
Dam and Dcm –ve strain. 
GM124  F , lacZ118(Oc), rpsL275(strR), dam 4  Dam –ve strain. Streptomycin resistant. 
GM161  F , thr 1, leuB6(Am), fhuA21, lacY1, glnV44(AS), LAM , dam 4, thi 1, 
hsdS1 
Dam –ve strain. 




F , araC14, leuB6(Am), fhuA13, lacY1, tsx 78, glnV44(AS), galK2(Oc), 
galT22, LAM , mcrA0, dcm 6, hisG4(Oc), rfbC1, rpsL136(strR), dam 
13::Tn9, xylA5, mtl 1, recF143, thi 1, mcrB9999, hsdR2 
Dam –ve strain. Chloramphenicol resistant. 
Streptomycin resistant. 
JM110 (13)  rpsL (StrR,) thr, leu, thi 1, lacY, galK, galT, ara, tonA, tsx, dam, dcm, 
supE44,  (lac proAB), [F´ traD36 proAB lacIqZ M15] 
Dam and Dcm –ve. Streptomycin resistant. 
TOP10 (Genotype 
same as DH10B 
(14)) 
F , mcrA,  (mrr hsdRMS mcrBC), φ80lacZ M15,  lacΧ74, recA1, 
araD139,  (ara leu) 7697, galU, galK, rpsL(StrR), endA1, nupG λ  
High transformation efficiency, used for the 
maintenance of plasmids. Streptomycin 
resistant. Chapter 2 
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Time (minutes)

































































































Figure 2.2 Growth curves of induced (●) and uninduced (○) cultures of E. coli strains 
BL21  (DE3)  (upper  graph),  JM110  (middle  graph)  and  GM215  (lower  graph) 
harbouring plasmid pRJW421307. A time course of the absorbance of the cultures at 
600 nm is shown. Chapter 2 
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SDS PAGE  analysis  suggested  that  there  was  probably  low  level  Y.  pestis  Dam 
expression in all of the cell strains tested (Figure 2.3, Figure 2.4, Figure 2.5). An extra 
protein, with the expected molecular weight of Y. pestis Dam, 32,118 Da, was seen in 
every  induced  sample  of  BL21  (DE3)  (Figure  2.3).  In  JM110,  expression  was  also 
faintly observed 1 3 hours after induction but beyond this time it was difficult to judge 
Dam levels (Figure 2.4). 
 
        M         R         1( )    2(+)     3( )     4(+)      5( )     6(+)     7( )      8(+) 
Figure 2.3 15 % SDS PAGE analysis of Dam expression in strain BL21 (Dam +). M = 
Marker, R = Dam reference, Lanes 1, 3, 5 and 7 = lysate from uninduced cultures at 1, 
2, 3 and 4 hours respectively, Lanes 2, 4, 6 and 8 = lysate from induced cultures at 1, 2, 
3 and 4 hours after induction. 
 
 
          M         R           1( )   2(+)     3( )     4(+)     5( )    6(+)     7( )      8(+) 
Figure 2.4 15 % SDS PAGE analysis of Dam expression in strain JM110 (Dam  ). M = 
Marker, R = Dam reference, Lanes 1, 3, 5 and 7 = lysate from uninduced cultures at 1, 
2, 3 and 4 hours respectively, Lanes 2, 4, 6 and 8 = lysate from induced cultures at 1, 2, 
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             M        R          1( )    2(+)     3( )     4(+)     5( )     6(+)     7( )      8(+) 
Figure 2.5 15 % SDS PAGE analysis of Dam expression in strain GM215 (Dam  ). M 
= Marker, R = Dam reference, Lanes 1, 3, 5 and 7 = lysate from uninduced cultures at 1, 
2, 3 and 4 hours respectively, Lanes 2, 4, 6 and 8 = lysate from induced cultures at 1, 2, 
3 and 4 hours after induction. 
 
With strain GM215, the 32 kDa protein band was clearly more intense after 1 hour in 
the induced culture sample. Between 3 and 4 hours post induction this protein band 
reduced in intensity, which may indicate degradation of the protein.  
 
E. coli strain GM215 was chosen to express Y. pestis Dam on a large scale. GM215 
grew significantly better than BL21 (DE3) and was chosen over JM110 because, whilst 
there was evidence of protein expression in both strains, GM215 was endA negative. 
Herman and Modrich reported endonuclease A contaminating E. coli Dam they purified 
from GM31 (15). Endonuclease A can digest oligonucleotides over 7 bp long and so 
could have adversely affected assay development (16,17).  
 
Large scale expression of Y. pestis Dam was carried out in 5 L cultures of E. coli 
GM215 harbouring plasmid pRJW421307. Typically such growths yielded 20 g of cell 
paste  from  which  Dam  could  be  purified  by  nickel  affinity  chromatography.  A 
purification using 10 g of cell paste normally yielded 1.5 mg of protein. Y. pestis Dam 
prepared in this manner was estimated to be > 95 % pure based on SDS PAGE analysis 
(Figure  2.6).  Protein  was  dialysed  for  two  half  hour  periods  into  storage  buffer 
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           M      S      D 
Figure  2.6  15  %  SDS PAGE  analysis  of  N terminally  His tagged  Y.  pestis  Dam 
purified from GM215. M = Marker, S = Supernatant, D = Dam. 
 
2.2.2 Subcloning, expression and purification of restriction enzyme DpnI 
 
2.2.2.1 Harvesting of DpnI gene template DNA 
 
DNA encoding the DpnI restriction endonuclease was kindly provided by Professor 
Sanford Lacks of Brookhaven National Laboratory in the form of a plasmid, pLS251, 
harboured in lyophilised E. coli GM 33 bacteria (5). The bacteria were recovered by re 
suspension  in  liquid  growth  media  and  plating  out  onto  solid  ampicillin containing 
media. Plasmid was isolated from overnight cultures of the bacteria grown from single 
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                      M    1    2    3     4     5     6     7      8 
Figure 2.7 1 % AGE analysis of digested plasmid extracted from cultures of GM33 
harbouring plasmid pLS251 (8.7 kbp). Lane M = DNA ladder. Lanes 1 4 show plasmid 
from four colonies linearised with BamHI, expected size = 8700 bp. Lanes 5 8 show 
plasmid from the same four colonies, in the same order, digested with NcoI, expected 
sizes = 7500 and 1200 bp (5). 
 
Only plasmid isolated from colonies 1 and 3 produced DNA fragments consistent with 
pLS251 upon digestion. 
 
2.2.2.2 Subcloning of the dpnI gene 
 
Plasmid isolated from colony 1 was used as template DNA in PCR reactions to amplify 
the dpnI gene with primers DpnIf and DpnIr (Table 2.2).  
 
Primer  Sequence 5’ to 3’ 
DpnIf  CCCCCCATGGAATTACACTTTAATTTAGAATTAGTA 
DpnIr  CCCCCTCGAGTCATAATTTCCGATACTTTCC 
Table  2.2  Sequences  of  the  forward  (DpnIf)  and  reverse  (DpnIr)  primers  used  to 
amplify the DpnI gene. The NcoI and XhoI restriction sites are shown underlined and in 
bold italics respectively. 
 
Analysis of the PCR reactions by agarose gel electrophoresis revealed that DNA of the 
expected length had been synthesised (Figure 2.8). 
 
bp   
9162           
6108        
5090 





     
1018 
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                    M           1     2     3     4       
Figure 2.8 1 % AGE analysis of PCR reactions to amplify the dpnI gene. Lane M = 
DNA ladder. Lanes 1 4 = PCR reactions containing 1, 10, 100 and 1000 fold diluted 
template respectively, expected size = 781 bp. 
 
The purified dpnI gene was digested with restriction enzymes XhoI and NcoI to produce 
sticky ends. A vector, with complementary sticky ends and an ampicillin resistance 
marker, was made by digestion of plasmid pMK171, a pBad derivative, with the same 
enzymes. This vector also encoded a His6 tag which would be appended onto the start 
of the dpnI gene. Both gene and vector were purified by gel electrophoresis before 
analysis by 1 % AGE (Figure 2.9). 
 
   
                               M          1     2                                M              G 
Figure 2.9 (Left) 1 % AGE analysis of NcoI and XhoI doubly digested, gel purified, 
fragments of plasmid pMK171. Lane M = DNA ladder, 1 = insert, 2 = vector, expected 
size = 4015. (Right) 1 % AGE analysis of NcoI and XhoI doubly digested, gel purified 
dpnI gene, expected size = 767 bp. 
 
Vector and dpnI gene DNA appeared as single bands of the expected sizes. These DNA 
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aliquots  of  chemically  competent  E.  coli  GM2929.  Transformants  were  cultured 
overnight on solid, ampicillin containing growth media. 
 
Selected colonies were screened by PCR to confirm that they possessed a copy of the 
dpnI gene. Of the fourteen colonies screened, nine gave a correctly sized fragment in the 
PCR reaction (Figure 2.10). 
506, 517
 
                            M   1    +    2    3    4   5    6    7    8   9   10  11 12  13  14  15   M 
Figure 2.10 1 % AGE analysis of colony PCR screen for the dpnI gene. Lane M = DNA 
Ladder. 1 = negative control (E. coli GM2929 transformed with pMK171). + = positive 
control (pLS251). Lanes 2 – 15 = Colonies transformed with ligation mixture. 
 
Plasmid  harvested  from  overnight  growths  of  the  same  colonies  was  subjected  to 
digestion by XhoI or a combination of XhoI and NcoI. Analysis of the digests by AGE 
gave results consistent with the PCR screen (Figure 2.11). The nine colonies which had 
yielded a PCR product with the DpnI primers also harboured a plasmid of the expected 
size, 4782 bp, which contained an anticipated 767 bp insert delimited by XhoI and NcoI 
restriction sites. This new DpnI expression plasmid was named pMMS495859. Colonies 














506, 517  
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                                     M  1    2   3   4    5   6   7    8   9   10 11 12  13 14  15  M 
 
Figure 2.11 1 % AGE analysis of plasmid extracted from transformants. Lane M = 
DNA Ladder. Upper lanes 1 – 15 show plasmid isolated from transformants 1 – 15 (as 
labelled in figure 2.9) linearised with XhoI. Lower lanes 1 – 15 show plasmid from the 
same transformants digested with NcoI and XhoI.  
 
2.2.2.3 Expression and purification of His6 DpnI 
 
Expression studies were carried out on colonies 2, 3, 6 and 14 which contained plasmid 
pMMS495859.  Cultures  derived  from  the  respective  colonies  were  grown  to  an 
absorbance of 0.6 at 600 nm and induced with arabinose. Protein content of the cells 
was analysed by SDS PAGE 1 and 2 hours post induction and compared with that of 
GM2929 harbouring pBad HisA as a negative control (Figure 2.12). 
 
bp   
5090         
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                   M        N1    2a      3a    6a     14a            N2     2b     3b      6b     14b       
Figure 2.12 15 % SDS PAGE analysis of DpnI expression in GM2929. M = molecular 
weight marker. N1 = negative control (E. coli  GM2929 containing a pBad plasmid 
without the DpnI gene one hour after induction). 2a 14a = protein from growths of 
colonies 2, 3, 6 and 14 one hour after induction. N2 = negative control (two hours after 
induction). 2b 14b = protein from growths of colonies 2, 3, 6 and 14 two hours after 
induction. 
 
After 1 hour, significantly more protein with the molecular weight of DpnI, 30,810 Da, 
was being expressed in the E. coli GM2929 containing pMMS495859 (Figure 2.12, 
black arrow). After 2 hours the amount of this protein of interest had continued to 
increase. 
 
It was concluded that DpnI was probably being produced and so a large scale expression 
and purification using strain GM2929 were undertaken. A 5 L culture grown at 27 °C 
for 3 hours after induction yielded 23 g of cell paste. Two purifications were carried out 
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                       M    R     S     FT                            Fractions 1   11                             
Figure 2.13 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM2929 
without protease inhibitors. M = molecular weight marker, R = reference sample of 
DpnI, S = supernatant, FT = flow through.  
 
SDS PAGE analysis of the protein from the first purification showed that it was impure 
(Figure  2.13).  Only  a  small  amount  of  the  protein  eluted  from  the  column  had  the 
expected molecular weight of DpnI (30,810 Da). The majority was in the form of two 
proteins,  at  similar  concentration,  with  molecular  masses  of  approximately  17  and 
13 kDa. A hypothesis for this observation was that the two smaller proteins were the 
result of proteolytic degradation of DpnI. To test this, protease inhibitor tablets and 
PMSF, a serine protease inhibitor, were included in a second purification (Figure 2.14) 
  
 
                               M     S     FT                            Fractions 1   7                             
Figure 2.14 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM2929 
with protease inhibitor tablets and PMSF. M = molecular weight marker, R = reference 
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The addition of protease inhibitors considerably improved the purification step. SDS 
PAGE analysis of fractions eluted from the second column showed that they had a 
higher proportion of DpnI to impurity.  
 
This DpnI was however still not considered pure enough and so different cell strains 
were investigated for its overexpression. E. coli strains GM33, 48, 124, 161 and 215 
were  all  transformed  with  plasmid  pMMS495859  and  DpnI  was  expressed  in  1  L 
cultures of each (Table 2.3, Table 2.1). Because DpnI cleaves DNA containing N6 
methyladenine only Dam negative strains were tested. 
 
E. coli strain  Cell paste from growth (g)  Cell paste used in purification (g) 
GM33 
#  23*  6* 
GM48 
#  2  2 
GM124 
‡  3.8  3.8 
GM161 
‡  6  6 
GM215 
‡  1.4  1.4 
Table  2.3  Cell  paste  yielded  from  1  L  growths  of  E.  coli  harbouring  plasmid 
pMMS495859. 
# Cells cultured for 3 hours post induction. 
‡ Cells cultured for 4 hours 
post induction. * Cells obtained as a watery slurry. 
 
A nickel affinity purification, supplemented with protease inhibitors, was performed 
with cell paste from each of the strains. Samples of the protein fractions eluted from the 
nickel column were analysed by 15 % SDS PAGE (Figure 2.15 Figure 2.19). 
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                        M       S        FT                            Fractions 1   5                             
Figure 2.15 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM215 with 
protease inhibitor tablets and PMSF. M = molecular weight marker, S = supernatant, FT 
= flow through. 
 
 
                                M      S     FT                            Fractions 1 – 8 
 
Figure 2.16 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM161 with 
protease inhibitor tablets and PMSF. M = molecular weight marker, S = supernatant, FT 
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                          M      S     FT                        Fractions 1 – 8 
 
Figure 2.17 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM124 with 
protease inhibitor tablets and PMSF. M = molecular weight marker, S = supernatant, FT 




                        M      S      FT                        Fractions 1   8                                          
 
Figure 2.18 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM48 with 
protease inhibitor tablets and PMSF. M = molecular weight marker, S = supernatant, FT 
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                           M    S     FT                      Fractions 1   8                                          
 
Figure 2.19 15 % SDS PAGE analysis of DpnI purified from E. coli strain GM33 with 
protease inhibitor tablets and PMSF. M = molecular weight marker, S = supernatant, FT 
= flow through. 
 
Expression  in  strain  GM215  was  poor,  with  little  DpnI  or  impurity  present.  In  the 
remaining strains, which all performed better than GM2929, a good quantity of DpnI 
was produced along with varying amounts of the two impurities. The two strains giving 
the highest proportion of intact DpnI were found to be GM33 and GM48. GM33 tended 
not to form a cohesive pellet upon centrifugation, instead remaining as a slurry which 
was difficult to manipulate. For this reason GM48 was chosen as the new preferred 
strain for DpnI overexpression. Typically 24 g of cell paste were obtained from a 5 L 
culture  of  E.  coli  strain  GM48  harbouring  plasmid  pMMS495859.  Approximately 
25 mg of protein was obtained from a purification using 5 g of cell paste. After elution 
from the nickel column, DpnI was dialysed for two one hour periods into storage buffer 
containing 50 % glycerol and kept in frozen aliquots at a concentration of 2.3 mg ml 
 1. 
The storage and purification buffers contained 400 mM sodium chloride. At lower salt 
concentrations the protein was observed to precipitate shortly after elution from the 
nickel column. 
 
His6 DpnI  expressed  in  this  way  was  incubated  with  unmethylated  and  methylated 
plasmid DNA as a rudimentary test of its activity. In parallel DpnI from a commercial 
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                                       M         1          2          3           4 
Figure  2.20  1  %  AGE  analysis  of  digests  using  commercial  DpnI  and  His DpnI 
expressed  in  GM48.  M  =  DNA  ladder,  lanes  1  and  3  =  Unmethylated  plasmid 
pBadHisA  (4102  bp)  incubated  with  His6 DpnI  and  commercial  DpnI  respectively. 
Lanes 2 and 4 = Methylated plasmid pMK171 (5114 bp) incubated with His6 DpnI and 
commercial DpnI respectively, largest four expected fragments = 979, 660, 543, 507 bp. 
 
His6 DpnI  displayed  similar  behaviour  to  its  commercial  counterpart,  leaving  the 
unmethylated plasmid intact but cleaving the methylated one into numerous fragments, 
the largest of which were of the expected sizes. 
 
His6 DpnI activity was measured as 0.38 ± 0.03  mol mg
 1 min
 1, which corresponds to 
a turnover of 12 ± 1 min
 1 (J. McKelvie). Activity measurements were made using the 
optimised Dam methyltransferase assay principle which is discussed in the remaining 
part of this chapter (Figure 2.25). A fully methylated oligonucleotide  substrate at a 
concentration  of  30  nM  was  used.  The  His6 DpnI  was  six  times  more  active  than 
commercial DpnI tested under the same conditions (0.06 ± 0.01  mol mg
 1 min
 1, J. 
McKelvie). Lacks and co workers reported a specific activity of 0.03  mol mg
 1 min
 1 
for  their  DpnI  (5).  To  make  this  measurement  they  used  plasmid  DNA,  at  a 
concentration of 4 nM, containing two fully methylated GATC sites. It is likely that the 
measured commercial DpnI activity was low because the enzyme had been stored for 
several weeks in solution at  20 °C. Whilst Lacks and co workers stored their pure DpnI 
at  80 °C prior to use, their five step purification took three days to complete. This, 
along  with  the  different  substrates,  may  explain  the  lower  activity  of  their  DpnI 
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The unit definition of the commercial DpnI is the amount of the enzyme required to 
digest 1  g of pBR322 DNA in 1 hour at 37 °C. One unit is equivalent to 0.12 pmol of 
commercial DpnI. 
 
2.3 Design and optimisation of an assay for Dam activity 
 
2.3.1 Oligonucleotide design 1 
 
Early  work  on  the  optimisation  of  the  Dam  activity  assay  was  carried  out  in 
collaboration with Dr R. Wood. Oligonucleotide 1 (ODN 1) was a 20 bp hairpin with an 
unmethylated GATC Dam recognition sequence in the middle and a fluorophore and 
quencher on opposite ends (Figure 2.21). 
 
 









F = Fluoresceine fluorophore Q = Dabcyl quencher
 
Figure 2.21 Oligonucleotide design 1. The fluorophore and quencher are attached to 
opposite ends of the same DNA strand containing the Dam recognition sequence. The 
hairpin loop is formed from a hexaethyleneglycol linker, denoted by a black curve. 
 
The  fluoresceine  fluorophore  has  an  absorption  maxima  at  494  nm  and  emission 
maxima at 517 nm. It exists predominantly as the dianion at the assay pH of 7.9 (18). 
The Dabcyl quencher has an absorption maxima at 475 nm but quenches effectively 
over a wide range of wavelengths including the 517 nm fluorescein emission maxima 
(19).  Dabcyl  is  a  dark  quencher  and  returns  to  its  ground  electronic  state  through Chapter 2 
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nonradiative processes. FRET quenching efficiency for a fluorescein dabcyl pair has 
been measured as 80 % using a short oligonucleotide where the separation was 5 bases. 
When  the  fluorescein  and  dabcyl  are  in  very  close  proximity  static  quenching  is 
possible. The pair form a complex with altered absorption characteristics which can 
return to a ground electronic state without the emission of a photon. The efficiency of 
static quenching for a fluorescein dabcyl pair is 91 % (19). 
  
Fluorescence timecourses of assays containing ODN 1, AdoMet, Dam and DpnI were 
measured in a plate reader (Figure 2.22). It was anticipated that methylation of ODN 1 
by  Dam and subsequent DpnI restriction would separate the FRET pair and  give a 
measureable fluorescence increase. 
Time (s)










































Figure 2.22 The fluorescence timecourse of Dam activity assays (triplicate averaged) 
using ODN 1. Assays contained AdoMet (500  M), ODN 1 (25 nM), Dam (30 nM) and 
DpnI from a commercial source (2  l, 40 Units (solid line), 0 Units (dotted line)). 
 
A significant background fluorescence of 23 24 arb units was observed at the start of 
the assays and the signal increase specifically due to methyltransferase activity was 
small.  The  background  increases  in  fluorescence  may  have  been  attributable  to  a 
contaminant  in  the  Dam  or  changes  in  the  meniscus  of  the  assays  throughout  the 
experiment. During the course of the assays the meniscus developed a more pronounced 
upward curvature at the edges of the wells, which may have artificially changed the 
measured fluorescence of the solution.  
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The poor signal to background fluorescence was attributed to Dam instability and the 
remote positioning of fluorophore and quencher on opposite ends of ODN 1. A second 
oligonucleotide was designed to overcome the latter of these problems. 
 
2.3.2 Oligonucleotide design 2 
 
The fluorophore and quencher of oligonucleotide 2 (ODN 2) were positioned adjacent 
to one another on the same side of the Dam recognition sequence (Figure 2.23). Since 
FRET  efficiency  increases  with  decreasing  distance  and  static  quenching  is  more 
efficient  than  FRET  it  was  reasoned  that  this  would  lower  the  background  assay 
fluorescence, improving the signal to noise ratio. By necessity the oligonucleotide had 
to become much shorter. With the fluorophore and quencher on the same side of the 




Figure 2.23 Oligonucleotide design 2. F and Q represent a fluorescein fluorophore and 
Dabcyl quencher respectively. The hairpin loop is formed by four unpaired thymine 
bases. 
 
Assays containing AdoMet, Dam, DpnI and a range of ODN 2 concentrations were 
carried  out.  Background  fluorescence  was  as  expected  much  improved,  as  was  the 
signal generated upon oligonucleotide cleavage (Figure 2.24).  Chapter 2 
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Time (s)





















































Figure 2.24 The fluorescence timecourse of Dam activity assays (triplicate averaged) 
using oligonucleotide design 2. Assays contained AdoMet (500  M or 0  M), ODN 2 
15 nM (red), 25 nM (orange dash), 35 nM (green), 45 nM (blue dash), 55 nM (grey), 
55 nM negative control (black), DpnI (1  l, 20 U) and Dam (20 nM). 
 
Fluorescence of the active assays was observed to increase significantly more than that 
of the negative controls. At low DNA concentrations, rates of fluorescence increase 
were  highest  at  the  start  of  the  assay  and  then  slowed,  either  as  the  substrate  was 
exhausted  or  Dam  inactivated.  At  higher  DNA  concentrations  an  unwanted 
phenomenon  was  observed.  Rates  of  fluorescence  increase  were  reduced  and  a  lag 
phase appeared before the maximum rate was reached. An explanation for this lay in the 
fact  that  Dam  had  to  methylate  ODN  2  twice  before  it  could  be  cut  by  DpnI  and 
generate a fluorescence signal. Following the first methylation event, hemi methylated 
ODN 2 was left in competition with the remaining unmethylated ODN 2 for Dam. The 
higher the starting ODN 2 concentration the less likely it was that the hemi methylated 
oligonucleotide would find a free Dam active site. Li and co workers developed an 
analogous Dam activity assay which used a DNA substrate requiring two methylations. 
It showed a similar phenomenon which they termed a ‘retention time’ (6). To overcome 
this drawback, and produce an assay that would permit in depth kinetic characterisation, 
a third oligonucleotide was designed. 
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2.3.3 Oligonucleotide design 3  
 
The  final  version  of  the  assay  used  oligonucleotide  3  (ODN  3),  identical  to  its 




Figure 2.25 The real time, fluorescence based, coupled enzyme assay for Y. pestis Dam 
activity.  
 
It was reasoned that with a hemi methylated DNA substrate, each turnover by Dam 
should lead to cleavage of the oligonucleotide by DpnI and an associated fluorescence 
increase.  
 
Test assays at three Dam concentrations were carried out (Figure 2.26). Maximum rates 
of fluorescence increase occurred at the start of the timecourses despite the high DNA to 
Dam ratio which had caused a lag phase in the antecedent ODN 2 assay. Assay results 
suggested  that  the  fluorescence  signal  generated  was  proportional  to  Y.  pestis  Dam 
activity. Doubling of the Dam concentration from 0.3 to 0.6 nM doubled the observed 
fluorescence increase over the first 180 s from 17.1 ± 2.1 to 34.7 ± 1.8 arb units s
 1. A 
background increase of 4.7 ± 1.7 arb units s
 1 was measured in assays lacking Dam 
which was attributed to cleavage of the hemi methylated oligonucleotide by DpnI.  



















































































































































Figure 2.26  (Upper graph) Raw fluorescence timecourses of Dam activity assays using 
ODN 3. Assays contained DpnI (10 U), Dam (0 (black), 0.3 (blue) or 0.6 (green) nM), 
AdoMet (240  M) and ODN 3 (33 nM). (Lower graph) Sextuplet averaged fluorescence 
timecourses. The instrument gain was 200, excitation and emission wavelengths were 
486 and 518 nm respectively and the bandwidths were both 5 nm.  
 
2.3.4 Optimisation of sodium chloride concentration 
 
It is known that DpnI can cut hemi methylated GATC sequences in DNA, but at a 
slower rate than fully methylated (20). Reports in the literature suggest that sodium 
chloride  concentration  plays  a  role  in  the  specificity  of  DpnI  for  fully  over  hemi 
methylated DNA (21,22). As sodium chloride concentration is increased DpnI must Chapter 2 
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compete  with  an  increasing  concentration  of  cations  for  binding  sites on  the  DNA, 
reducing its binding affinity (23). Screening of the non specific electrostatic attractive 
forces may have a more pronounced effect on hemi methylated DNA binding since 
there are likely to be fewer specific hydrogen bonding and hydrophobic interactions 
with the DpnI (24).  
 
To find the optimal salt concentrarion which would minimise background cleavage, 
without inhibiting Y. pestis Dam, a series of assays were set up. Assay buffer, which 
already contained 10 mM Mg 
2+ and 50 mM K
+, was supplemented with between 0 and 
150 mM NaCl (Figure 2.27). For each set of activity assays at a particular sodium 
chloride concentration a set of negative controls without Dam was also run. Rates of 
fluorescence  change  caused  by  Dam  activity  were  presumed  to  be  the  total  rate  of 
fluorescence change minus the DpnI background as determined in the negative control. 
Sodium chloride concentration (mM)






















































Figure 2.27 The effect of sodium chloride concentration on the apparent activity of 
Dam (○) and DpnI (●) (duplicate assays averaged). Assays (200  l) contained Dam (0 
or  0.6 nM),  DpnI  (10  U),  AdoMet  (30   M),  oligonucleotide  3  (30  nM)  and  were 
supplemented with the specified amount of sodium chloride.  
 
As  sodium  chloride  concentration  increased,  DpnI  cleavage  of  the  hemi methylated 
DNA  fell  sharply.  With  20  mM  sodium  chloride  there  was  75  %  less  background 
cleavage compared to unsupplemented assays. Unwanted DpnI activity continued to fall 
and  was  effectively  absent  at  sodium  chloride  concentrations  above  100  mM.  Dam 
activity  was  also  reduced  by  increased  salt  concentration  but  this  effect  was  only Chapter 2 
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apparent above 20 mM sodium chloride. This concentration was therefore felt to be 
optimal for achieving the best signal to background ratio in the assay. 
 
2.3.5 The effect of excess Dam or DpnI in the assay 
 
Because this was a coupled enzyme assay, measurement of Dam activity relied on DpnI 
being present in excess, ensuring methylation was rate limiting. Fluorescence assays 
were conducted to examine the effect of varying the concentration of the two enzymes 
relative to each other. A set of assays containing 2 nM Dam and 0 – 10 U of DpnI were 
run, along with negative controls lacking Dam (Figure 2.28, upper graph).  
 
Highest initial increases in fluorescence tended to be seen in the assays and negative 
controls  with  the  most  DpnI.  At  these  high  DpnI  concentrations  the  fluorescence 
timecourses  had  the  expected  downward  curvature  attributable  to  progressive 
methyltransferase  inactivation.  By  contrast,  at  low  DpnI  concentration  the  rate  of 
fluorescence  change  increased  as  the  assays  progressed.  This  was  due  to  the 
accumulation of fully methylated ODN 3 in the opening minutes of the assay, driving 
the DpnI active sites towards saturation point. The two types of curve were typified by 
the background subtracted fluorescence timecourses of the assays with 1 and 10 U of 
DpnI (Figure 2.28, lower graph).  
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Figure  2.28  Fluorescence  timecourses  of  Dam  activity  assays  (triplicate  averaged). 
(Upper Graph) Assays contained DpnI (0  (black), 1 (purple), 3 (blue), 5 (green), 8 
(grey) or 10 U (red)), oligonucleotide 3 (33 nM), Dam 0 or 2 nM (dashed and solid lines 
respectively) and AdoMet (5  M). (Lower Graph) Timecourses for assays containing 
1 U (purple) and 10 U (red) of DpnI with background subtracted. 
 
The complementary set of experiments with variable Dam and fixed DpnI concentration 
were  carried  out.  DpnI  was  fixed  at  1  U  in  all  of  the  assays  whilst  the  Dam 
concentration varied between 0 and 4 nM (Figure 2.29). Chapter 2 
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Figure  2.29  Fluorescence  timecourses  of  Dam  activity  assays  (triplicate  averaged). 
Assays contained Dam (0 (black), 1 (purple), 1.5 (dark blue), 2 (light blue), 2.5 (dark 
green), 3 (light green), 3.5 (grey) or 4 nM (red)), DpnI (1 U), ODN 3 (33 nM), and 
AdoMet (5  M). 
 
Because the DpnI concentration was low, all of the Dam concentrations assayed yielded 
fluorescence timecourses with some upward curvature. At higher Dam concentrations 
the curvature became more pronounced. Raising the Dam concentration from 1 – 3 nM 
increased steady state concentrations of the fully methylated DpnI substrate leading to 
faster ODN 3 cleavage. Increasing Dam concentration above 3 nM had little effect on 
the assays, presumably because there was already enough to completely saturate the 
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2.4 Summary and conclusions 
 
Y.  pestis  Dam  was  expressed  and  purified  from  E.  coli  strain  GM215  harbouring 
plasmid pRJW421307. Previous work by Dr. R. Wood had shown the enzyme to be 
unstable, even at 4 °C over long periods of time. This problem was surmounted by use 
of a short purification procedure in which the protein was kept as cold as possible. 
Enough Dam was obtained to permit development of the activity assay. 
 
The restriction  enzyme  DpnI was  expressed and purified from E. coli  strain GM48 
harbouring plasmid pMMS495859. Evidence had suggested that DpnI was subject to 
proteolytic degradation during purification. Choice of an appropriate expression strain 
and use of protease inhibitors were therefore necessary to ensure production of high 
quality restriction endonuclease.  
 
A real time, fluorescence based, coupled enzyme assay for Yersinia pestis Dam was 
successfully developed. Two design features of the oligonucleotide were found to be 
important for assay efficacy. Firstly, the position of the fluorophore and quencher pair 
adjacent to one another on the hairpin stem, which leads to a large fluorescence change 
upon oligonucleotide cleavage. Secondly, the methylation pattern, which ensures that 
only one methylation per oligonucleotide is necessary to form the substrate which is 
rapidly cleaved by DpnI. Other researchers developing a similar E. coli Dam activity 
assay did not make this final development (6). 
 
Specificity of the DpnI restriction enzyme for fully methylated substrate was enhanced 
by optimisation of salt concentration. Provided that sufficient amounts of DpnI were 
used,  the  real time  fluorescence  increases  observed  in  the  assay  were  found  to  be 
proportional to the amount of methyltransferase present. Fluorescence timecourses in 
which  this  was  not  the  case  and  DpnI  was  rate  limiting  could  be  identified  by  a 
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3  Chapter 3 
 
Chapter 3:  Kinetic analysis of Y. pestis Dam and validation of 
the assay 
 
3.1  Introduction 
 
The fluorescence based assay which had been developed appeared to provide a real time 
measure  of  Dam  activity.  To  gain  additional  evidence  for  this  and  demonstrate 
functionality, the assay was used to perform a kinetic analysis of Y. pestis Dam with its 
two  substrates.  A  study  of  the  known  Dam  inhibitor,  S adenosylhomocysteine,  was 
carried out to demonstrate that the assay was also useful for probing the kinetics of 
enzyme inhibition. Furthermore we sought to show that the assay was suitable for high 
throughput screening of compound libraries by validating it in 96 well format. This 
chapter describes the use of the assay to study the kinetics of methylation by Y. pestis 
Dam and its validation for high throughput screening.   
 
3.2  Kinetic analysis of Y. pestis Dam 
 
3.2.1  Calibration of oligonucleotide fluorescence 
 
In  order  that  fluorescence  increases  measured  with  the  assay  might  be  related  to 
methylation rate, a calibration experiment was carried out. Known concentrations of 
oligonucleotide FM ODN 3, a fully methylated analogue of the DNA substrate used in 
the assay, were subjected to cleavage with DpnI. Fluorescence of the DNA solutions 
was measured before and after cleavage (Figure 3.1). Subtraction of the pre cleavage 
from post cleavage fluorescence gave the increase following restriction by DpnI (Figure 
3.1,  lower  graph).  A  calibration  plot  of  fluorescence  increase  against  DNA 
concentration  was  fitted  well  by  a  straight  line  of  gradient  9268  ±  294  arbitrary 
units nM
 1 (R
2 = 0.996). This calculated gradient allowed the conversion of fluorescence 
increases, measured under the same conditions, into amount of substrate turned over. 
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Figure 3.1 Calibration plots showing the relationship between fluorescein fluorescence 
and oligonucleotide concentration (gain 200, λ  excitation = 486 nm, λ  emission = 518 nm, 
bandwidths 5 nm). Solutions contained 0, 0.5, 1, 2, 3 and 3.5 nM FM ODN 3. (Upper Chapter 3 
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graph) averaged raw fluorescence data from wells containing FM ODN 3 exposed to 
10 U of DpnI. (Middle graph) fluorescence of FM ODN 3 before (filled circles) and 
after (open circles) exposure to restriction enzyme DpnI. (Lower graph) Increase in FM 
ODN 3 fluorescence following exposure to DpnI. 
 
Using the calibration plot and the standard deviation in the plate reader fluorescence 
measurements, the assay sensitivity was estimated. In each of the six assays containing 
3.5 nM FM ODN 3, the standard deviation in the fluorescence measurements between 
600 and 1200 s was on average 579 arbitrary units (three standard deviations = 1738 
arbitrary units). It was assumed that DpnI had cleaved all of the oligonucleotide before 
600 s and that variations in the fluorescence measurements were due to the imprecision 
of the plate reader (Figure 3.1, upper graph). Since three standard deviations represents 
a 99.73 % confidence limit it may be said that there is only a 0.27 % chance that a 
measured fluorescence change of 1738 arbitrary units in a single assay is due to plate 
reader imprecision. This fluorescence increase corresponds to cleavage of 37.5 fmol of 
oligonucleotide.  Combining  several  replicate  measurements  increases  the  assay 
sensitivity. From the same data it was estimated that averaging measurements from six 
assays  increases  the  sensitivity  to  13.2  fmol.  Roth  and  Jeltsch  have  reported  a 
radioactive assay capable of measuring the incorporation of 0.8 fmol of methyl groups 
into DNA (1). In theory, the fluorescence based assay could be optimised in 384 well 
format to detect as little as 0.17 fmol of DNA methylation and cleavage. This theoretical 
limit  is  based  on  the  typical  sensitivity  of  modern  plate  readers  (BMG  POLARstar 
Omega 0.2 fmol / well fluorescein, Tecan Infinite M1000 0.17 fmol / well fluorescein). 
 
3.2.2  Investigation of Y. pestis Dam stability 
 
During  purification,  Y.  pestis  Dam  was  observed  to  readily  inactivate  so  it  was  of 
interest to study the kinetics of this process and the effect of the substrates upon it. Dam 
was incubated at 30 °C for between 0 and 500 seconds under three sets of conditions; 
without substrates, with 30 nM ODN 3 or with 120  M AdoMet. Aliquots of enzyme 
were taken periodically and assayed for activity. Activity data were fitted to a single, 
two parameter exponential decay, y = ae
–kinactt, to obtain values for the rate of Dam 
inactivation (kinact) and subsequently half life, since t1/2 = ln2 / kinact (Figure 3.2).  Chapter 3 
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Figure  3.2.  A  plot  showing  the  measured  activity  of  Y.  pestis  Dam  following  pre 
incubation  at  30  °C  for  between  0  and  500  seconds.  Dam  was  incubated  without 
substrates  (filled  circles),  with  120   M  AdoMet  (open  circles)  and  with  30  nM 
oligonucleotide (filled triangle). Activity is expressed as percentage activity of Dam 
which was not pre incubated.  
 
Dam was highly unstable when incubated alone at 30 °C, with a half life of 42.5 ± 7.5 s 
(Figure 3.2). Protection of enzyme activity was afforded by both of the substrates in 
solution. AdoMet increased the half life four fold to 170.5 ± 16.5 s but DNA had the 
greater effect giving a half life of over 2300 s. Dam is not the first methyltransferase 
which  has  been  observed  to  be  unstable.  The  Caulobacter  crescentus  cell  cycle 
regulated adenine MTase (CcrM) was found to have a half life of 300 s at 30 °C and 
was also stabilised by DNA  (2). A truncated S. typhimuirium Dam mutant has also 
displayed temperature sensitivity  (3). 
 
3.2.3  The effect of S adenosylmethionine concentration on Dam activity 
 
The dependence of Dam activity on AdoMet concentration was measured in sets of 
assays at two different temperatures, 30 °C and 37 °C. Dam activity was measured at 
seven  different  concentrations  in  triplicate  (Figure  3.3).  For  simplicity  the  DNA 
substrate was kept at a fixed concentration that was assumed to be saturating (33 nM).  Chapter 3 
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Figure  3.3  Fluorescence  timecourses  from  Dam  activity  assays  used  to  measure 
KM 
AdoMet.  Data  shown  is  averaged  from  triplicate  assays.  Assays  contained  33  nM 
ODN 3, 1 nM Dam, 10 U DpnI and 2.5, 5, 10, 20, 40, 100 and 200  M AdoMet, (upper 
graph) 30 °C, (lower graph) 37 °C. 
 
Fluorescence increases due to methylation were faster at 37 °C than 30 °C however the 
methylation  rate  was  seen  to  reduce  over  the  timecourse  at  the  higher  temperature, 
indicating a higher rate of enzyme inactivation. At both temperatures, methylation rates 
were increased by higher AdoMet concentrations. Plots of the methylation rate against 
AdoMet  concentration  were  in  accordance  with  a  Michaelis Menten  mechanism  of 
enzyme action, ignoring the effect of DNA concentration (Figure 3.4, Figure 3.5) (4). 
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Figure 3.4 Derivation of the Michaelis Menten equation from the Michaelis Menten 
mechanism  of  enzyme  action.  In  this  mechanism  an  enzyme  substrate  complex  is 
formed first. The substrate is either then released from the complex or converted into 
product. The rate of product formation is given by equation (2). Using the steady state 
approximation (3) it is possible to obtain equation (4) which gives the concentration of 
enzyme substrate complex in terms of the free enzyme and substrate concentrations. 
Using the assumptions that [E]0 = [E] + [ES] and [S] ≈ [S]0 where a large excess of 
substrate  over  enzyme  is  used  equation  (5)  may  be  obtained.  Substituting  this 
expression for [ES] into equation (2) gives equation (6), the Michaelis Menten equation. 
Using  the  fact  that  Vmax  =  k2[E]0  and  the  Michaelis  constant  KM  =  (k 1+k2)/k1  = 
[E][S]/[ES] the Michaelis Menten equation may be re written (7). Chapter 3 
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Figure 3.5 The dependence of Dam activity on AdoMet concentration at 30 °C (filled 
circles) and 37 °C (open circles). Initial rate measurements were based on the first 180 s 
of the fluorescence timecourses. 
 
 
Data were fitted to the Michaelis Menten equation (v = Vmax [AdoMet] / (KM 
AdoMet + 
[AdoMet]) to obtain values for KM 
AdoMet and kcat. At 37 °C, KM 
AdoMet and kcat were 
found to be 11.3 ± 0.6  M and 0.55 ± 0.01 min
 1 (Vmax = 284.3 ± 4.3 pmol mg
 1 s
 1) 
respectively. At the lower temperature of 30 °C, KM 
AdoMet and kcat were found to be 
10.3 ± 0.7  M and 0.35 ± 0.01 min
 1 (Vmax = 181.9 ± 3.3 pmol mg
 1 s
 1) respectively.  
 
This  non linear  curve  fitting  method  of  KM  determination  was  used  because  it  was 
simple and avoided the plotting of reciprocals which can bias data. The 37 °C rate data 
was  however  also  analysed  with  Lineweaver Burk,  Eadie Hofstee  and  Hanes Woolf 
plots to allow a comparison of the respective KM and Vmax values (Figure 3.6, Figure 
3.7, Figure 3.8). Within error all of these alternative plots yielded the same Vmax and 
KM 
AdoMet as obtained from the fit of the Michaelis Menten equation to the data. The 
Lineweaver Burk and Hanes Woolf plots gave the highest and lowest values for the KM 
respectively. On both of these plots the data points were unevenly distributed and the 
KM was derived from extrapolation of the data to the x axis. 
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Figure  3.6  A  Lineweaver Burk  plot  of  the  Dam  activity  data  used  to  determine 
KM 
AdoMet at 37 °C (R
2 = 0.99). The x axis intercept =  1 / KM 
AdoMet. KM 
AdoMet was 
determined as 12.6 ± 1.1  M from this intercept. The y axis intercept = 1 / Vmax. From 
this intercept Vmax was determined as 294.1 ± 18.4 pmol mg
 1 s
 1. 
Initial rate (pmol mg
-1s
-1) / [AdoMet]  M





































Figure 3.7 An Eadie Hofstee plot of the Dam activity data used to determine KM 
AdoMet 
at 37 °C (R
2 = 0.99). The gradient of the line =   KM 
AdoMet. KM 
AdoMet was determined as 
11.9 ± 0.6  M. The y axis intercept is equal to Vmax which was determined as 287.5 ± 
6.5 pmol mg
 1 s
 1.  Chapter 3 
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Figure 3.8 A Hanes Woolf plot of the Dam activity data used to determine KM 
AdoMet at 
37 °C. The x axis intercept =   KM 
AdoMet. KM 
AdoMet was determined as 10.6 ± 0.8  M. 





3.2.4  The effect of DNA concentration on Dam activity 
 
The dependence of Dam activity on oligonucleotide concentration was studied in a set 
of assays at 37 °C. Methylation rates were measured in triplicate at seven different 
oligonucleotide  concentrations.  For  simplicity  the  AdoMet  was  kept  at  a  fixed 
saturating concentration of 120  M.  Fluorescence increases obtained from the assays 
were small and quickly levelled off throughout the timecourse (Figure 3.9). This fits in 
with  previous  observations  that  the  methyltransferase  was  unstable  without  DNA. 
Fluorescence  increases  were  greatest  in  the  assays  which  contained  the  highest 
concentrations of DNA. 
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Figure 3.9 Fluorescence timecourses from Dam activity assays used to measure KM 
DNA. Data shown is averaged from triplicate assays. Assays contained 0.31 nM Dam, 
10 U DpnI, 120  M AdoMet and 0.5, 1.5, 2.5, 3.5, 4.5, 5.5 and 6.5 nM ODN 3. 
 
Methylation rate was plotted against concentration of ODN 3 (Figure 3.10). Data were 
fitted to the Michaelis Menten equation to obtain a value for KM 
DNA which was found to 
be 3.4 ± 1.8 nM. The large error in this value is due to the relatively poor fit of the data 
to the equation (R
2 = 0.91) which can be attributed to the instability of the enzyme 
under  the  assay  conditions.  At  low  DNA  concentration  the  assay  will  tend  to 
underestimate methyltransferase turnover. 
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Figure 3.10 The dependence of Dam activity on DNA concentration at 37 °C. Initial 
rate measurements were based on the first 180 s of the fluorescence timecourses.  
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3.2.5  Inhibition of Dam by S adenosylhomocysteine 
 
To  demonstrate  the  ability  of  the  assay  to  probe  the  kinetics  of  enzyme  inhibition, 
experiments were carried out using AdoHcy, a known Dam inhibitor. AdoHcy, an end 
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Figure 3.11 Modification of the Michaelis Menten mechanism of enzyme action by a 
competitive inhibitor. The enzyme can bind the substrate to form the enzyme substrate 
complex (1) or the inhibitor to form an unproductive enzyme inhibitor complex (2). An 
equilibrium exists between E, ES and EI. The apparent KM of the enzyme and substrate 
= KM(1 +([I]/Ki)).   
 
With the goal of determining Ki 
AdoHcy, assays were carried out with seven inhibitor 
concentrations at seven AdoMet concentrations (Figure 3.12). Initial rate data was used 
to produce a series of double reciprocal plots (Figure 3.12, upper graph) with gradient = 
KM.app  /  Vmax  and  y axis  intercept  =  1  /  Vmax.  As  expected  for  a  series  of  double 
reciprocal plots at a range of competitive inhibitor concentrations, all of the lines fitted 
to the data intersected the y axis at the same point (Figure 3.12, Table 3.1). Regardless 
of the AdoHcy concentration, the same Vmax is reached as the AdoMet concentration 
rises towards infinity. Data derived from this graph was used to construct a plot of 
apparent KM (KM.app) against inhibitor concentration (Figure 3.12, lower graph). The 
negative of the x axis intercept of this plot yielded Ki 
AdoHcy which was found to be 6.93 
± 2.01 M. 
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Figure 3.12 Inhibition of Dam by AdoHcy. (Upper graph) Double reciprocal plots of 
methylation rate against AdoMet concentration. Assays contained 1 nM Dam, 10 U 
DpnI and 33 nM ODN 3. AdoHcy concentrations were 0, 5, 10, 15, 20, 30 and 40  M 
and AdoMet concentrations were 20, 25, 30, 40, 70, 140 and 200  M. (Lower graph) 
Apparent KM 
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[AdoHcy]  M  y axis intercept  Vmax (pmol mg
 1 s
 1) 
0  0.0034 ± 0.0003  294.1 ± 28.5 
5  0.0033 ± 0.0004  303.0 ± 41.8 
10  0.0037 ± 0.0004  270.3 ± 32.8 
15  0.0039 ± 0.0005  256.4 ± 37.7 
20  0.0037 ± 0.0004  270.3 ± 32.8 
30  0.0041 ± 0.0007  243.9 ± 50.2 
40  0.0042 ± 0.0009  238.1 ± 64.9 
Table 3.1 The y axis intercepts (= 1 / Vmax) and corresponding Vmax values derived 
from the double reciprocal plots used to determine Ki 
AdoHcy. 
 
Four kinetic parameters of Y. pestis Dam were measured using the coupled enzyme 
assay (Table 3.2). For comparison, the same kinetic parameters of eight other DNA 
methyltransferases are included in the table. E. coli, T4 and T2 Dam, also target adenine 
in the sequence GATC. C. crescentus CcrM and M.EcoRV, methylate the underlined 
adenine within the sequences GANTC and GATATC respectively. M.HhaI and M.MspI 
are C5 cytosine MTases which target the first cytosine in the sequences GCGC and 
CCGG respectively. M.BamHI is an N4 cytosine MTase targeting the first cytosine in 
























Substrate  kcat (min









E. coli Dam 
(5)  ds20 mer  0.93 ± 0.06  17.4 ± 3.0  5.60 ± 1.1  41.6 ± 10.4 
  16 bp hp UM  1.19 ± 0.33  28.6 ± 0.2  6.40 ± 1.2    
(6) 
a  ds14 mer HM  1.25 ± 0.27  25.5 ± 5.2  1.5 ± 0.1    
  ds14 mer HM  0.93 ± 0.52  44.8 ± 18.6  3.5 ± 0.2    
(7)  plasmid DNA  3.6 
b     6.5 ± 0.7 
b  7.0  ± 0.5 
b 
           3.0 ± 1.5 
c  2.5 ± 2 
c 
(8)  ColE1 DNA  19  3.6  12.2    
    T4 Dam 
(9)  T4 DNA  8.4  0.0011  0.1  2.4 
(10)  ds24 mer UM  0.84 ± 0.18  7.7 ± 2.1  0.33    
    T2 Dam 
(11)  T4 DNA  18.6  0.0011  0.1  2.4 
Y. pestis Dam 
(12)*  10 bp hp HM  0.55 ± 0.01  3.4 ± 1.8  11.3 ± 0.6  6.9 ± 2.0 
   M.EcoRV 
(13)  ds20 mer UM  0.065  300  12    
     CcrM 
       (2) 
b  ds45/50 mer 
HM 
0.02          
    M.HhaI 
(14)  polydGdC  1.3  2.3  0.015  0.002 
    M.MspI 




  M.BamHI 
(16)  ds20 mer UM  3.18 ± 0.18  196 ± 50  1.22 ± 0.25    
Table  3.2  Kinetic  parameters  of  selected  DNA  methyltransferases.  ds  =  double 
stranded, hp = hairpin, UM = unmethylated, HM = hemimethylated.
a Measurements 
made at 6 °C. 
b Measurements made at 30 °C.
c Measurements made at 8 °C.* This 
study. Chapter 3 
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Y. pestis Dam turnover was measured as 0.55 min
 1 with the coupled enzyme assay. 
This is plausible based on a comparison with values reported for E. coli and T4 Dam 
with similar substrates (Table 3.2). Longer DNA substrates, containing several GATC 
sites, permit processive methylation which allows a higher rate of enzyme turnover (3.6 
– 19 min
 1, E. coli Dam, Table 3.2). Due to its instability it is probable that not all of the 
Y. pestis Dam was active in the assays used to determine kcat. The value of 0.55 min
 1 
would therefore be an underestimate, with the true value even closer to that of T4 and 
E. coli Dam. It has been shown that T4 Dam loses none of its activity when incubated at 
37 °C for 30 minutes even without its substrates (11). E. coli Dam is probably also more 
stable  than  Y.  pestis  Dam.  Both  enzymes  have  a  high  degree  of  similarity  to 
S. typhimurium Dam but Y. pestis Dam has a C terminus which is shorter by nine amino 
acids (Table 3.3). It has been shown that truncation of the C terminus of S. typhimurium 
Dam by ten amino acids renders the protein temperature sensitive (3). Interestingly a 
methyltransferase which has 95 % of the amino acids found in Y. pestis Dam and an 
additional seven amino acids on the C terminus is encoded in Yersinia rohdei (Table 
3.3).  
 
MTase  Sequence at C Termini 
Wt S. typhimurium Dam  RKKVDELLALYQPGVATPARK 
E. coli Dam  RKKVDELLALYKPGVVSPAKK 
Y. rohdei Dam  RSKVNELLALYSCAETAAQ 
Y. pestis Dam  RSKVNELLALYS 
Ts S. typhimurium Dam  RKKVDELLALY 
Table 3.3 A comparison of the C termini of selected Dam MTases. Wt = wild type. Ts 
= temperature sensitive. 
 
Y. pestis Dam turnover is considerably faster than that of regulatory MTase CcrM or 
M.EcoRV but six times slower than M.BamHI. At 10 bp, the Y. pestis Dam assay 
substrate is one of the shortest used to measure the activity of a methyltransferase. It is 
possible that a longer substrate, still containing just one GATC site, would allow faster 
Y.  pestis  Dam  turnover.  M.EcoRV  turnover  rates  are  strongly  effected  by  DNA 
substrate length. Jeltsch and co workers found that doubling the substrate length from 
12 to 24 bp resulted in a fourfold increase in kcat  (13). They postulated that this rate Chapter 3 
  73
increase was due to altered electrostatic properties, the increased order of longer DNA 
duplexes and the influence of the DNA outside of the target sequence on the kinetic 
mechanism of the enzyme (13). 
 
At 11.3  M the Y. pestis Dam KM 
AdoMet was within the range of values reported for E. 
coli Dam and very close to the measured value for M.EcoRV. By contrast T4 and T2 
phage Dam have a KM 
AdoMet which is 30 100 times lower (Table 3.2). Tight substrate 
binding may be particularly advantageous for the phage enzymes as it would help them 
compete  for  resources  within  the  host  cell.  The  two  bacterial  C5 cytosine  MTases 
M.HhaI and M.MspI also have a very high affinity for AdoMet when compared to Y. 
pestis Dam.  
 
At 3.4 nM the Y. pestis Dam KM 
DNA was significantly lower than values reported for E. 
coli or T4 Dam with oligonucleotide substrates. The error on the measurement was 
high, but this was a reflection of enzyme instability rather than a weakness in the assay 
strategy. This instability may also account for the low KM 
DNA. It was shown that the 
substrate DNA stabilises the enzyme by a factor of fifty (Figure 3.2). A high affinity for 
the genomic DNA would therefore help to preserve Y. pestis Dam. Use of a lower 
temperature  in  the  Y.  pestis  Dam  assay  might  serve  to  allow  a  more  accurate 
determination of KM 
DNA. Marzabal and co workers have measured E. coli Dam activity 
at just 6 °C but the coupled assay is limited by the temperature needed to rapidly melt 
the DpnI digested substrate and separate the FRET pair (6).  
 
The Y. pestis Dam Ki 
AdoHcy was measured as 6.9  M with the assay, demonstrating its 
efficacy in probing the kinetics of Y. pestis Dam inhibition. The Ki is similar to those 
reported in the literature for E. coli Dam (Table 3.2). Because Dam is unstable at low 
oligonucleotide  concentrations,  the  assay  may  not  perform  as  well  if  used  to  study 
inhibitors which are competitive with DNA. 
 
 
3.3  Assay validation in high throughput format 
 
Before embarking on high throughput screening we sought to quantify the robustness of 
the assay in 96 well format. The Z’ parameter, a simple statistical parameter developed Chapter 3 
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by Zhang and co workers for the validation of high throughput screening assays, was 
used to this end (17). The Z’ parameter takes into account the signal of the assay ( C+  
  C ) and the standard deviation in the data generated (3σC+ + 3σC ) (Equation 3.1). 
Scores between 0.5 and 1 indicate an excellent assay whilst scores less than 0 show the 

















   
σ σ 3 3
1 '  
Equation 3.1 The equation for calculation of the Z’ parameter. σ = standard deviation, 
  = average, C+ = positive control signal, C  = negative control signal. 
 
Ideally,  high  throughput  screening  conditions  would  have  used  both  substrates  at 
concentrations near to their respective KM’s (KM 
AdoMet = 10.3 ± 0.7  M, KM 
DNA = 3.4 ± 
1.8 nM). This minimises assay bias toward detection of competitive, uncompetitive or 
noncompetitive  inhibitors  and  so  helps  identify  lead  compounds  with  a  variety  of 
modalities (18 21). Y. pestis Dam instability prohibited such a low DNA concentration 
and so 33 nM ODN 3 and 5  M AdoMet were used. Consequently the assay was biased 
against  compounds  competitive  with  DNA  and  toward  Adomet  competitive  or 
uncompetitive inhibitors binding the initial non specific enzyme DNA complex (5,22). 
Dam activity was measured with these substrate concentrations, at 30 °C, in three 96 
well plates containing an even mixture of assays and negative controls lacking Dam. 
Initial rates of fluorescence increase were plotted against well number for each plate of 
assays (Figure 3.13). A temperature of 30 °C was used rather than 37 °C to minimise 
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Well number































































































































































Figure 3.13 High throughput assay validation. Rates of fluorescence increase are shown 
plotted against well number for three 96 well plates. Solid red lines show the mean rates 
for positive and negative control datasets. Dashed lines indicate ± 3 standard deviations 
from the mean. Assays contained 33 nM ODN 3, 5  M AdoMet, 5 U DpnI and 2 nM 
Dam except for negative controls, which lacked Dam. 
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Some clustering of assay data into sets of 12 wells was observed (Figure 3.13, upper 
graph, middle graph and lower graph negative controls). Within these sets, measured 
rate would increase with well number, the rate then dropped and the pattern repeated in 
the next set. Robotic initiation of the assays, column by column, with an eight channel 
pipette was the likely cause of this systematic trend. Assays initiated later produced 
faster rates because the enzymes were more active. This trend was however sometimes 
masked by other factors, possibly temperature variations across the assay plate (Figure 
3.13, lower graph positive controls). 
 
Data were used to calculate the Z’ parameter for each of the assay plates according to 
equation 3.1 (Table 3.4). Based on an average of these values, the Z’ parameter for the 
assay in 96 well format was found to be 0.71 ± 0.07. This indicated an excellent assay, 
suitable for high throughput screening. 
 
Data Set (Figure 
3.11) 
 C+   C   3σC+  3σC   Z’ 
Upper  37.86  6.57  4.32  2.20  0.79 
Middle  40.95  9.95  5.62  3.86  0.69 
Lower  37.36  10.07  6.46  3.03  0.65 
Table 3.4 Data gathered for validation of the assay in high throughput format.  
 
Mashhoon  and  co workers  have  carried  out  the  largest  literature  reported  high 
throughput screen for Dam inhibitors (23). They do not detail a quantitative validation 
of the discontinuous assay which they used. Since it operates on a similar principle to 
the Y. pestis Dam assay and uses a FRET pair labelled oligonucleotide, it would be 
reasonable to expect it to have a similar Z’ parameter.  
 
 
3.4  Summary and conclusions 
 
A  calibration  plot  was  produced  to  allow  fluorescence  signals  to  be  converted  into 
methylation rates. From this calibration data it was also estimated that the assay could 
detect as little as 37.5 fmol of methylation. Experimental results confirmed the previous Chapter 3 
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observation that Y. pestis Dam inactivated rapidly. This inactivation was slowed when 
Dam was incubated with substrate DNA. Consequently, the assay setup procedure was 
optimised to minimise the time which Dam spent in solution without DNA.  
 
The KM of both substrates, Ki 
AdoHcy and the maximum rate of Y. pestis Dam turnover 
were  determined  using  the  assay  and  judged  to  be  reasonable  (Table  3.2).  Enzyme 
instability resulted in a larger error on the KM 
DNA measurement at low oligonucleotide 
concentrations. 
 
A validation of the Y. pestis Dam activity assay in 96 well format was carried out. The 
Z’  parameter  of  0.71  showed  that  it  was  an  excellent  assay,  suitable  for  the  high 
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4  Chapter 4 
 





Following the successful assay development and validation in high throughput format 
the next objective was to screen a compound library and identify novel Dam inhibitors. 
Library  1  was  a  commercial  collection  of  potential  kinase  inhibitors.  Many  kinase 
inhibitors target the adenine binding pocket and so might also hit the AdoMet or DNA 
base binding pockets of Dam. These compounds were screened, using the real time 
fluorescence based assay, for activity against Y. pestis Dam. Identified inhibitors were 
to be synthesised in sufficient quantity to allow counter screening against other DNA 
binding enzymes to assess selectivity. The initial tests for selectivity would involve a 
counter screen against the restriction enzyme DpnI and measurement of the ability of 
the  compounds  to  bind  DNA.  This  chapter  describes  the  screening  process  and 
subsequent synthesis and analysis of hit compounds.  
 
4.2 High throughput screening of library 1 
 
4.2.1 Data collection and analysis 
 
Library compounds were each screened twice for activity against the Y. pestis DNA 
adenine methyltransferase. Compounds were assayed at 30 °C in batches of 80 in the 
middle columns of a 96 well plate at a concentration of 100  M. This layout was a 
reflection of the typical storage format of library compounds in 96 well plates (1). The 
remaining 16 wells, in columns 1 and 12, contained 4 positive and negative controls 
with  and  without  AdoMet  and  8  controls  having  100   M  of  the  known  inhibitor 
AdoHcy. Average rates of fluorescence increase during the first 675 s of the assay were 
calculated based on the gradient of a straight line fitted to the raw data (Figure 4.1). This 
average was used for subsequent data analysis and hit evaluation. The period chosen Chapter 4 
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reflects the time it took fluorescence signals to span the measurement  range of the 
instrument under the assay conditions used. At the end of this time Y. pestis Dam had 
typically carried out 1.5 – 2 turnovers and 10 – 15 % of the DNA substrate had been 
consumed. Most compounds from the library were successfully screened in this way, 
the  exception  being  compounds  with  a  large  inherent  fluorescence  at  the  emission 
wavelength of fluorescein. These types of compound were however a rare occurrence 
with  only  4  being  prohibitively  fluorescent  in  the  1000  tested.  Details  of  which 
compounds were fluorescent and how data was manipulated to compensate are included 
as an appendix (appendix D). 
Time (s)










































Figure 4.1 Example raw data obtained from one row of assays. Ten of the assays shown 
contained a library compound (grey circles joined by black lines), one lacked AdoMet 
(dotted red line) and one contained the known Dam inhibitor AdoHcy (solid blue line). 
 
Initial rates derived from the raw data were tabulated to make them suitable for further 
analysis with the programme HTS corrector (Table 4.1) (2). Control assays were used to 
check  assay  performance  but  were  omitted  from  the  subsequent  analysis  and  hit 
selection. Based on the four positive and negative controls the average Z’ parameter 
within a plate was 0.79 ± 0.12, indicative of an excellent assay. For the whole library 
screen, considering all 100 positive and negative controls together, the Z’ parameter 
was  just  0.35  (Figure  4.2).  These  two  Z’ parameters  indicate  that  there  was  good 
reproducibility in the assay data within one row of one plate but large plate to plate 
variations. 
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6130  2  3  4  5  6  7  8  9  10  11 
A  36.4  38.7  37.3  38.7  39.7  41.0  39.5  39.4  44.2  39.8 
B  37.4  38.1  36.8  39.2  39.8  39.6  44.3  36.6  39.1  39.1 
C  39.7  37.4  40.8  37.7  39.9  39.5  38.6  38.3  37.7  38.3 
D  34.8  37.8  40.3  38.3  42.4  41.0  39.2  37.6  38.8  36.8 
E  34.6  36.1  47.0  36.1  36.9  41.2  39.4  41.9  38.7  36.6 
F  35.3  36.9  37.7  38.2  37.4  37.2  37.9  37.7  36.3  35.3 
G  35.2  34.3  36.2  35.1  37.2  36.0  39.1  37.2  37.6  37.9 
H  33.5  35.9  37.5  37.0  41.0  41.0  35.2  38.0  38.2  34.5 
Table 4.1 Tabulated data obtained from a screen of compounds in library plate 6130. 
Each well position was assigned a single number based on the rate of fluorescence 
increase measured in the assay. 
Control number






















































Figure 4.2 Measured rates of fluorescence increase in positive and negative controls 
carried out during the HTS. Positive and negative control assay data is denoted with 
grey and white circles respectively. The mean averages and 3 σ limits are shown with 
solid red and dashed black lines respectively. 
 
Raw screening data for the compound containing assays appeared in distinct clusters 
(Figure 4.3). This arrangement of the data was caused by the inconsistencies between 
different batches of assay mix, different assay runs and different locations on the plate. 
The data as a whole was moderately well fitted by a normal distribution (R
2 = 0.979) 
(Figure 4.4). Deviation from this distribution was found to be due to the plate 6132 and 
6134  repeat  screening  data  (compound  160 240  and  320 400  green  circles),  which Chapter 4 
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contained atypically low rates. A frequency versus rate plot with this data removed was 
very well fitted by a normal distribution (R
2 = 0.993) (Figure 4.5). 
Compound number


























































Figure  4.3  Unprocessed  data  from  the  duplicate  screen  of  compound  library  1. 
Measured rate of fluorescence increase is shown for each of the 1000 compounds. Data 
from the first and repeat round of screening are shown with blue squares and green 
circles respectively. The mean and 3 σ limit are denoted with horizontal black and red 
lines. 
Rate of fluorescence increase (arb units s-1)
















Figure 4.4 Distribution of unprocessed data from the duplicate screen of compound 
library  1.  Data  is  shown  by  filled  circles  and  the  fit  of  a  three  parameter  normal 
distribution by a black line. Chapter 4 
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Rate of fluorescence increase (arb units s-1)
















Figure 4.5 Distribution of unprocessed data from the duplicate screen of compound 
library 1 without data from plate 6132R (compounds 160 240) and 6134R (compounds 
320 400).  Data  is  shown  by  filled  circles  and  the  fit  of  a  three  parameter  normal 
distribution by a black line. 
 
The large standard deviation caused by patterns in the data masked the true effect of 
compounds  on  Dam  activity.  A  simple  3  σ  hit  detection  threshold  represents  the 
99.73 % confidence level and is frequently used in HTS (3). To make the assay data 
suitable for hit selection in this manner it first had to be processed.  
 
Compound containing  assays  themselves  provided  the  most  abundant  source  of 
reference data for processing because the significant majority of compounds had no 
effect on the measured rates. It was felt to be imprudent to rely on the positive control 
assay data because it was comparatively sparse and all from one column of each plate. 
In retrospect, having only four positive controls in each assay plate was a mistake, 
typically eight positives are used and can be spread between columns 1 and 12 (1). Data 
processing methods which rely on control assay data were therefore not considered. 
 
There are several ways HTS data can be normalised to account for inter plate assay 
variations but one of the simplest methods, which was used to process this screening 
data, is Z score standardisation (1) (Equation 4.1). Plate averages are subtracted from 
the individual rates and this residual divided by the standard deviation of the plate data.   
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Z = (X    ) / σ 
 
Equation 4.1 The Z score standardisation equation used by HTS corrector. Z = Z score, 
X = rate of methylation measured in well,   = average rate of methylation within plate, 
σ = standard deviation of measured rates. 
 
HTS corrector was used to Z score standardise the data and evaluate background trends 
according to well number (Figure 4.6). Outliers greater than 3 σ from the mean were 
discounted from this background evaluation on the basis that they most likely contained 
compounds having an effect on the rate. 
 
 
Figure 4.6 Observed background trends in the assay data for the screen of compound 
library 1. Blue wells tended to yield assays whose rates were below average whilst red 
ones on balance gave above average rates. Intensity of colour reflects the strength of the 
effect. Wells H02 and A11 typically gave respective rates 0.8 σ below and 1 σ above the 
averages in the normalised dataset. 
 
As expected, based on the patterns in the HTS validation data discussed in chapter 
three, a column bias was observed in the data. Columns on the right of the plate, which 
were initiated later, tended to give higher rates (Figure 4.6). A row bias was also seen 
with rows nearest H giving the slowest rates of fluorescence increase. A speculative 
explanation for this is that wells nearest the front edge of the plate reader may have 
remained slightly colder than those at the back. Row E was an exception to this trend 
with a consistently higher average background than its neighbouring rows. A possible Chapter 4 
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explanation  for  this  is  that  the  multichannel  pipette  head  of  the  robot  may  have 
introduced slightly more enzyme into row E assays. 
 
Biases due to well position were removed by subtraction of this evaluated background 
to  give  processed  data  from  which  hit  compounds  were  more  readily  identifiable 
(Figure 4.7) 
Compound number

































Figure 4.7 Processed data from the screen of compound library 1. Data was subjected 
to  Z score  normalisation  and  background  subtraction.  Deviation  of  the  rate  of 
fluorescence  increase  from  the  mean  is  shown  versus  the  compound  number  being 
tested. Data from the first and repeat round of screening are shown with blue squares 
and green circles respectively. Two and three standard deviations above and below the 
mean are denoted with horizontal red lines. 
 
Three library compounds were identified as hits based on a 3 σ threshold (Figure 4.10). 
Assays containing compounds 638 (well H09, plate 6137), 920 (well D11, plate 6141) 
and 978 (well D04, plate 6142) all  yielded  rates below 3 σ in two separate  assays 
(Figure 4.7, Figure 4.8). Values in σ for these compounds were  3.6 ± 0.2,  4.3 ± 0.4 
and  4.9 ± 1 respectively. Additionally compound 966 (B02 6142) which yielded an 
average value of  2.4 ± 0.4 was deemed worthy of further study because of structural 
homology to two of the hits (Figure 4.10). Chapter 4 
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Compound number























































Figure 4.8 Selected processed data from the screen of compound library 1. Data was 
subjected to Z score normalisation and background subtraction. Deviation of the rate of 
fluorescence  increase  from  the  mean  is  shown  versus  the  compound  number  being 
tested. Data from the first and repeat round of screening are shown with blue squares 
and green circles respectively. Two and three standard deviations above and below the 
mean are denoted with horizontal red lines. (Upper Graph) Data from the screen of 
compounds in plate 6137 which contained one hit. (Lower Graph) Data from the screen 
of compounds in plate 6141 and 6142 which contained two hits and a compound of 
interest. 
 
Despite  normalisation  and  background  subtraction,  retrospective  inspection  of  some 
processed data revealed small unwanted trends were still present. An example of this 
can be seen in assay data on compound numbers 880 – 960 (Figure 4.8, lower graph). Chapter 4 
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Rates for the first forty of these compounds sit mostly above the mean whilst rates from 
the second forty are disproportionately below. 
 
An alternative, more complicated method for the processing of HTS data, which takes 
into account plate to plate and well to well variation, is B scoring (4,5). Whilst this was 
not originally used to process data and select hits, it was of interest to carry out a 
retrospective B score analysis as it has been described as a ‘robust analogue of the Z  
score’  (1).  B scoring uses median average estimates to correct for row and column 
biases within a plate and then differences between plates in the screen. HTS corrector, 
the software originally used to analyse screening data is also equipped with a B scoring 
function which was used to re process the raw data (Figure 4.9) 
Compound number



















Figure 4.9 B score processed data from the screen of compound library 1. B scores are 
shown versus the compound number. Data from the first and repeat round of screening 
are shown with blue squares and green circles respectively. Two and three standard 
deviations above and below the mean are denoted with horizontal red lines. 
 
Data processed in this way had no discernable residual trends so with hindsight B 
scoring  looks  to  be  a  superior  processing  method  which  is  preferable  to  Z scoring 
followed by background subtraction. Background subtraction from Z score normalised 
data relies on the assumption that well to well trends remain constant throughout the Chapter 4 
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course of the whole screen, in reality this may not be the case. If a simple 3 σ hit 
detection threshold were applied to the B scored data then compound 638 (H09 6137) 
would not have been classed as a hit. The remaining two hits and compound of interest, 
966 (B02 6142), would all have been classified as hits by this method. Importantly 
therefore, failure to process data by B score at the time of the screen did not result in 
compounds of interest being missed. 
 
4.2.2 ‘Hit’ structures 
 
Four compounds which comprised three true ‘hits’ and a compound of interest were 
taken through to the next phase of the project. Structures of these molecules could be 
divided  into  two  types.  Compound  638  (H09 6137)  was  unique  amongst  the  four, 
consisting of an imidazopyrazine core appended with pyridine and methylpiperazine 
rings.  The  three  remaining  compounds,  920  (D11 6141),  966  (B02 6142)  and  978 
(D04 6142) consisted of a pyrazine core attached directly to an aromatic ring and also to 


































Figure 4.10 Compounds from library 1 identified as potential inhibitors of Y. pestis 
Dam.  Structures  638  (H09 6137),  920  (D11 6141),  966  (B02 6142)  and  978  (D04 
6142) are shown from left to right respectively.  Chapter 4 
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Three  compounds  were  also  identified  in  the  library  which  consistently  raised  the 
measured rate of fluorescence increase above 3 σ. Compounds 43, 261 and 474 yielded 


























Figure 4.11 Structures of compounds identified as increasing the measured rates of 
fluorescence increase. Compounds 43 (E04 6130), 261 (C02 6133) and 474 (H05 6135) 
are shown from left to right respectively. 
 
Apart from the fact that all of these compounds contained one or more tertiary amines 
and a heterocycle there were no conserved structural motifs in the group. It was unclear 
how such compounds illicit the abnormally high fluorescence increases observed. A 
slow  intercalation  of  the  compounds  into  DNA  with  an  associated  change  in  the 
absorbance and emission spectra was one possible explanation. Another was that the 
compounds were actually interacting with the methyltransferase. An AdoHcy analogue, 
5’ S (Propionic  acid)5’ deoxy 9 (1’ β D ribofuranosyl)1,3 dideaza  adenine,  with  a 
limited activating effect on E. coli Dam has been reported in the literature but such 
compounds  are  rare  (6)  (Figure  4.12).  These  compounds,  whilst  curious,  were 
considered unlikely to be useful for the development of novel antibiotics and so were 











Figure  4.12  5’ S (Propionic  acid)5’ deoxy 9 (1’ β D ribofuranosyl)1,3 dideaza 
adenine. 
 
4.3 Synthesis and testing of ‘hits’ from the library screen 
 
4.3.1 Synthesis of compound H09 6137 
 






















     Coupling
2 H09-6137
 
Scheme  4.1  Synthetic  route  to  compound  H09 6137.  (i)  Nucleophilic  aromatic 
substitution:  Compound  1  (6,8 dibromoimidazo [1,2 a]pyrazine),  1 methylpiperazine 
(40  %  v/v,  aqueous),  room  temperature  overnight  under  N2.  (ii).  Suzuki  Coupling: 
Compound  2  (6 bromoimidazo 8 (1 methylpiperazine)[1,2 a]pyrazine),  pyridine 3 
boronic  acid  (1  eq),  tetrakis(triphenylphosphine)palladium(0)  (3  mol  %),  sodium 
carbonate (3 eq), 1,2 dimethoxyethane / water (3:1 v/v), reflux 8 hours under nitrogen. 
 
This approach was based on a patent covering the synthesis of certain kinase inhibitors 
(7).  Compound  2  (Scheme  4.1)  was  formed  by  selective  nucleophilic  aromatic 
substitution  of  compound  1  with  1 methylpiperazine  at  the  8  position  in  a  reaction 
similar to that used by Bonnet and co workers (8). Recrystallisation from hot hexane Chapter 4 
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gave the pure product, a beige powder in a moderate 64 % yield. Compound 2 was 
taken on in a standard Suzuki Miyaura cross coupling reaction with pyridine 3 boronic 
acid to give compound H09 6137, also a beige solid in 63 % yield (9 11). The yield for 
the two step synthesis of H09 6137 was therefore 40 %. 
 
4.3.2 Synthesis of compounds D11 6141, B02 6142 and D04 6142 
 
Initial attempts to form compound 5 (Scheme 4.3) from 2,5 dibromopyrazine, according 
to  a  patent  covering  the  synthesis  of  potential  kinase  inhibitors,  were  unsuccessful 
(Scheme 4.2) (12). It remains unclear why the nucleophilic aromatic substitution failed 


























Scheme 4.2 Initial proposed first step in the synthetic route to compounds D11 6141 
and  B02 6142.  Nucleophilic  aromatic  substitution:  2,5  Dibromopyrazine, 
N (4 aminophenyl) 4 methylbenzenesulfonamide (1 eq), N,N diisopropylethylamine (1 
eq), MeOH, 160 °C, 10 minutes. 
 
An alternative reaction considered for the formation of compound 5 was the Buchwald 
Hartwig amination (13,14) (Scheme 4.3). This palladium catalysed reaction can be used 
to form a C N bond between an aryl halide and amine starting material in the presence 
of  stoichiometric  amounts  of  base  (15).  The  reaction  mechanism  proceeds  with 
oxidative  addition  of  the  aryl  halide  onto  the  Pd(0)  centre,  formation  of  an 
arylpalladium amido complex and finally reductive elimination to form the C N bond 
(16,17). Developments have given the reaction a wide scope but its complexity means 
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Scheme  4.3  Synthetic  route  to  compounds  D11 6141  and  B02 6142.  (i)  Buchwald 
Hartwig  Amination:  Compound  4  (2,5 dibromopyrazine), 
N (4 aminophenyl) 4 methylbenzenesulfonamide  (1  eq),  caesium  carbonate  (1.4  eq), 
tris(dibenzylideneacetone)dipalladium(0) (2.5 mol % Pd), 4,5 bis(diphenylphosphino) 
9,9 dimethylxanthene (5 mol %), 18 crown 6 (10 mol %), 1,4 dioxane at 90 °C under 
N2  overnight.  (ii)  Suzuki  Coupling:  Compound  5,  boronic  acid  (1.1  eq),  caesium 
carbonate  (4  eq),  tetrakis(triphenylphosphine)palladium(0)  (10  mol  %),  1,2 
dimethoxyethane / water (3:1) reflux under nitrogen overnight. 
 
Following a search for optimal conditions by a project student under my supervision, 
the  pyrazine  ring  of  compound  4  was  aminated  with 
N (4 Aminophenyl) 4 methylbenzenesulfonamide in sufficient yield (Scheme 4.3) (19). 
Compound  5  a  pale  yellow  solid  was  obtained  after  an  aqueous  work  up  and 
purification by column chromatography in 50 % yield.  
 
The  yield  of  the  reaction  was  particularly  sensitive  to  the  ligand  and  solvent  used. 
Effective amination was achieved in 1,4 dioxane with 4,5 bis(diphenylphosphino) 9,9 
dimethylxanthene (xantphos) as the ligand and a weak caesium carbonate base (20,21). 
Dioxane  is  a  more  polar  solvent  than  toluene,  the  other  commonly  used  solvent  in 
Buchwald  Hartwig  aminations,  and  dioxane  facilitated  the  dissolution  of  the 
sulfonamide  start  material  (17).  A  test  reaction  between 
N (4 aminophenyl) 4 methylbenzenesulfonamide  and  2 bromopyridine  conducted  in 
toluene,  with  a  weak  caesium  carbonate  base  and  a  bidentate  2,2’ 
bis(diphenylphosphino) 1,1’ binapthyl (BINAP) ligand, had given a low 8 % yield. By 
contrast aniline had been able to aminate 2 bromopyridine in 50 % yield in toluene with Chapter 4 
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a bidentate phosphine ligand and strong sodium tert butoxide base. 1,4 Dioxane was 
Yin and Buchwalds choice of solvent when arylating a sulphonamide containing start 
material (22). Xantphos is bidentate, such ligands are known to be good for reactions 
involving aryl amines and also suppress the formation of bis pyridine complexes which 
terminate the catalytic cycle (16,23 25). When the reaction was instead carried out with 
BINAP, another bidentate phosphine ligand, the required amination product was given 
with a 20 %  yield. The noteable differences between Xantphos and other bidentate 
ligands are its large P Pd P ‘bite angle’ and the presence of a heteroatom (oxygen) 
which alters the electronic properties of the Pd centre (26,27) (Figure 4.13). Xantphos 
has previously been reported as an effective ligand for aminations involving anilines 
(28). Before use, the caesium carbonate base was ground in a pestle and mortar as there 
was literature evidence to suggest smaller particle size improves reaction rates (29). 
Research has also suggested that addition of a crown ether, 18 crown 6, may increase 
rates of amination by interaction with the Cs and Pd ions (30,31). Reactions with and 
without  a  crown  ether  were  both  observed  to  have  yielded  product  based  on  TLC 













BINAP Xantphos  
Figure 4.13 Structures of the two bidentate phosphine ligands used in the amination of 
compound 4. 
 
A yield of 50 % from the final amination reaction conditions was fit for purpose. Time 
could have been spent trying to enhance yields further but this would have slowed down 
the screening process. That said, a modification to the reaction conditions which was 
overlooked and should have been tried was the addition of a triethylamine co solvent 
which Buchwald and Ali say provided ‘significant rate enhancements when running 
reactions with caesium carbonate’ (28). Chapter 4 
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Buchwald Hartwig amination was also to be used in the first step of compound D04 































Scheme  4.4  First  step  of  the  synthetic  route  to  compound  D04 6142.  (i)  Buchwald 
Hartwig Amination: Compound 4 (2,5 dibromopyrazine), 4,4’ diaminobenzanilide (1 
eq), caesium carbonate (1.4 eq), tris(dibenzylideneacetone)dipalladium(0) (2.5 mol % 
Pd),  4,5 bis(diphenylphosphino) 9,9 dimethylxanthene  (5  mol  %),  18 crown 6 
(10 mol %), 1,4 dioxane, 90 °C, under nitrogen overnight. 
 
TLC analysis of this reaction showed that a new ninhydrin active compound had been 
formed. This material was isolated by a combination of normal and reversed phase 
chromatography and analysed by electrospray mass spectrometry. Mass ions of 384, 
386 and 406, 408 were consistent with [M + H]
+ or [M + Na]
+ respectively for either 
product 5 or 6. To differentiate between these potential products, samples were sent for 
analysis  by  electrospray  mass  spectrometry  at  increased  cone  voltage  (50  V)  (J. 
Herniman). This led to the formation of two new mass ions at 276 and 278 which were 
consistent  with  a  breakdown  of  product  6  at  the  amide  bond  within  the  mass 
spectrometer.  On  this  basis  the  identified  product  was  attributed  to  reaction  at  the 
unwanted end of the 4,4’ diaminobenzanilide. The yield of this product was, at 28 %, 
low. An alternative route to D04 6142 was considered, but it was felt that optimising 
this strategy, particularly the amination step, so as to achieve an acceptable yield would 
prove time consuming. Analysis of the two very similar compounds to D04 6142 had 
shown  that  they  were  not  selective  Dam  inhibitors  and  therefore  further  efforts  to 
complete its synthesis were discontinued. 
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4.3.3. Counter screening of compounds for selective inhibition of Dam 
 
The three successfully synthesised compounds of interest were re tested to determine 
their effect in the Dam activity assay. As a counter screen their effect in a DpnI activity 
assay was also measured. This DpnI assay operated on the same principle as the Dam 
assay but used FM ODN3, a fully methylated analogue of ODN 3. Compound H09 
6137 was tested in both assays at eleven concentrations between 0 and 2 mM (Figure 
4.14). 
[Compound H09-6137]  M




























Figure  4.14  Compound  H09 6137  concentration response  curve  for  apparent  Dam 
(filled circles) and DpnI (open circles) activity. The fractional activity in the Dam or the 
DpnI assay is plotted against the compound concentration. DpnI data were fit to a 3 
parameter logistic sigmoid to obtain the IC50 and the Hill coefficient (solid line). 
 
In  the  Dam  assay  H09 6137  caused  an  increase  in  measured  activity  up  to  a 
concentration of approximately 400  M. Above this a steady decrease in activity was 
seen with 60 % remaining at a compound concentration of 2 mM. DpnI activity was 
reduced by the compound at much lower concentrations than those required in the Dam 
assay. DpnI activity dropped to less than 50 % at a compound concentration of 1 mM 
and continued to fall to ~ 25 % with 2 mM H09 6137. The IC50 for the inhibition of 
DpnI was calculated as 781 ± 83  M from the fit of a 3 parameter logistic sigmoid to 
the data (R
2 = 0.98) (Equation 4.2). A poor fit of the Dam concentration response plot 
data to this sigmoid made it unsuitable for the determination of an IC50 (R
2 = 0.69). 








Equation  4.2  The  3  parameter  logistic  sigmoid  used  to  derive  the  IC50  and  Hill 
coefficients  from  the  concentration response  assay  data.  [I]  is  the  compound 
concentration and h is the Hill coefficient. 
 
The Hill coefficient for the inhibition of DpnI by H09 6137 was determined as 1.0 ± 
0.1. This indicates that the inhibition of enzyme activity was the result of stoichiometric 
binding of one inhibitor molecule to one component of the assay (3). 
 
Compound  H09 6137  was  only  weakly  inhibitory  in  the  Dam  activity  assay.  These 
repeat results are inconsistent with the compound being identified as a hit in the initial 
screen at a concentration of 100  M. An explanation could be that the original library 
sample was contaminated with a small amount of a more potent inhibitor. Compound 
H09 6137 was not selective for Y. pestis Dam as it was found to inhibit the restriction 
enzyme DpnI.  
 
Compound D11 6141 was tested at several concentrations between 0 and 500  M in the 
Dam activity assays and between 0 and 200  M in the DpnI assay (Figure 4.15). 
[Compound D11-6141]  M



























Figure  4.15  Compound  D11 6141  concentration response  curve  for  apparent  Dam 
(filled circles) and DpnI (open circles) activity. The fractional activity in the Dam or the 
DpnI assay is plotted against the compound concentration. Dam and DpnI data were fit Chapter 4 
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to a 3 parameter logistic sigmoid to obtain the IC50 and the Hill coefficient (solid (R
2 = 
0.95) and dashed (R
2 = 0.97) lines respectively). 
 
A very similar inhibitory effect was observed with compound D11 6141 in both types 
of activity assay. Between 0 and 200  M the compound steadily reduced measured rates 
to nothing. The IC50s in the Dam and DpnI assays were 101 ± 12  M and 120 ± 5  M 
respectively. Results from these assays are consistent with the compounds identification 
as a hit in the initial screen. These results also suggest that D11 6141 was not selective 
for Y. pestis Dam. The Hill coefficients from the fits of the Dam and DpnI data were 2.9 
± 0.8 and 3.8 ± 0.5 respectively. These high Hill coefficients, greater than one, provide 
additional evidence that D11 6141 is non selective in its mode of action (3). Where an 
inhibitor was targeting a specific site in an enzyme a Hill coefficient of one would be 
expected. Coefficients above one can indicate cooperativity in the inhibitor binding, the 
targeting  of  multiple  equivalent  binding  sites  or  other  non ideal  behaviour  by  the 
inhibitor.  Non ideal  inhibition  can  result  from  compound  aggregation  or  protein 
denaturation by the inhibitor (3). 
 
Compound B02 6142 was tested at several concentrations between 0 and 150  M in the 
Dam and DpnI assays (Figure 4.16). 
[Compound B02-6142]  M



























Figure  4.16  Compound  B02 6142  concentration response  curve  for  apparent  Dam 
(filled circles) and DpnI (open circles) activity. The fractional activity in the Dam or the 
DpnI assay is plotted against the compound concentration. Dam and DpnI data were fit 
to a 3 parameter logistic sigmoid to obtain the IC50 and the Hill coefficient (solid (R
2 = 
0.99) and dashed (R
2 = 0.97) lines respectively). Chapter 4 
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Compound B02 6142 was only weakly inhibitory in the Dam activity assay up to a 
concentration of 60  M. Measured activity then dropped by 80 % as the compound 
concentration was raised further from 60 to 100  M. At a concentration of 150  M no 
measurable activity remained. By contrast the effect of the compound on DpnI activity 
was pronounced even at low concentrations, with enzyme activity halving at 40  M 
B02 6142.  No  DpnI  activity  remained  in  assays  with  a  compound  concentration  of 
110  M. The IC50s in the Dam and DpnI assays were 86 ± 1  M and 40 ± 3  M 
respectively. These results are consistent with the classification of the compound as a 
hit in the initial screen but also show it to be non specific in its mode of action. The Hill 
coefficients from the fits of the Dam and DpnI data were 15.1 ± 2.2 and 3.0 ± 0.5 
respectively.  As  discussed  for  compound  D11 6141  these  high  coefficients  provide 
additional evidence that B02 6142 was a non specific inhibitor. 
 
Tests on the synthesised compounds H09 6137, D11 6141 and B02 6142 showed that 
they were all acting non specifically. DNA binding or intercalation was one possible 
mechanism by which the hit compounds elicited their non specific effect in the assays. 
Mashoon and co workers identified several such false hits in their HTS for E. coli Dam 
inhibitors (32). These DNA binding or intercalating compounds were identified with a 
‘Fluorescent Intercalator Displacement’ (FID) assay (33,34).  
 
A FID assay was used to test compounds H09 6137, D11 6141 and B02 6142. Thiazole 
orange is a molecule whose fluorescence is significantly higher when it is intercalated 
into DNA (35) (Figure 4.17). The Kd for thiazole orange with the DNA used in this 
assay is most likely in the range 3 – 15  M, based on literature reports detailing its 
affinity for other oligonucleotides (33,35). Thiazole orange was used in the FID assays 
at a concentration of 0.75  M, with 1.5  M of dsDNA base pairs, ensuring it could be 
effectively displaced by a rival DNA binding molecule. Test compounds were added to 
solutions containing thiazole orange and DNA at the concentration needed for ~ 50 % 
DpnI  inhibition.  The  fluorescence  of  these  solutions  was  compared  to  a  control 









































Figure 4.17 Principle of the FID  assay. Thiazole orange has  a low fluorescence in 
solution.  Upon  intercalation  into  a  DNA  double  helix  the  fluorescence  of  thiazole 
orange is enhanced. Test compounds interacting with DNA in such a way as to displace 








































Figure  4.18  FID  assay  results  for  compounds  H09 6137,  D11 6141  and  B02 6142. 
Fluorescence  of  assays  containing  test  compounds  is  shown  relative  to  a  negative 
control. 
 
Addition  of  compounds  H09 6137,  D11 6141  and  B02 6142  led  to  falls  in  assay 
fluorescence of 73, 92 and 61 % respectively. These decreases are consistent with the 
compounds binding or intercalating with the DNA causing an associated displacement 
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4.4 Summary and conclusions 
 
A 1000 compound library was screened in duplicate for activity against Y. pestis Dam 
using  the  real time,  fluorescence  based,  coupled  enzyme  assay.  Raw  data  from  this 
screen was processed by Z score standardisation followed by background subtraction to 
negate  plate  and  well  biases.  B scoring  appeared  to  be  a  better  method  of  data 
processing on the basis that it removed some of the background patterns in the data 
which  Z scoring  did  not  (Figure  4.8).  Three  hits  and  a  compound  of  interest  were 
identified from the screen and synthetic routes to them were devised. H09 6137 was 
made by a nucleophilic aromatic substitution followed by a Suzuki Miyaura coupling. 
D11 6141 and B02 6142 were synthesised in a two step process involving a Buchwald 
Hartwig amination followed by a Suzuki Miyaura coupling. Disappointingly, all three 
of the synthesised compounds inhibited DpnI as well as Dam, showing that they were 
non specific. Further testing with an FID assay revealed that the hits had elicited their 
inhibitory effects by binding to the DNA substrates rather than the enzymes. 
 
Whilst disappointing, it should not have been surprising that a small compound library 
yielded only a few hits which subsequently turned out to be false positives. There are 
several  ways  in  which  compounds  can  inhibit  enzyme  activity  assays  without 
specifically targeting the enzyme of interest. These include reaction with the protein, 
optical interference, compound aggregation and DNA intercalation (36 38). Mashoon 
and co workers screened a library of 50,000 compounds for activity against E.coli Dam. 
Their hit rates for compounds with an IC50 below 400 and 25  M were 0.7 and 0.1 % 
respectively. About one third of the most potent inhibitors identified were found to have 
some interaction with DNA (32).  It is worth noting that compared to other screens 
against different antibacterial targets this ranks as one of the more favourable outcomes. 
Mashoon and co workers felt it validated a HTS strategy for this class of enzymes. 
Between  1995  and  2001  GlaxoSmithKline  ran  67  HTS  campaigns  on  antibacterial 
targets,  none  of  which  were  DNA  MTases,  using  a  library  containing  hundreds  of 
thousands of compounds. Only 16 of these resulted in hits and just 5 progressed  to give 
leads (39). This scenario is typical of the worse than expected success rate which often 
accompanies HTS against a specific antibacterial target (40). Consequently some have Chapter 4 
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even suggested that HTS on a selected target is an unsuitable paradigm for discovery of 
novel antibacterials (39,40).  
 
One drawback of the real time, fluorescence based assay, which was apparent during 
the screen, was its inherent reliance on two enzymes. For compounds inhibiting DpnI it 
was impossible to deconstruct data from the whole assay to determine how much they 
affected  the  Dam DNA  interaction.  A  counter screen  against  the  restriction  enzyme 
allowed the effect on the DNA DpnI interaction to be measured. A direct assay for Dam 
activity would prevent false hits by DpnI inhibitors and also allow the study of the 
effect of compounds purely on the Dam DNA interaction. With such an assay a true 
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5  Chapter 5 
 




In our original Dam assay, measurement of N6 adenine methyltransferase activity relied 
on coupling of methylation to oligonucleotide cleavage by DpnI (1). As a consequence 
the observed Y. pestis Dam activity measurements could have been distorted by DpnI 
inhibitors.  Such  compounds  might  give  the  appearance  of  Dam  inhibition  via  DpnI 
inhibition. We sought to produce a real time, fluorescence based, direct assay for Dam 
activity to overcome this weakness. The direct assay used the known destabilising effect 















Figure  5.1  Phenogram  showing  the  sequence  similarity  of  selected  N6 adenine 
methyltransferases from various organisms (3). Differences between methyltransferase 
sequences are shown in Point Accepted Mutation (PAM) (4). 
 
For development purposes it was desirable to use a highly stable methyltransferase, 
which  would  allow  long  assay  times  at  a  wide  range  of  temperatures.  It  was  also Chapter 5 
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preferable for the methyltransferase to retain a high sequence similarity to the original 
enzyme of interest, Y. pestis Dam. A homology search identified Pyroccocus horikoshii 
Dam (M. PhoDam) as a suitable candidate (Figure 5.1).  
 
 
Figure 5.2 An alignment of the P. horikoshii, R.felis and Y. pestis Dam amino acid 
sequences carried out using the program Multialign (3). Sequences with high and low 
consensuses are shown in red and blue respectively. In the consensus sequence, symbols 
are used to show the conservation of particular sets of amino acids; # = D, E, N or Q, ! = 
I or V, $ = L or M and % = F or Y. For comparison an alignment of Y. pestis Dam with 
that of E. coil and T4 phage may be found in appendix G. Chapter 5 
  106
Pyroccocus horikoshii is a hyperthermophillic archaeon and, with an optimal growth 
temperature of 98 
oC, its proteins are by necessity thermally stable (5). P. horikoshii 
Dam shows a high degree of sequence similarity to the adenine MTases of pathogenic 
bacteria such as Y. pestis and R. felis (Figure 5.2). P. horikoshii Dam is 330 amino acids 
long and when aligned has 93 and 125 amino acids identical to Y. pestis and R. felis 
Dam respectively. 
 
This chapter describes the production of P. horikoshii Dam and its application in a 
novel  and  direct  real time  fluorescence  based  N6 adenine  methyltransferase  activity 
assay. 
 
5.2 Cloning, expression and purification of P. horikoshii Dam 
 
5.2.1 Cloning of the P. horikoshii dam gene 
 
PCR reactions were set up using P. horikoshii genomic DNA as a template and primers 
designed to copy the dam gene adding NcoI and XhoI restriction sites at the start and 
end respectively. The reverse primer encoded a His6 tag which would be appended to 
the C terminus of the protein upon translation. 
 
Primer  Sequence 5’ to 3’ 
PhoCfo  GATCGACCATGGCAGAACCCGTTTTA 
PhoCre  GACTCCTCGAGTTAATGATGATGATGATGATGATTAATCCACTC 
AAGTATTGATCTC 
Table 5.1 Sequences of the forward (PhoCfo) and reverse (PhoCre) primers used to 
amplify the P. horikoshii dam gene. The NcoI and XhoI restriction sites are shown in 
italics and bold respectively. The sequence encoding the His6 tag is underlined. 
 
Previous work had been carried out within the group by Dr. R. J. Wood, J. McKelvie, C. 
Williams, D. Coomber and A. Stares in which N terminally His6 tagged P. horikoshii 
Dam was expressed and purified. A shorter protein was observed to co purify with this 
full length Dam (6). It was thought that this contaminant may have been a product of Chapter 5 
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premature  termination  of  translation.  Since  translation  proceeds  from  the  N  to  C 
termini, it was reasoned that a C terminal His6 tag would permit the isolation of pure 
full length Dam.  
 
 
                                                      M           1             2           3 
Figure 5.3 1 % AGE analysis of PCR reactions to amplify the P. horikoshii dam gene. 
Lane M = DNA ladder. Lanes 1 3 = PCR reactions containing 10, 1 and 0.1 ng  l
 1 
template DNA respectively, expected size = 1030 bp. 
 
Analysis  of  the  PCR  reactions  by  agarose  gel  electrophoresis  showed  that  at  each 
template  DNA  dilution  a  fragment  consistent  with  the  dam  gene  had  been  formed 
(Figure 5.3) 
 
The purified dam gene was digested with restriction enzymes XhoI and NcoI to form 
sticky ends. A second fragment, with complementary sticky ends and  an ampicillin 
resistance  marker,  was  made  by  digestion  of  plasmid  pBadHisA  with  the  same 
enzymes. Both gene and vector were purified with agarose gel electrophoresis before 
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                      M            1a                  2a                                   M        1b          2b  
Figure 5.4 (Left) 1 % agarose gel purification of digests of pBadHisA and the cloned P. 
horikoshii dam gene. Lane M = DNA ladder, 1a = digested pBadHisA, expected size = 
3989  bp,  2a  =  dam  gene,  expected  size  1013  bp.  (Right)  1  %  AGE  analysis  of 
pBadHisA vector and the dam gene after gel purification. M = DNA ladder. Lane 1b = 
digested pBadHisA, 2b = dam gene. 
 
Both gene and vector appeared as single bands of the expected sizes. Overnight ligation 
reactions were carried out at two different insert to vector ratios, 3:2 and 6:2. A negative 
control  without  any  insert  was  also  prepared.  Competent  E.  coli  TOP10  cells  were 
transformed with these ligations. High and low insert to vector ratio ligations yielded 
thirty  and  forty  five  colonies  per  plate  respectively  whilst  the  vector  only  negative 
control plate had eleven colonies. Transformants which contained a copy of the dam 
gene were identified by colony PCR (Figure 5.5). 
 
 
                                     M       +    1   2   3   4   5   6   7   8   9  10 11 12 13 14 15 
Figure 5.5 1 % AGE analysis of colony PCR reactions. Lane M = DNA Ladder.   = 
negative  control  (colony  containing  pBadHisA).  +  =  positive  control  (P.  horikoshii 
genomic DNA), expected size 1030 bp. Lanes 1 – 15 represent PCR reactions set up 
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Of  the  fifteen  colonies  screened,  eleven  were  found  to  contain  a  copy  of  the  P. 
horikoshii  dam  gene.  Plasmid  was  extracted  from  overnight  cultures  of  colonies 
numbered 9, 10, 13 and 14, and subjected to analytical digestion (Figure 5.6).  
 
 
                                                 M        1    2    3    4         5    6    7    8 
Figure  5.6  1  %  AGE  analysis  of  digests  of  plasmid  extracted  from  transformants 
containing the dam gene. Lane M = DNA Ladder. Lanes 1 4 = plasmid from colonies 9, 
10, 13 and 14 linearised with NcoI, expected size = 5002 bp. Lanes 5 8 = plasmid from 
colonies 9, 10, 13 and 14 digested with NcoI and XhoI, expected sizes 1013, 3989 bp. 
 
Linearised plasmids appeared to be of the correct size as did the excised dam gene and 
vector. Some DNA was not cut twice in the double digestion reactions leading to the 
observation  of  a  third  band  the  size  of  linearised  plasmid  (Figure  5.6,  lanes  5 8). 
Plasmid from one of the colonies was subjected to further restriction mapping with a 
selection of restriction enzymes (Figure 5.7). 
 
bp 
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                                                         M           1     2     3    4     5 
Figure 5.7 1 % AGE analysis of digests of plasmid extracted from colony 9. Lane 1: 
NcoI, expected = 5002 bp, observed ~ 5000 bp. Lane 2: NcoI, XhoI, expected = 1013, 
3989 bp, observed ~ 1000, 4000, 5000 bp (linearised plasmid). Lane 3: BamHI, PciI, 
expected = 1677, 3325 bp, observed ~ 1600, 3300 bp. Lane 4: BamHI, NheI, expected = 
710, 4292 bp, observed ~ 700 (faint), 4000, 5000 bp (linearised plasmid). Lane 5: NsiI = 
1551, 3451 bp, observed ~ 1500, 3400 bp. 
 
Plasmid from colony 9 digested in a manner consistent with the expected structure. 
Competent E. coli BL21 pLysS Rosetta 2 cells were transformed with this plasmid. The 
Rosetta 2 strain, which supplies additional tRNA for seven rare codons, had proved the 
most successful for expression of the N terminally His6 tagged Dam (6,7). The plasmid, 
which contained the P. horikoshii dam gene under the control of an arabinose inducible 
promoter, was designated pMMS511811.   
 
5.2.2 Expression of C His6 P. horikoshii Dam 
 
2YT media supplemented with ampicillin and chloramphenicol was inoculated from an 
overnight culture of BL21 pLysS Rosetta 2 harbouring pMMS511811. The culture was 
grown at 27 °C for two hours after induction with arabinose at an absorbance of 0.6 at 
600 nm. Approximately 12 g of cell paste was harvested from the 4 L culture, of which 
5 g  were  subsequently  used  for  a  nickel  affinity  purification  of  P.  horikoshii  Dam. 















506,517 Chapter 5 
  111
 
                     M     S       FT     1                                                                          10 
Figure 5.8 15 % SDS PAGE analysis of C His6 tagged P. horikoshii Dam expressed in 
BL21 pLysS Rosetta 2. M = molecular weight marker. S  =  supernatant. FT = column 
flow through. 1   10 = eluted fractions, expected size = 40,171 Da. 
 
The full length C His6 tagged P. horikoshii Dam was not observed to be any purer than 
the N His6 tagged enzyme which had been prepared previously. In the purer fractions 
eluted from the nickel column an impurity, approximately 10 kDa smaller than the full 
length  Dam, was still observed. Expression was therefore also tested in three other 
E. coli  cell  strains,  GM161,  GM124  and  JW3351 1  from  the  Keio  collection  of 
knockouts (8) (Figure 5.9, Figure 5.10, Figure 5.11). 
 
 
                                            M      S    FT     1                                  5      R 
Figure 5.9 15 % SDS PAGE analysis of C His6 P. horikoshii Dam expressed in strain 
JW3351 1. M = molecular weight marker. S  =  supernatant. FT = column flow through. 
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                               M     S    FT    1                                                                 10 
Figure  5.10  15  %  SDS PAGE  analysis  of  C His6 P.  horikoshii  Dam  expressed  in 
GM161. M = molecular weight marker. S  =  supernatant. FT = column flow through. 1 
  10 = eluted fractions, expected size = 40,171 Da. 
 
                                         M    S    FT    1                                                 7 
Figure  5.11  15  %  SDS PAGE  analysis  of  C His6 P.  horikoshii  Dam  expressed  in 
GM124. M = molecular weight marker. S  =  supernatant. FT = column flow through. 1 
  7 = eluted fractions, expected size = 40,171 Da. 
 
These alternative expression strains afforded no enhancement in Dam purity. C His6 
tagged P. horikoshii Dam was consistently judged to be more contaminated than the N 
terminally tagged enzyme on 15 % polyacrylamide gels  (Lane R, Figure 5.9). This 
assessment was supported by high resolution polyacrylamide gel analysis of samples 
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                         M               N               C 
Figure 5.12. High Resolution 16 % Tricine SDS PAGE analysis of N and C terminally 
His6 tagged P. horikoshii Dam. M = marker, N / C = termini to which the His6 tag was 
attached. Expected mass of the full length protein was 40 kDa (see arrow). 
 
The ratio of P. horikoshii Dam to truncated impurity was clearly lower with the C 
terminal affinity tag. It was also noted that the impurity appeared slightly larger with the 
tag on the C terminus. Both of these observations were inconsistent with the hypothesis 
of premature termination of translation. 
 
To provide a definitive identification, the contaminating protein was isolated by SDS 
PAGE, electroblotted onto a PVDF membrane and sent for N terminal sequencing at 
Cambridge Peptides (appendix E). The six N terminal amino acids were found to be M   
  E Y N, were – represents an unidentified amino acid. This amino acid sequence, 
MRREYN,  was  found  in  the  middle  of  P.  horikoshii  Dam.  The  contaminant  was 
therefore attributed to a mis initiation of translation at this internal methionine residue. 
This explanation also accounted for the observation that a C terminal His6 tag made the 
contamination worse and slightly increased the mass of the impurity.  
 
To  eliminate  this  contaminant,  directed  mutagenesis  of  N His6 M.PhoDam  was 
undertaken. The methionine amino acid, where mis initiation of translation began, was 
to be replaced with an alanine residue. Alanine was chosen because it is a small and 
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5.2.3 Directed mutagenesis of P. horikoshii Dam 
 
Plasmid pCLW469397, encoding N His6 Dam, was isolated from E. coli strain TOP10 
and used as template DNA in PCR reactions containing two mutagenic primers. These 
primers each contained a mismatch which replaced the troublesome methionine codon 
with an alanine one (Table 5.2). 
 
Primer  Sequence 5’ to 3’ 
PhofM98A  GGGAGTACTACTATAGAGCGCGAAGAGAATACAATAAACTTGCCC 
PhorM98A  GGGCAAGTTTATTGTATTCTCTTCGCGCTCTATAGTAGTACTCCC 
Wild type sequence: GAGTACTACTATAGAATGCGAAGAGAATACAATAAAC 
Table 5.2 Sequences of the primers used to mutate the P. horikoshii dam gene. The 
mismatched codons are underlined. The methionine codon which was replaced is shown 
in bold italics in the wild type sequence. 
 
PCR reactions were analysed by AGE, subjected to incubation with DpnI to destroy any 
original template DNA and re analysed by AGE (Figure 5.13).  
 
 
                                       M      1       2        3        4        5       6         7       8  
Figure 5.13. 1 % AGE analysis of PCR reactions used to mutate the P. horikoshii dam 
gene in plasmid pCLW469397. M = DNA ladder, lanes 1 4  = samples from PCR 
reactions containing 5, 10, 20 and 40 ng of template DNA respectively, expected size = 
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The  PCR  reactions  all  gave  a  product  of  the  expected  length  but  those  with  more 
template appeared to be higher yielding. Since DpnI is specific for methylated DNA it 
degraded  the  bacterially  synthesised  pCLW469397  plasmid  but  left  the  new  PCR 
product intact (Figure 5.13).  
 
E. coli strain TOP10 was transformed with this newly formed mutated DNA. Staggered 
strand breaks in the DNA will have been ligated by repair enzymes within the bacteria. 
The  resultant  plasmid  encoding  N His6 M98A P.  horikoshii  Dam  was  designated 
pMMS528431.  Plasmid  DNA  was  isolated  from  overnight  bacterial  cultures  and 
subjected to analytical digestion (Figure 5.14). 
    
               M  1                               8, 9                             16, 17                             24 M                
Figure 5.14. 1 % AGE analysis of plasmid pMMS528431 isolated from E. coli TOP10. 
M = DNA Ladder, lanes 1/2, 3/4, 5/6, 7/8 = plasmid isolated from two separate colonies 
of bacteria transformed with PCR reactions 1 to 4 respectively, lanes 9 – 16 =  plasmid 
as for lanes 1 – 8 but linearised with NcoI, expected size = 5007 bp, lanes 17 – 24 = 
plasmid as for lanes 1  8 but digested with NcoI and XhoI, expected sizes = 1016 and 
3991 bp. 
 
All of the plasmids examined were of the expected length and contained a XhoI, NcoI 
excisable insert of the expected size. Plasmid DNA, from a couple of the colonies, was 
sent for sequencing using two primers which extended towards the centre of the gene 
from a region beyond each of its ends (pBad forward and reverse, appendix B). In both 
plasmids the gene was found to contain the specific mutation which would exchange 
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Plasmid pMMS528431 was transformed into E. coli strain BL21 pLysS Rosetta 2 and 
Dam expression carried out under conditions optimised for the wild type enzyme (7). 
After induction, a 5 litre culture was maintained at 16 °C overnight and yielded 66 g of 
cell paste upon centrifugation. A nickel affinity purification was carried out on 10 g of 
cell paste. Fractions eluted from the column were analysed by SDS PAGE (Figure 5.15) 
 
 
                M        S          FT       R       1                                                                     8 
Figure 5.15.  15 % SDS PAGE analysis of N His6 M98A P. horikoshii Dam expressed 
in BL21 pLysS Rosetta 2. M = molecular weight marker, S = supernatant, FT = flow 
through,  R  =  wild  type  Dam  reference,  lanes  1  –  8  =  eluted  fractions,  expected 
40,228 Da.  
 
A protein with the mass of P. horikoshii Dam was observed and found to be free from 
the  product  of  mis translation,  clearly  visible  in  the  reference  sample  of  wild  type 
enzyme  (Figure  5.15,  lane  R).  From  10  g  of  cell  paste,  3.5  mg  of  the  mutant 
hyperthermophilic  N6 adenine  methyltransferase  was  isolated.  This  enzyme  was 
dialysed  into  a  storage  buffer  containing  20  %  glycerol  and  frozen  in  0.2  mg  ml
 1 
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5.3 A direct assay for N6 adenine methyltransferase activity 
 
5.3.1 A preliminary test of the assay principle 
 
The direct assay was designed to use the destabilising effect that adenine methylation 
has on double helical DNA to increase the mean separation of a FRET pair attached to 
an  oligonucleotide.  To  test  the  feasibility  of  measuring  the  real time  fluorescence 
increases associated with this process, a preliminary experiment, using P. horikoshii 
Dam and the hairpin oligonucleotide from the coupled assay, was carried out (Figure 
5.16, Figure 5.17). 
 
Figure  5.16  High  temperature  Fluorescence  Equilibrium  Perturbation  (FEP)  assay 
scheme. At temperatures near to the Tm, methylation shifts the equilibrium between 
closed and open ODN 3 towards the more fluorescent open form. 
 
Four different concentrations of P. horikoshii Dam were added to duplicate buffered 
solutions  of  ODN  3  and  AdoMet.  Fluorescence  timecourses  of  the  solutions  were 
measured in a Roche lightcycler at 78 °C (Figure 5.17). 
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Figure  5.17  (Upper  graph)  Raw  duplicate  fluorescence  timecourses  of  direct  Dam 
activity  assays  performed  at  78  °C.  Assays  (20   l)  contained  20  mM  potassium 
phosphate buffer (pH 7.8), 200 mM NaCl, 1 mM MgCl2, 1 mM DTT, 0.1 mg ml
 1 BSA, 
25  M AdoMet, 100 nM ODN 3 and 0 nM (black), 1 nM (red), 2 nM (green) or 4 nM 
(blue) P. horikoshii Dam. (Lower graph) Averaged fluorescence timecourses for assays 
containing  1,  2  and  4  nM  Dam  with  the  background  fluorescence  (0  nM  Dam) 
subtracted. 
 
Real time fluorescence increases were observed in all of the Dam containing assays 
(Figure 5.17). The greatest increases in fluorescence were seen in the assays which 
contained the most Dam. This effect was attributed to incomplete substrate turnover 
caused by enzyme inactivation at the high assay temperature. Complete turnover would 
have resulted in the same fluorescence endpoints being reached in each of the assays Chapter 5 
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regardless of methyltransferase concentration. Initial rates of fluorescence increase in 
the Dam containing assays, after background subtraction, were determined as 1.8 x 10
 3 
± 0.1 x 10
 3 (1 nM Dam), 3.8 x 10
 3 ± 0.1 x 10
 3 (2 nM Dam) and 6.9 x 10
 3 ± 0.2 x 10
 3 
arb units s
 1 (4 nM Dam). The initial rates of fluorescence increase were almost directly 
proportional to Dam concentration.  
 
Once the fluorescence increases had ceased, the thermal melting profile of the DNA in 
each  of  the  eight  duplicate  assays  was  measured  (Figure  5.18).  The  melting 
temperatures of the DNA in the assays containing 0 and 4 nM Dam were determined by 
the fit of a 4 parameter sigmoid, f = f0 + (a / 1 + e 
– (T – Tm / b)), to the profiles. In this 
equation fluorescence and fluorescence at a low temperature are denoted with f and f0, 
temperature and the melting temperature are denoted with T and Tm. 
Temperature 
oC










































Figure  5.18  Thermal  melting  profiles  of  the  eight  duplicate  Dam  activity  assays. 
Profiles are of assays containing 0 nM (black), 1 nM (red), 2 nM (green) and 4 nM 
(blue) Dam. 
 
The oligonucleotides in the 0 and 4 nM Dam assays had melting temperatures of 83.3 ± 
0.1 and 80.8 ± 0.1 °C respectively. This reduction of the melting temperature in the 
assays containing Dam could be accounted for by methylation of the oligonucleotide.  
 
On the basis of these encouraging results, oligonucleotides were designed to allow the 
assay to be conducted at a lower temperature, permitting the use of a microplate reader Chapter 5 
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to  collection  the  experimental  data.  This  was  also  necessary  to  make  the  assay 
applicable to the study of non thermophilic adenine MTases from pathogenic bacteria. 
 
 
5.3.2 Proof of the assay principle at lower temperatures 
 
The  lower  temperature  assay  would  rely  on  using  enzymatic  DNA  methylation  to 
perturb the equilibrium between intermolecular single and double stranded DNA and 




Figure 5.19 Fluorescence Equilibrium Perturbation (FEP) assay scheme. ODN 4 and M 
ODN  7  were  annealed  to  form  the  initial  double  stranded,  hemi methylated  MTase 
substrate (upper left). Ks and Kp are the substrate and product equilibrium constants 
respectively. 
 
The assay was to be conducted a few degrees below the melting temperature of the 
initial hemi methylated  duplex, labelled on opposite strands with a FRET pair. The 
equilibrium between double and single stranded DNA would at the start of the assay be 
governed by equilibrium constant Ks. Upon methylation this equilibrium would instead 
be governed by constant Kp. Since equilibrium Kp lies more in favour of single stranded 
DNA, methylation would be accompanied by an increases in the mean distance between 
the FRET pair. A measurable increase in fluorescence would result. 
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A  gel  based  assay  was  used  to  confirm  that  the  mutant  hyperthermophilic  adenine 
MTase  was  active  at  the  intended  assay  temperature  of  33  °C.  Hemi methylated 
oligonucleotide  (1   M),  formed  from  ODN  4  and  M  ODN  7,  was  incubated  with 
100 nM P. horikoshii Dam for between 0 and  80 minutes before exposure to DpnI 
which cut any fully methylated duplex. The resulting mixture of uncut and cut DNA 
was analysed by short oligonucleotide gel electrophoresis with visualisation under UV 
light (Figure 5.20).  
 
 
Figure 5.20  20 % PAGE analysis of fluorescently labelled DNA, digested with DpnI, 
following incubation with P. horikoshii Dam for between 0 and 80 minutes. Lanes + 
and – contained synthetic fully and hemi methylated DNA exposed to DpnI. Numbered 
lanes were incubated with Dam, for the indicated time in minutes, prior to digestion 
with DpnI. 
 
Without staining, only the full length (13 mer) or digested (6 mer) ODN 4 with its 
fluorescent label were visible on the gel. Results indicated that the methyltransferase 
was  active,  with  longer  incubation  times  producing  a  higher  proportion  of  DpnI 
susceptible  DNA.  Relative  intensities  of  the  bands  from  this  and  a  repeat  short 
oligonucleotide gel were quantified and plotted on a graph (Figure 5.21). 









6mer Chapter 5 
  122
                Time (minutes)

































Figure 5.21 Quantification of the gel electrophoresis analysis of fluorescently labelled 
duplex DNA, digested with DpnI, following incubation with P. horikoshii Dam. The 
percentage of the DNA susceptible to DpnI cleavage versus the time for which the DNA 
had previously been incubated with P. horikoshii Dam is shown. 
 
Methyltransferase  activity  looked  to  be  near  linear  for  at  least  40  minutes  and 
methylation of the substrate appears to approach completion after 80 minutes. Turnover 
of the methyltransferase was estimated to be 0.10 ± 0.03 min
 1 from the quantification 
of the gel. 
 
The gel based assay was carried out in the same phosphate buffer which was to be used 
for the direct assay. A phosphate based buffer was chosen instead of Tris because its pH 
is less affected by temperature changes. Work by  J. Mckelvie and A. Stares had shown 
that  greater  fluorescence  increases  were  observed  upon  oligonucleotide  melting  in 
phosphate buffer (7). A sodium chloride concentration of 200 mM was chosen based on 
Watanabe  and  co workers  study  of  a  hyperthermophilic  adenine  MTase  from  an 
archaeon of the same genus (9). 
 
DNA melting profiles of hemi and enzymatically fully methylated duplex were carried 
out in this buffer to demonstrate that there would be a clear fluorescence increase upon 
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Figure 5.22 (Upper graph) Melting curves (duplicate averaged) for hemi (black) and 
enzymatically fully methylated (grey) ODN 4 / M ODN 7. Solutions contained 20 mM 
potassium  phosphate  buffer  pH  7.8,  200  mM  sodium  chloride  and  50 nM 
oligonucleotide. Melting temperatures were 38.37 ± 0.02 and 36.26 ± 0.02 °C for hemi 
and  fully  methylated  oligonucleotide  respectively  as  determined  by  a  fit  of  a  4 
parameter sigmoid to the data. (Lower graph) The difference between hemi and fully 
methylated duplex fluorescence at a range of temperatures. The maximum difference in 
fluorescence between the fully and hemi methylated duplex was found to occur at 38.10 
±  0.02  °C,  based  on  the  fit  of  a  Gaussian  3  parameter  peak, 
f = ae 
( 0.5 (T   Tmax difference) /  b) 2),
 to the data.  
 
The normalised fluorescence melting profiles showed that at a fixed temperature the 
fluorescence  of  the  fully  methylated  duplex  was  higher,  as  predicted.  Under  the 
conditions used the melting temperature of the fully methylated oligonucleotide was Chapter 5 
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2.1 °C  lower  than  its  hemi methylated  analogue.  Fluorescence  increases  upon 
methylation were highest near to the hemi methylated duplex melting temperature. 
 
In the coupled enzyme assay it had been important to prove that DpnI activity was not 
constraining measurements. Similarly with the direct assay it was important to know 
when the kinetics of oligonucleotide melting would be rate limiting. The kinetics of 
oligonucleotide  melting  were  therefore  studied  with  a  series  of  temperature  jump 
experiments similar to those used by James, Brown and Fox (10).  
Time (s)























































































Figure 5.23 Example temperature jump relaxtion profiles for hemi (upper graph) and 
enzymatically fully methylated oligonucleotide (lower graph) for T jumps from 28 to 30 
°C (filled circles), 30 to 32 °C (open circles), 32 to 34 °C (filled triangles), 34 to 36 °C 
(open  triangles)  and  36  to  38  °C  (filled  squares).  Relaxation  profiles  shown  were 
obtained using 50nM duplex ODN 4 / M ODN 7.  
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Several buffered solutions containing a range of DNA concentrations were exposed to a 
series of 2 °C temperature jumps and the fluorescence relaxation profiles monitored 
(Figure 5.23). 
 
As expected, the fluorescence of the solutions showed an exponential rise to a new 
maximum, reflecting the new equilibrium between single and double stranded DNA. 
Data were fitted to the equation Ft = Ff x (1 e
 bt) + F0 where F0, Ft and Ff are the initial, 
time t and final fluorescences. From this fit the rate constant b for the relaxation at each 
DNA concentration and temperature was obtained. These rate constants were plotted 
against the single stranded DNA concentration, derived from melting curves which had 
been carried out previously (Figure 5.24). 
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Figure 5.24 Plots of rate constant b versus total concentration of single stranded DNA 
in solution for hemi (filled circles) and fully (open circles) methylated oligonucleotide. 
Upper and lower graphs show T jumps from 30 – 32 °C and 32 – 34 °C respectively. Chapter 5 
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Data on this second plot were fitted to the equation b = k1[ssDNA] + k 1 to obtain values 
of k1 and k 1, the rate constants for the association and dissociation of the DNA duplex 
respectively (11). The calculated values appear  reasonable when compared with the 
literature (Table 5.3) (11).  
 






k 1  
(min 
 1) 
A9.U9  9  0  32 x 10
6  38400 
A10.U10  10  0  37 x 10
6  10500 
A11.U11  11  0  30 x 10
6  1680 
A14.U14  14  0  43 x 10
6  60 
A4U4.A4U4  8  0  60 x 10
6  180000 
A5U5.A5U5  10  0  108 x 10
6  9000 
A6U6.A6U6  12  0  90 x 10
6  480 
A7U7.A7U7  14  0  48 x 10
6  48 
A2GCU2.A2GCU2  6  2  96 x 10
6  27000 
A3GCU3.A3GCU3  8  2  45 x 10
6  180 
A4GCU4.A4GCU4  10  2  7.8 x 10
6  90 
A5G2.C2U5  7  2  264 x 10
6  20400 
A4G3.C3U4  7  3  252 x 10
6  300 
ODN 4/M ODN 7 (HM, 28 30 °C)  13  3  405 x 10
6  0.30 
ODN 4/M ODN 7 (FM, 28 30 °C)  13  3  287 x 10
6  0.27 
ODN 4/M ODN 7 (HM, 30 32 °C)  13  3  334 x 10
6  0.23 
ODN 4/M ODN 7 (FM, 30 32 °C)  13  3  215 x 10
6  0.39 
ODN 4/M ODN 7 (HM, 32 34 °C)  13  3  248 x 10
6  0.35 
ODN 4/M ODN 7 (FM, 32 34 °C)  13  3  155 x 10
6  0.74 
ODN 4/M ODN 7 (HM, 34 36 °C)  13  3  164 x 10
6  1.11 
ODN 4/M ODN 7 (FM, 34 36 °C)  13  3  97 x 10
6  1.94 
ODN 4/M ODN 7 (HM, 36 38 °C)  13  3  99 x 10
6  2.77 
ODN 4/M ODN 7 (FM, 36 38 °C)  13  3  60 x 10
6  4.01 
Table 5.3 Relaxation kinetics of oligonucleotide duplexes (21 to 23 °C) (11). ODN 4 / 
M ODN 7 values measured in this study, average standard error on k1 = 6 % and k 1 = 
17 %. Chapter 5 
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It was noted that since Dam was by necessity a DNA binding protein it could potentially 
affect  the  equilibrium  between  single  and  double  stranded  DNA  by  stabilising  the 
duplex. To test this hypothesis a rudimentary experiment was conducted in which a 
fixed concentration of DNA was incubated with increasing amounts of the enzyme, in 
the  absence  of  AdoMet.  This  would  allow  binding  of  Dam  to  the  DNA  whilst 
prohibiting methylation. 
Concentration of M.PhoDam (nM)












































Figure  5.25  The  relationship  between  P.  horikoshii  Dam  concentration  and  DNA 
fluorescence in solution. Solutions contained 20 mM potassium phosphate buffer pH 
7.8, 200 mM sodium chloride, 5 nM ODN 4 / M ODN 7 and P. horikoshii Dam 0, 5, 10, 
20, 40, 60, 80, 100 nM. 
 
A  reduction  in  fluorescence  intensity  of  about  20  %  was  observed  as  the  Dam 
concentration was increased from 0 to 100 nM. Fluorescence reduction was not linearly 
proportional to methyltransferase concentration but rather had three apparent phases. An 
initial steep decrease up to 20 nM was seen, followed by relatively little change between 
20 and 60 nM and another sharper decrease above 60 nM. A speculative explanation for 
this behaviour is that two Dam molecules could be binding to the DNA above 60 nM. 
Whatever the complexities, results suggested that the hypothesised effect existed but 
was relatively weak. Any potential problems would be avoided simply by keeping the 
Dam concentration significantly lower than that of the DNA substrate.  
 
Proof of principle assays were set up with 50 nM hemi methylated duplex in phosphate 
buffer at 33 °C in a 96 well plate. These direct activity assays were initiated with the Chapter 5 
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addition  of  0,  1.25,  2.5  or  5  nM  Dam,  to  demonstrate  that  measured  fluorescence 
increases were proportional to the rate of methylation (Figure 5.26). Negative controls 
which lacked Dam were prepared in wells interspersed with these assays, which was 
important to negate the effect of small temperature differences across the plate. The 
temperature at which assays were maintained, 33 °C, reflected a compromise between 
wanting the DNA in duplex form so it could be recognised by Dam and the desire to 
maximise the fluorescence signal, which was greatest near the Tm.  
 
Gratifyingly, fluorescence increases appeared to be directly proportional to the Dam 
concentration (Figure 5.26). Initial rates of fluorescence increase over the first 1000 s 
were determined as 22.7 ± 3.0, 9.6 ± 1.5, 5.9 ± 1.5 and 0.7 ± 3.1 for assays with 5, 2.5, 
1.25 and 0 nM Dam respectively. At each P. horikoshii Dam concentration the same 
endpoint fluorescence was reached. The observation is consistent with full turnover of 
the substrate by the highly stable MTase and is in contrast to the early coupled assay 
experiments with the inactivation prone Y. pestis Dam. Fluorescence increases in the 
assays  were  calibrated  from  this  endpoint  and  the  rate  of  Dam  turnover,  kcat,  was 
determined as 0.26 ± 0.03 min
 1 at 33 °C.  
 
For the real time fluorescence increases measured with the assay to be proportional to 
Dam concentration the rates of duplex association and dissociation must have been non 
limiting and therefore fast compared to the methylation rate. This can be demonstrated 
from the rate constants derived from the temperature jump experiments (Table 5.3). 
Hemi methylated DNA jumped from 32   34 °C had k1 and k 1 values of 248 x 10




 1 and 0.354 ± 0.090 min
 1 respectively. Fully methylated DNA jumped 
from 32   34 °C had k1 and k 1 values of 155 x 10
6 ± 7 x 10
6 M
 1min
 1 and 0.738 ± 0.096 
min
 1 respectively. Rates of strand association, dissociation and methylation are equal to 
k1[strand 1][strand 2], k 1[duplex] and kcat[Dam] respectively. Copasi, a simulator for 
biochemical networks was used to calculate the concentrations of each of the DNA 
species  at  several  different  assay  timepoints.  From  this  data  the  rates  of  DNA 
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Figure 5.26 (Upper graph) Raw fluorescence timecourses for activity assays containing 
5 (grey), 2.5 (green), 1.25 (blue) and 0 (black) nM P. horikoshii Dam. (Middle graph) 
Fluorescence increases (triplicate averaged) for activity assays (solid lines, 5 – 0 nM 
Dam)  and  their  negative  controls  (dashed  lines,  0  nM  Dam).  (Lower  graph) Chapter 5 
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1  1.47 x 10
 8  1.44 x 10
 8  1.3 x 10
 9  3.20 x 10
 10  7.25 x 10
 10 
2  1.44 x 10
 8  1.41 x 10
 8  1.3 x 10
 9  8.67 x 10
 10  1.32 x 10
 9 
3  1.41 x 10
 8  1.38 x 10
 8  1.3 x 10
 9  1.45 x 10
 9  1.90 x 10
 9 
Table 5.4 Rates of processes occurring in the proof of principle FEP assays containing 
5 nM Dam. All rates are in moles L
 1 min
 1. Assoc and dissoc refer to association and 
dissociation of the duplex respectively. HM and FM refer to fully or hemi methylated. 
 
The rate of methylation is ten times slower than the rate of hemi methylated duplex 
association and dissociation at the beginning of the assay. There is however a period of 
two to three minutes at the start of the assay during which methylation of the duplex is 
faster  than  the  rate  of  fully  methylated  duplex  association  and  disscociation. 
Theoretically this should result in a small lag phase at the start of the fluorescence 
timecourses. In practice this lag is not noticeable because of the initiation time and the 
FEP assay sensitivity. 
 
An  estimate  of  FEP  assay  sensitivity  was  made  from  the  standard  deviation  in  the 
averaged 5 nM P. horikoshii Dam activity data between 4000 and 10,000 s (Figure 5.26, 
lower graph, grey line). The standard deviation in the fluorescence measurement during 
this time, due to temperature fluctuations and the imprecision of the plate reader, was 
780 arbitrary units (three standard deviations = 2339 arbitrary units). Therefore there is 
a 99.73 % likelihood that a measured fluorescence increase of 2339 arbitrary units is 
statistically significant. This corresponds to methylation of 222 fmol of oligonucleotide. 
The direct FEP assay is an order of magnitude less sensitive than the coupled assay used 
to measure Y. pestis Dam activity (13 – 38 fmol sensitivity). The theoretical maximum 
FEP assay sensitivity, assuming it could be carried out in 384 well format, is 2 fmol of 
methylation.  This  limit  is  based  on  the  sensitivity  of  modern  plate  readers  (BMG 
POLARstar Omega 0.2 fmol / well fluorescein) and the fact that methylation causes a 
fluorescence increase equal to around 10 % of the free fluorophore fluorescence (Figure Chapter 5 
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5.22, lower graph). FEP assays carried out in smaller volumes may however be subject 
to  larger  errors  in  the  fluorescence  measurements  due  to  increased  temperature 
fluctuations.  
 
To further substantiate the new assay principle it was used to characterise the kinetics of 
P. horikoshii Dam methylation. 
 
5.3.3 Kinetic characterisation of P. horikoshii Dam 
 
5.3.3.1 The effect of AdoMet concentration on P. horikoshii Dam activity 
 
The dependence of Dam activity on AdoMet concentration was measured in a set of 
100  l assays at 33 °C. Duplicate assays contained nine AdoMet concentrations and the 
DNA duplex was kept at a fixed saturating concentration (Figure 5.27). Fluorescence 
increases in these assays were calibrated by comparison with the endpoint fluorescence 
increase in the assays whose fluorescence had reached a plateau. Levelling off of the 
fluorescence timecourses was assumed to be due to complete DNA methylation.  The 
gel  based  assay  had  demonstrated  that,  given  enough  time,  P.  horikoshii  Dam 
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Figure  5.27  (Upper  graph)  Example  raw  fluorescence  timecourses  containing  100 
(green), 400 (blue) or 6400 (brown) nM AdoMet and 0 (dashed) or 2.5 (solid) nM P. 
horikoshii Dam. (Lower graph) Fluorescence timecourses of Dam activity assays used 
to  measure  KM 
AdoMet.  Data  shown  is  averaged  from  duplicate  assays,  background 
fluorescence  changes  have  been  subtracted.  Assays  contained  2.5  nM  Dam,  50  nM 
ODN 4 / M ODN 7 and 0 (black), 50 (red), 100 (green), 200 (yellow), 400 (blue), 800 
(pink), 1600 (cyan), 3200 (grey) and 6400 (brown) nM AdoMet.  
 
Measured methylation rates increased as the AdoMet concentration was raised from 0 to 
6.4  M. Plots of the initial methylation rate, calculated from the first 3000 s of data, 
against  AdoMet  concentration  showed  this  relationship  was  in  accordance  with  a 
Michaelis Menten  mechanism  of  enzyme  action,  ignoring  the  effect  of  DNA 
concentration (Figure 5.28). Chapter 5 
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Concentration of AdoMet ( M)





































Figure 5.28 The dependence of P. horikoshii Dam activity on AdoMet concentration. 
Initial rate measurements were based on the first 3000 s of data. 
 
Data were fitted to the Michaelis Menten equation (v = Vmax [AdoMet] / (KM 
AdoMet + 
[AdoMet]) to obtain values for KM 
AdoMet and kcat. The R
2 value of the fit was 0.99. At 33 
°C, KM 
AdoMet and kcat were found to be 396 ± 33 nM and 0.24 ± 0.01 min
 1 (100 ± 2 
pmol  mg
 1 s
 1) respectively. 
 
5.3.3.2 The effect of DNA concentration on P. horikoshii Dam activity 
 
The dependence of Dam activity on DNA concentration was measured in a set of 100  l 
assays at 32 °C. This was one degree lower than for the AdoMet assays, a reflection of 
the lower melting temperatures seen when DNA concentrations were reduced. Duplicate 
assays were run at nine different DNA concentrations whilst the AdoMet was kept at a 
fixed saturating concentration. Chapter 5 
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Figure 5.29 (Upper graph) Raw fluorescence timecourses of Dam activity assays used 
to  measure  KM 
DNA.  Solid  and  dashed  lines  represent  activity  assays  and  negative 
controls respectively. Colour scheme is as for lower graph.  (Lower graph) Fluorescence 
timecourses of Dam activity assays used to measure KM 
DNA. Data shown is averaged 
from duplicate assays, background fluorescence changes have been subtracted. Assays 
contained 20  M AdoMet, Dam at 10 % of the DNA concentration and 15 (black), 10 
(red),  6.7  (green),  4.4  (yellow),  3.0  (blue),  2.0  (pink),  1.3  (cyan),  0.9  (grey)  and  0 
(brown) nM duplex oligonucleotide ODN 4 / M ODN 7. 
 
Rates of fluorescence increase became larger as the DNA concentration was increased 
from 0 to 15 nM. A calibration plot was constructed from the endpoint fluorescence 
increases  measured  at  each  DNA  concentration  to  allow  the  determination  of 
methylation rates (Figure 5.30). As expected, the endpoint fluorescence increases were Chapter 5 
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not  quite  linearly  dependent  on  the  DNA  concentration.  Deviation  from  a  linear 
relationship  was  attributable  to  the  changes  in  Tm  experienced  by  intermolecular 
duplexes as their concentrations are changed. At higher DNA concentrations the system 
is operating further below the Tm and so the fluorescence increase upon methylation is 
proportionally smaller. 
Concentration of duplex DNA (nM)




































Figure 5.30 The relationship between fluorescence increase upon full methylation and 
DNA concentration at 32 °C. 
 
An equation of the form  F = a(1 e
 b[DNA]), where  F is the fluorescence increase upon 
methylation and a and b are constants, accurately described the relationship between the 
variables  on  the  calibration  plot  (R
2  =  0.997)  (Figure  5.30).  This  plot  was  used  to 
determine the expected endpoint fluorescence increases due to complete methylation in 
each  of  the  assays,  allowing  methylation  rates  to  be  determined.  Using  all  of  the 
measured endpoints to make a calibration plot was preferable to individual calibration 
of the assays using their own endpoints. There was concern that at the lowest DNA 
concentrations full turnover would not be achieved because of the slow methylation 
rates.  By  using  all  of  the  available  data  to  calibrate  these  assays  the  effect  of  any 
incomplete turnover on the apparent initial rates was minimised. 
 
Plots of initial methylation rates, calculated from the first 1500 s of data, versus DNA 
concentration showed the relationship to be in accordance with a Michaelis Menten 
model of enzyme substrate interaction, ignoring the effect of AdoMet concentration 
(Figure 5.31). Chapter 5 
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Figure  5.31  Dependence  of  P.  horikoshii  Dam  activity  on  oligonucleotide 
concentration. 
 
Data  were  fitted  to  the  Michaelis Menten  equation  (v = Vmax [DNA] / (KM 
DNA  + 
[DNA])  with  an  R
2  of  0.99  to  obtain  values  for  KM 
DNA  and  kcat.  Values  for  these 
parameters were determined as 1.91 ± 0.14 nM and 0.25 ± 0.01 min 
 1 (106 ± 2 pmol 
mg
 1  s
 1)  respectively.  The  errors  are  higher  for  the  data  points  at  low  DNA 
concentrations  because  assays  contained  Dam  at  10  %  of  the  DNA  concentration. 
Correction factors were used in the analysis to standardise the rates so they appeared to 
be for the same amounts of Dam. 
 
Over  half  of  the  measurements  used  to  determine  KM 
DNA  relied  on  an  amount  of 
methylation  below  the  previously  estimated  222 fmol  limit  of  FEP  assay  sensitivity 
(Table  5.5).  Despite  this,  the  data  did  fit  the  Michaelis Menten  model  of  enzyme 
activity  very  well.  The  assay  is  probably  more  sensitive  than  the  previous  estimate 
because initial rate measurements are based on the fit of a trend line to seventy five 
successive  data  points,  which  has  an  averaging  effect.  By  contrast  the  initial  rate 
measurements used to determine KM 
DNA for Y. pestis Dam, measured with the coupled 
assay, were based on the fit of a trend line to just seven data points. This was because 
the  Y.  pestis  Dam  quickly  inactivated,  leaving  a  short  initial  period  when  the 
fluorescence timecourses were linear.  
 Chapter 5 
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DNA concentration in 
assay (nM) 
Dam concentration in 
assay (nM) 
Amount of methylation used to 
determine rate (fmol) 
15.0  1.50  894 
10.0  1.00  561 
6.7  0.67  346 
4.4  0.44  198 
3.0  0.30  118 
2.0  0.20  72 
1.3  0.13  34 
0.9  0.09  19 
Table  5.5  Amount  of  methylation  used  to  determine  the  rates  in  assays  for  the 
measurement of KM 
DNA. 
  
It is also relevant that the sensitivity of 222 fmol was calculated with a background 
fluorescence  from  50  nM  duplex  DNA.  At  lower  DNA  concentrations  the  assay 
sensitivity is increased. Estimating assay sensitivity from the standard deviation in the 
measurements  on  the  linear  portion  of  the  15,  10,  6.7  and  0.9  nM  DNA  assay 
fluorescence timecourses gives values of 74, 55, 42 and 24 fmol (Figure 5.29, lower 
graph, black, red, green and grey lines). 
 
The KM values for both of the P. horikoshii Dam substrates appear reasonable when 
compared to literature values for similar enzymes (Table 5.6). The KM for AdoMet was 
396 ± 33 nM, lower than the 11.3  M calculated for Y. pestis Dam with the coupled 
enzyme assay or literature values for E. coli Dam (Table 5.6) (1). The value is closer to 
that of MTases from the thermophiles T. thermophilus and P. abyssi. AdoMet is known 
to be unstable in solution and it may well be that the higher affinity of the thermophilic 
MTases for AdoMet is a reflection of its relative paucity within the cell (12,13). The 
thermophilic methyltransferases may derive a beneficial stabilisation from binding to 
their substrates. DNA and AdoMet did stabilise Dam from the mesophile Y. pestis and 
substrate stabilisation of thermophilic enzymes is well known (1,14 16). If this were 
true then a high affinity for AdoMet would help to preserve the enzymes at elevated 
temperatures.  
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E. coli (17)  GATC  20 bp 
Duplex 




TCGA  36 bp 
Duplex 
600 ± 200  3.7 ± 1.1  44 ± 7 
T. thermophilus 
(19) 
TCGA  λ DNA     0.8  0.25 
P. abyssi (9) 
c  GTAC  40 bp 
Duplex 
159  1.28  2.46 
P. horikoshii 
a  GATC  13 bp 
Duplex 
1.9 ± 0.1  0.40 ± 0.03  0.24 ± 0.06 
Table 5.6 A comparison of the kinetic parameters of N6 adenine MTases found in E. 
coli and four thermophilic organisms.
a Results from this study at 32 33 °C.
b Values 
obtained at 60 °C.
c Values obtained at 75 °C. 
 
The KM 
DNA of P. horikoshii Dam was, at 1.9 nM, lower than any of the values for the 
mesophilic MTases listed in table 3.2 with oligonucleotide substrates. This observation 
can be explained in the same way as the tight AdoMet binding. If the DNA substrate 
stabilises  the  enzyme  then  a  high  affinity  will  serve  to  protect  the  thermophilic 
methyltransferase from inactivation. The high temperatures at which the T. aquaticus 
and P. abyssi MTases were assayed might account for the comparatively high KM 
DNA 
they both possess. 
 
At 0.24 min
 1 the kcat was lower than the value of 0.55 min
 1 measured for Y. pestis Dam 
and reported rates for E. coli and T4 Dam at 37 °C (table 3.2). Thermophilic enzymes 
are  often  slower  than  their  mesophilic  counterparts  if  assayed  at  low  temperatures 
because of their higher structural rigidity (14). The thermophilic adenine MTase of T. 
thermophilus, which was assayed at 37 °C, had a value of kcat similar to P. horikoshii 
Dam (Table 5.6). This value was not measured with an oligonucleotide substrate. 
 
 
The effect of the 200 mM sodium chloride concentration on the measured methylation 
rate was not investigated. This value had been chosen, for expediency, based on the Chapter 5 
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salinity under which a Pyrococcus abyssi adenine MTase was active (9). It also gave 
convenient melting temperatures for the DNA duplex substrate.  At this salinity the Y. 
pestis enzyme would have appeared inactive, based on observations from the coupled 
enzyme  assay.  E.  coli  Dam  is  reported  to  retain  35  %  activity  in  tris  buffer 
supplemented with 200 mM sodium chloride (20). 
 
5.3.4 Application of the FEP assay principle to another DNA modifying enzyme 
 
Uracil DNA glycosylases catalyse the excision of uracil bases from DNA. A direct real 
time fluorescence based assay for the activity of this enzyme has been reported in the 
literature  (21).  This  assay  uses  the  removal  of  four  uracil  bases  to  cause  complete 
melting of a 14 bp duplex labelled with a FRET pair.  
 
A  proof  of  principle  experiment  was  carried  out  to  determine  if  it  was  possible  to 
monitor the excision of single uracil bases from a 13 bp duplex in real time with the 
FEP  assay.  For  simplicity,  these  assays  were  prepared  in  the  same  way  as  the  P. 
horikoshii Dam assays but without AdoMet. The DNA duplex used consisted of ODN 
4, also used in the Dam assay, and ODN 5, a complementary uracil containing strand 
labelled with a dabcyl quencher (Table 5.7). 
 
Strand  DNA Sequence 5’ to 3’ 
ODN 4  ATTTAGATCACAA 
ODN 5  TTGTGAUCTAAAT 
Table 5.7 Sequences of oligonucleotides used in the uracil DNA glycosylase assay. 
 
Triplicate assays containing 50 nM duplex were initiated with 0, 63, 125 and 250 pM of 
commercially  available  Archaeolobus  fulgidis  uracil DNA  glycosylase.  An  equal 
number  of  negative  controls  were  initiated  without  uracil DNA  glycosylase.  The 
fluorescence timecourses of the assays were measured at 31 °C (Figure 5.32). 
 Chapter 5 
  140
Time (s)
































































































































Figure 5.32 (Upper graph) Raw fluorescence timecourses for activity assays containing 
250  (grey),  125  (green),  63  (blue)  and  0  (black)  pM  Afu UDG.  (Middle  graph) 
Fluorescence increases (triplicate averaged) for activity assays (solid lines, 0 – 250 pM Chapter 5 
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Afu UDG) and their negative controls (dashed lines, 0 nM Afu UDG). (Lower graph) 
Fluorescence increases (triplicate averaged) after subtraction of their respective negative 
controls. 
 
Initial rates of fluorescence increase in the assays containing 0, 63, 125 and 250 pM 
Afu UDG were 0.1 ± 0.6, 2.7 ± 0.7, 5.3 ± 1.0 and 9.7 ± 0.8 respectively. The initial rates 
of  fluorescence  increase  were  therefore  proportional  to  the  amount  of  uracil DNA 
glycosylase in the assays. This result provides evidence that the FEP assay could be 




5.4 Summary and conclusions  
 
The Dam gene from the hyperthermophilic archaeon Pyrococcus horikoshii was cloned 
and placed in an expression plasmid, pMMS511811, under the control of an arabinose 
inducible promoter. Expression and purification of the C terminally His6 tagged Dam 
by immobilised nickel affinity chromatography yielded not only the full length protein 
but a shorter contaminant. Sequencing showed that the 28,556 Da contaminant was due 
to  mis initiation  of  translation  beginning  at  what  should  have  been  an  internal 
methionine residue. SDS PAGE carried out by Koike and co workers on P. horikoshii 
Dam which they expressed in E. coli BL21 (DE3) also shows the presence of a 28 kDa 
protein (22). It may be that they too were seeing the same product of mis translation. 
Mutagenesis of the dam gene to replace the problematic codon with that of alanine 
facilitated isolation of purer N His6 P. horikoshii Dam. 
 
The thermophilic methyltransferase was shown to be active with a gel based assay and 
subsequently  used  in  a  novel  Fluorescence  Equilibrium  Perturbation  (FEP)  activity 
assay. It was demonstrated that in the FEP assay the measurements of the methylation 
rate  were  not  limited  by  the  kinetics  of  the  duplex  association  and  dissociation. 
Fluorescence increases in the assay reflected methyltransferase activity. This was the 
first example of a direct, fluorescence based, real time assay suitable for studying subtle 
base  modifications.  The  assay  was  successfully  used  to  measure  some  kinetic 
parameters for P. horikoshii Dam. The KM of both substrates and the maximum rate of Chapter 5 
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Dam  catalysis,  kcat,  were  determined  and  judged  to  be  reasonable  on  the  basis  of 
literature reports on other methyltransferases. The FEP assay was estimated to be at 
least ten fold less sensitive than the coupled enzyme assay under similar conditions. 
This lower sensitivity was compensated for by the stability of P. horikoshii Dam which 
allowed  reliable  kinetic  measurements  to  be  made  at  a  wide  range  of  substrate 
concentrations.  
 
The FEP assay principle was used in conjunction with another enzyme, Archaeolobus 
fulgidis  uracil DNA  glycosylase,  to  demonstrate  its  possible  application  beyond  the 
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Chapter 6:  Overall conclusions and future work 
 
6.1 Y. pestis, Dam and the need for novel antibacterial compounds 
 
Thousands of cases of bubonic plague occur annually and MDR strains of Y. pestis, the 
causative agent, have been isolated (1,2). There is concern that Y. pestis could be used 
as a biological weapon (3).  
 
Dam is an enzyme with a regulatory role in Y. pestis and has a proven link to virulence. 
This has led to the suggestion that Dam inhibitors could provide a novel source of 
antibiotics (4). 
 
With the aim of identifying and characterising such inhibitors, two new assays for Dam 
activity were developed. The first, a coupled enzyme assay, was used to characterise Y. 
pestis Dam and screen a library of compounds for inhibitors. The other, a direct assay, 
was demonstrated with the hyperthermophilic P. horikoshii Dam.  
 
6.2 Development of an assay for Dam activity 
 
Y. pestis Dam was expressed from plasmid pRJW421307 in E. coli strain GM215. The 
protein had an N terminal His6 tag which facilitated purification by immobilised nickel 
affinity chromatography. To maximise activity of this unstable enzyme the purification 
procedure and dialysis were carried out at 4 °C and kept as short as possible. 
 
The DpnI restriction endonuclease was expressed from plasmid pMMS495859 in E. coli 
strain GM48. The protein had an N terminal His6 tag which permitted purification by 
immobilised  nickel  affinity  chromatography.  DpnI  was  observed  to  be  subject  to 
degradation and so selection of an appropriate expression strain and use of protease 
inhibitors were essential to maximise enzyme quality. 
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A fluorescence based coupled enzyme assay for Y. pestis Dam activity was developed. 
Assay efficacy relied on a well designed oligonucleotide substrate. It was important that 
the  FRET  pair  were  in  close  proximity  and  that  the  oligonucleotide  had  an  ‘n 1’ 
methylation  pattern,  where  n  is  the  number  of  methyl  groups  recognised  by  the 
restriction enzyme in the assay. The signal to background noise ratio of the assay was 
improved by optimisation of the salt concentration. 
 
Future work could include trying to expand the range of MTases which can be assayed 
with the real time coupled enzyme approach. To some extent this process has begun 
with the development of a coupled enzyme assay for Dnmt1 activity within the Roach 
group (5). This assay came about after it was noticed that restriction enzyme GlaI had 
the appropriate recognition sequence to complement Dnmt1 (M. Maynard Smith). A 
potentially important restriction enzyme which could be used in a similar manner is Mrr 
(methylated adenine recognition and restriction) which is part of the restriction system 
of E. coli responsible for recognising foreign DNA. Mrr appears to recognise not just 
one  but  a  variety  of  m6A  and  m5C  containing  sequences  including  (m5C)G  and 
G(m6A)NTC,  the  sequences  formed  by  Dnmt1  and  CcrM  respectively  (6 9).  It  is 
however unclear if the enzyme is specific for the fully or hemi methylated sequences. If 
Mrr could be substituted for GlaI in a Dnmt1 activity assay it would be advantageous 
because the mrr gene could be cloned from E. coli DNA and the enzyme overexpressed. 
 
6.3  Kinetic  characterisation  of  Y.  pestis  Dam  and  validation  of  the 
assay 
 
The fluorescence signals of the real time, coupled enzyme, assay were quantified with a 
set of calibration experiments. Activity measurements made with the assay showed that 
Y. pestis Dam inactivated rapidly in solution without either of its substrates present. 
This inactivation was significantly reduced when Dam was incubated with its DNA 
substrate.  
 
The affinity of Dam for both of its substrates was determined with the assay. Whilst the 
KM 
AdoMet was similar to literature reported values the measured KM DNA was somewhat 
lower and subject to a large error. This large error in the value was attributed to enzyme Chapter 6 
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instability and not an inherent weakness in the assay strategy. The measured rate of Y. 
pestis Dam turnover was considered plausible in view of the range of values reported 
for other DNA MTases.  
 
The  ability  of  the  assay  to  characterise  Dam  inhibitors  was  proven  by  using  it  to 
measure the Ki of AdoHcy. This known inhibitor is competitive with AdoMet and so 
low DNA concentrations, where the assay appears least effective, were not necessary. 
Future work could include use of the assay to characterise different inhibitors with other 
known  modalities  of  action.  Benkovic’s  borinic  esters  or  some  of  the  compounds 
discovered by Mashoon and co workers could be used for such purposes (10,11).  
 
It would be interesting to determine if certain dsDNA mimicking proteins could act as 
inhibitors of Dam. Protein HI145 found in H. influenzae has homologues in E. coli, P. 
multocida, S. typhimurium, V. cholerae and Y. pestis and might be a good initial dsDNA 
mimic to study since its target is unknown (12,13).  It is conceivable that a protein 
mimic  could  be  found  or  designed  specifically  to  inhibit  Dam  (14 16).  The  DNA 
mimicking protein Ugi inhibits the enzyme Uracil DNA glycosylase which, like Dam, 
flips a base out from the DNA double helix (17). 
 
It would be relatively easy to characterise E. coli Dam with the coupled enzyme assay 
since it is now being expressed and purified within the Roach group (J. Mckelvie and J. 
Harmer). This would allow comparison of measured kinetic parameters with ones for 
the identical enzyme reported in the literature. 
 
6.4 High throughput screening for Y. pestis Dam inhibitors 
 
A  1000  compound  library  was  screened  for  Dam  inhibitors  using  the  fluorescence 
based, coupled enzyme assay. Following reprocessing of the data, four compounds were 
identified  as  potential  Dam  inhibitors.  Three  of  these  compounds  of  interest  were 
successfully  synthesised  and  subjected  to  a  counter screen  against  DpnI  and  a 
fluorescence intercalation displacement assay for DNA binding. Results suggested that 
all three of the synthesised compounds were non selective Dam inhibitors exerting their 
effects through interaction with the DNA substrate. The remaining compound showed Chapter 6 
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considerable homology to two of the compounds which had been synthesised and so 
would most likely have been a non selective inhibitor. 
 
One drawback of the coupled assay was its reliance on two enzymes, Dam and DpnI. 
Where compounds were identified which inhibited both enzymes it was not possible to 
obtain an accurate IC50 for Dam, with the measured value merely being an apparent 
IC50. Values for the DpnI IC50 could be determined from the counter screen data. This 
highlighted the need for a direct fluorescence based Dam activity assay. 
 
Since this initial screen of 1000 compounds the coupled assay has been successfully 
employed  in  384  well  format  and  used  to  screen  a  library  of  3000  compounds  in 
duplicate (J. Mckelvie). Future work should and will include use of the coupled enzyme 
assay to screen additional compound libraries and to study the potential inhibitors which 
have been logically designed (Dr. G. Hobley). 
 
6.5 A novel and direct assay for Dam activity 
 
P. horikoshii Dam was expressed in E. coli strain BL21 pLysS Rosetta 2 with a C 
terminal  His6 tag  and  when  purified  by  immobilised  nickel  affinity  chromatography 
found to be contaminated with a shorter protein. N terminal amino acid sequencing 
revealed this protein to be a fragment of the full length enzyme formed by mis initiation 
of translation at an internal methionine residue. The sequence 5’ to this   methionine / 
start  codon,  GAAAGGGAGTACTACTATAGA[ATG],  happens  to  encode  a 
Shine Dalgarno sequence 13 bp upstream (underlined) (18 20). This observation could 
explain why translation began at this internal methionine whilst it was not observed at 
others. Pure N His6 P. horikoshii Dam was obtained following mutagenesis of the Dam 
gene to replace the problematic internal methionine residue with alanine. A superior 
approach  to  this  problem  may  have  been  to  mutate  the  sequence  upstream  of  the 
methionine to decrease the mRNA affinity for the 16s rRNA. In this way, because of the 
degeneracy in the genetic code, the contaminant protein expression could have been 
eliminated whilst the wild type protein sequence was retained. Optimising this region of 
the Dam gene to retain the wild phenotype and stop unwanted translation could form the 
basis of future work for a summer placement student. Chapter 6 
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Mutant thermophilic Dam was successfully used in a novel  and direct fluorescence 
based assay for adenine MTase activity. This Fluorescence Equilibrium Perturbation 
assay used the inherent destabilising effect of adenine methylation to increase the mean 
distance between an adjacent FRET pair on an oligonucleotide substrate. The KM of 
both substrates and the maximum rate of methylation were measured with this assay. 
 
The 200 mM sodium chloride concentration in the assay was, for expediency, simply 
based upon the conditions under which another thermophilic adenine MTase was known 
to  function  (21).  Future  work  could  include  an  investigation  into  the  relationship 
between salt concentration and P. horikoshii Dam activity. Collection and analysis of 
FEP assay data at a range of sodium chloride concentrations would not necessarily be 
straight forward due to changes in DNA melting kinetics and temperature with salinity. 
With  proper  calibration  experiments  it  should  however  be  possible  and  the  results 
would help assess the limits of the assay. 
 
The FEP assay provided a way to measure DNA methylation without the need for DpnI 
but it had disadvantages as well as advantages over the coupled assay. It was estimated 
that under similar conditions the FEP assay would be ten times less sensitive than the 
coupled enzyme assay. It also required a large number of negative controls interspersed 
with  the  activity  assays.  Tight  temperature  control  in  a  BMG  plate  reader  and  the 
stability of P. horikoshii Dam compensated for this lower sensitivity and allowed good 
experimental results to  be obtained. The specific oligonucleotide duplex limited the 
temperatures and salt concentrations which could be used in the FEP assay but DpnI 
places  similar  constraints  on  the  coupled  assay.  DpnI  based  assays  are  limited  to 
temperatures below ~ 40 °C, sodium chloride concentrations under ~ 150 mM and the 
recognition sequence GATC. With an appropriate set of oligonucleotides the FEP assay 
could be operated at a much wider range of temperatures, salinities and recognition 
sequences. Any Y. pestis Dam inhibitors identified from a high throughput screen could 
be  tested  with  the  FEP  assay  against  adenine  MTases  with  non GATC  recognition 
sequences. One such MTase is CcrM which recognises the sequence GANTC and is 
essential for viability in the pathogen Brucella abortus (22,23).  
 
Future work could include evaluation of the FEP assay in high throughput format and 
its use with the less stable Y. pestis Dam. For high throughput screening a stopped Chapter 6 
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version of the assay, in which methylation is carried out at a low temperature before the 
fluorescence is measured near the Tm, may be appropriate. It seems likely that with its 
higher sensitivity and need for fewer negative controls the coupled assay will still be the 
best method to initially screen for Y. pestis Dam inhibitors. The FEP assay could then be 
used as part of the counter screening process and to identify the mode of inhibition. 
 
Coupled  enzyme  assay  results  could  be  improved  by  the  use  of  a  thermally  stable 
enzyme, but it would not be appropriate to simply substitute P. horikoshii for Y. pestis 
Dam  in  a  library  screen.  Future  work  could  involve  engineering  of  a  hybrid 
methyltransferase which retains the majority of the Y. pestis Dam amino acids but has 
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Chapter 7:  Experimental 





® DNA polymerase and dNTPs were purchased from Stratagene. BioXACT 
Short
® and Mango Taq
® DNA polymerases were purchased from Bioline along with 
their associated reaction buffers. PCR primers were purchased from Sigma Genosys. 
Restriction  enzymes  were  purchased  from  New  England  Biolabs  and  used  with  the 
manufacturer’s  recommended  buffer.  New  England  Biolabs  buffer  compositions  are 
given in appendix H. T4 DNA Ligase and Wizard
® SV minipreps were purchased from 
Promega. QIAquick
® PCR cleanup and gel extraction kits were purchased from Qiagen. 
Electrophoresis grade agarose was purchased from Sigma Aldrich.  
 
Plasmids pRJW421307 (created by Dr. R. J. Wood), pCLW469397 (created by Dr. R. J. 
Wood and Miss C. Williams) and pMK171 (created by Dr. M. Kriek) were kept in 
frozen stocks at the University of Southampton. Plasmid pBADHisA was originally 
obtained from Invitrogen and kept in stocks at the University of Southampton. Plasmid 
pLS251, containing the dpnI gene, was a kind gift from Professor Sanford Lacks of 
Brookhaven National Laboratory. Pyrococcus horikoshii genomic DNA was obtained 
from the NITE Institute. DNA sequencing was carried out by Eurofins MWG Operon. 
 
E. coli strains beginning with GM were obtained from the Yale E. coli genetic stock 
centre. E. coli strain TOP10 was originally obtained from Invitrogen and, with all other 
strains used, kept in frozen stocks at the University of Southampton.  
 
Bacto tryptone and yeast extract were obtained from Oxoid. Ampicillin and DTT were 
obtained from Melford Laboratories Ltd. Bacto agar and SDS were purchased from 
Fisher Scientific. Complete, mini, EDTA free, protease inhibitor cocktail tablets were 
from  Roche.  Chelating  fast  flow  resin  was  from  Pharmacia  and  acrylamide  /  bis Chapter 7 
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acrylamide solution was from Amresco. N terminal protein sequencing was carried out 
by Cambridge Peptides. 
 
Microplates used to conduct assays were purchased from Greiner Bio One Ltd. Bovine 
serum  albumin  was  from  Advanced  Protein  Products  Ltd.  S adenosylmethionine 
chloride  and  S adenosylhomocysteine  were  purchased  from  Sigma  Aldrich.  All 
fluorescently labelled oligonucleotides used in assays were obtained from ATD Bio.  
 
1 Methylpiperazine,  tris(dibenzylideneacetone)diplladium(0),  4,5 
bis(diphenylphosphino) 9,9 dimethylxanthene  and 
tetrakis(triphenylphosphine)palladium(0)  were  purchased  from  Sigma  Aldrich.  [3 (2 
N,N dimethylaminoethylaminocarbonyl)phenyl]  boronic  acid  was  purchased  from 
Combi Blocks.  Pyridine 3 boronic  acid  was  purchased  from  Alfa  Aesar.  2,5 
Dibromopyrazine  and  6,8 dibromoimidazo[1,2 a]pyrazine  were  purchased  from 








Agarose gel electrophoresis was carried out in a Bio Rad mini sub cell. SDS PAGE was 
carried out in a Bio Rad mini PROTEAN
® cell. Electroblotting was carried out in a 
Bio Rad  mini  trans blot
®  electrophoretic  transfer  cell.  Short  oligonucleotide  gel 





Centrifugation was typically carried out at 4 °C in a Sorval Evolution RC centrifuge 
(Thermo  Scientific)  with  an  SLC 6000  (8000  g),  SLA 1500  (17,500  g)  or  SS 34 
(25,000 g) fixed angle rotor. Centrifugation of small overnight cultures (< 10 ml) was Chapter 7 
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carried out at 4 °C in a Heraeus Contifuge Stratos centrifuge with rotor #3057 (3000 g). 




pH measurements were determined using an Inolab level 3 bench pH meter with Sentix 





Liquid cultures were incubated in a New Brunswick Innova 44R shaker with orbital 
shaking, typically at 180 rpm. Cultures on solid media were incubated in a Heraeus 
Function Line incubator at 37 °C. 
 
Enzyme activity assays 
 
The activities of Y. pestis Dam and DpnI were measured in a Tecan Safire II microplate 
reader.  For  high  throughput  experiments  Y.  pestis  Dam  assays  were  prepared  and 
initiated using a Beckmann Coulter Biomek 3000 liquid handling system. Assays of 
P. horikoshii Dam activity were carried out in a BMG PolarStar Omega microplate 
reader.  
 
DNA melting analysis 
 
DNA melting profiles were measured in a Roche Lightcycler (ex 488 nm, em 520 nm). 
 
7.1.2 General experimental methods 
 
Standard sterile techniques were used during microbiological manipulations. Growth 
media, glassware and plastic pipette tips were sterilised in an autoclave and heat labile 
materials  such  as  ampicillin  and  arabinose  were  filter  sterilised  through  Millipore 
0.22  m filters. Plastic tubes for bacterial cell culture were pre sterilised by gamma 
irradiation. Chapter 7 
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SOC and 2YT bacterial growth media was prepared as described by Sambrook et al (1). 
Antibiotics were typically used to supplement media at the following concentrations: 
ampicillin, 100  g ml
 1; chloramphenicol, 30  g ml
 1; kanamycin, 10  g ml
 1. Plasmids 
and their antibiotic resistance markers are shown in appendix A. Protein expression 
from these pBad derived plasmids was induced by the addition of 0.2 % w/v arabinose 
to  the  growth  media.  Protein  samples  were  manipulated  at  4  °C  or  on  ice  unless 
otherwise stated. 
 
Method 1. Agarose gel electrophoresis 
 
Powdered agarose was added to 1 x TAE buffer (40 mM tris base, 20 mM acetic acid, 1 
mM EDTA) to give a 1 % w/v suspension. The mixture was heated with microwave 
irradiation  and  gently  swirled  to  achieve  complete  dissolution  of  the  agarose.  Once 
partially cooled the solution was poured into the gel mould and allowed to solidify 
around  a  comb.  DNA  samples  were  mixed  with  6  x  loading  buffer  (water,  20  % 
glycerol, 0.05 % bromophenol blue) and added to gel wells formed by removal of the 
comb. Gels were run at 4   5 V cm
 1 for 40 – 80 minutes and visualised under UV light 
following staining with ethidium bromide. 
 
Method 2. Miniprep isolation of plasmid DNA 
 
Plasmid  DNA  was  isolated  using  a  Wizard
®  Plus  SV  Minipreps  DNA  Purification 
System according to the manufacturer’s instructions. Plasmid DNA was eluted in filter 
sterilised water. 
 
Method 3. Agarose gel purification of DNA 
 
DNA samples were separated by electrophoresis on a 1 % agarose gel as described in 
general  method  1.  Bands  containing  DNA  of  interest  were  excised  and  the  DNA 
isolated  using  a  QIAquick
®  gel  extraction  kit  according  to  the  manufacturer’s 
instructions. 
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Method 4. Glycerol freeze preparation 
 
Frozen stocks of bacterial cell strains were prepared by gently mixing 125  l of sterile 
glycerol with 500  l of bacterial culture in a 1.5 ml microcentrifuge tube. These stocks 
were stored at  80 °C until required. 
 
Method 5. Determination of protein concentration 
 
Protein concentration was determined with the method of Bradford (2). Protein solution 
of unknown concentration (20  l) was mixed with 1 ml of Bradford reagent in a cuvette. 
The absorbance at 595 nm was measured after the spectrophotometer had been reset 
using a negative control containing 1 ml Bradford reagent and 20  l of water. This 
absorbance was compared to a 20  l sample of 1 mg ml 
 1 BSA. Calibration curves were 
prepared for each batch of Bradford reagent to ensure that the relationship between 
protein concentration and absorbance was linear between an absorbance of 0 and 1. 
 
Method 6. Preparation of competent cells 
 
Solutions TBF I and II were prepared according to the table (Table 7.1). Overnight 
cultures of E. coli were used as a 1 % inoculum for 100 ml of 2YT media. Cultures 
were maintained at 37 
oC with orbital shaking at 180 rpm until an absorbance of 0.6 at 
600 nm was reached. Cultures were then cooled on ice for ten minutes and separated 
into  50  ml  aliquots.  Cells  were  pelleted  by  centrifugation  for  10  minutes  at  4  °C 
(Heraeus Contifuge Stratos, rotor #3057, 4000 rpm) and the supernatant decanted off. 
The tubes were inverted on paper towel for 1 minute.  
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Solutions for competent cell preparation 
TBF I (pH 5.8)  Potassium acetate (30 mM) 
Rubidium chloride (100 mM) 
Calcium chloride (10 mM) 
Manganese chloride (50 mM) 
Glycerol 15 % v/v 
TBF II (pH 6.5)  MOPS (10 mM) 
Calcium chloride (75 mM) 
Rubidium chloride (10 mM) 
Glycerol 15 % v/v 
Table 7.1 
 
Each pellet was resuspended in 5 ml of TBF I solution and stored on ice. Cells were 
recovered by centrifugation as before. Each pellet was resuspended in 2 ml of TBF II 
solution. Aliquots of 100  l were quick frozen on dry ice and stored at  80 
oC. 
 
Method 7. SDS PAGE 
 
7a. Buffer preparation 
 
SDS PAGE was carried out using the stock solutions and buffers described in the table 
below (Table 7.2). 
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Buffers and stock solutions for SDS PAGE 
1 x SDS PAGE loading buffer  Tris.HCl (50 mM, pH 6.8) 
Dithiothreitol (100  M) 
SDS (2 %) 
Bromophenol blue (0.1 %) 
Glycerol (10 %) 
1 x Tris glycine electrophoresis buffer  Tris (25 mM) 
Glycine (250 mM, pH 8.3) 
SDS (0.1 %) 
Gel stain (100 ml)  Coomassie brilliant blue R250 (0.25 g) 
Methanol (45 ml) 
Water (45 ml) 
Glacial acetic acid (10 ml) 
Gel destain  Water (87.5 %) 
Methanol (5 %) 
Acetic acid (7.5 %) 
Table 7.2 
 
7b. Preparation of 15 % polyacrylamide gels 
 
Polyacrylamide  gels  contained  the  components  listed  in  the  table  (Table  7.3). 
Components were gently mixed together in the order shown, poured into glass moulds 
and allowed to set.  Whilst the 5 ml main gels were setting they were overlaid with 
50 % aqueous isopropanol. Once set, the aqueous isopropanol was removed and 1 ml of 
stacking gel and a comb were added to the mould. When solidified, gels were stored in 
moist tissue at 4 ºC until required. 
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Polyacrylamide gel components (ml) 
  15 % Main Gel (5 ml)  5 % Stacking Gel (5 ml) 
Water  1.1  3.4 
Acrylamide / bis acrylamide  
solution (30 % w/v, 37.5:1) 
2.5  0.83 
Tris (1.5 M, pH 8.8) and 
 (1 M, pH 6.8) respectively 
1.3  0.63 
SDS (10 % w/v)  0.05  0.05 
APS (10 % w/v)  0.05  0.05 
TEMED  0.002  0.005 
Table 7.3 
 
7c. Sample analysis 
 
Samples were mixed 1:1 with 2 x SDS PAGE loading buffer and heated at 95 
oC for 2 
minutes.  Alternatively,  in  the  case  of  expression  studies,  100   l  of  sample  loading 
buffer was added to cells harvested from 1 ml of culture and heated. The wells of the gel 
were filled with 20  l, or 2  l in the case of expression studies, of sample in loading 
buffer.  Electrophoresis  was  carried  out  at  200  V  in  1  x  tris glycine  electrophoresis 
buffer for 40 – 60 minutes. Gels were stained with coomassie blue and photographed 
following agitation in gel destain for 12 48 hours.  
 
Method 8. Tricine SDS PAGE 
 
8a. Buffer preparation 
 
Tricine SDS PAGE was carried out using the stock solutions and buffers described in 
the table below, based on a protocol by Schägger (Table 7.4) (3). 
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Tricine SDS PAGE buffers and stock solutions 
AB 3 stock  Acrylamide (48 g) 
Bisacrylamide (1.5 g) 
Water (bring to 100 ml) 
Gel buffer (3 x) pH 8.45  Tris (3 M) 
HCl (1 M) 
SDS (0.3 %) 
Anode buffer (10 x) pH 8.9  Tris (1 M) 
HCl (0.225 M) 
Cathode buffer (10 x) pH 8.25  Tris (1 M) 
Tricine (1 M) 
SDS (1 %) 
Sample loading buffer pH 7.0  SDS (12 % w/v) 
2 Mercaptoethanol (6 % v/v) 
Glycerol (30 % w/v) 
Coomasie blue G 250 (0.05 %) 
Tris.HCl (150 mM) 
Table 7.4 
 
8 b. Preparation of 16 % polyacrylamide gels 
 
Gels contained components listed in the table below (Table 7.5) and were prepared as 
described for normal SDS PAGE. 
 
Gel components 
Component  16 % Main Gel (30 ml)  4 % Stacking Gel (12 ml) 
AB 3 (ml)  10  1 
Gel Buffer (3 x) (ml)  10  3 
Glycerol (g)  3    
Water to volume (ml)  30  12 
10 % w/v APS ( l)  100  90 
TEMED ( l)  10  9 
Table 7.5 Chapter 7 
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8 c. Sample analysis 
 
Protein samples were mixed 3:1 with sample loading buffer and incubated at 37 °C for 
15 minutes. The gel electrophoresis apparatus was assembled with the gel and electrode 
buffers filling the appropriate sections. Samples of 50  l were loaded and the gel run at 
30 V until samples had entered the stacking gel. The voltage was then maintained for 3 
– 4 hours at 200 V.  Protein bands on the gel were visualized with coomassie staining as 
for SDS PAGE (general method 7).  
 
Method  9.  Preparation  of  20  %  polyacrylamide  gels  for  the  resolution  of 
oligonucleotides 
 
Components listed in the table were mixed and sonicated in a conical flask until no 
particulate material remained (Table 7.6).  
 
Component  Quantity 
Acrylamide / bis acrylamide (40 % w/v, 19:1)  35 ml 
TBE buffer (10 x ) [890 mM tris base, 890 mM boric acid, 
200 mM EDTA] 
7 ml 
Urea  29.4 g 
Water  5 ml 
Table 7.6 
 
To initiate polymerisation, 49  l of TEMED and 490  l of a 10 % APS solution were 
added to the solution. This mixture was immediately transferred into the 14 x 24 cm gel 
mould  containing  an  appropriate  comb.  Once  solidified,  the  gel  was  pre run  at  a 
constant 20 W for 2 3 hours in 1 x TBE buffer and then used for sample analysis. 
 
Method 10. Recharging of the nickel affinity column 
 
The 5 ml bed volume nickel column was stripped with a solution of 50 mM EDTA in 
50 mM tris until no blue colouration was observed on the column. The column was then 
sequentially washed with the solutions listed in the table below (Table 7.7).  Chapter 7 
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Solution  Quantity (ml) 
1. Water  100 
2. NiSO4 (0.2 M)  10  
3. Water  50 
4. Low imidazole buffer*  50 
5. High imidazole buffer*  50 
6. Low imidazole buffer  100 
Table 7.7 * Buffer composition varied depending on the subsequent protein to be purified. Low and 
High imidazole buffers typically contained 50 mM and 500 mM imidazole respectively. 
 
Method 11. Dam activity assays for the kinetic analysis of Y. pestis Dam 
 



















 Chapter 7 
  162
Dam activity assay buffers 
Buffer A (pH 7.9)  Tris acetate (22.4 mM) 
Sodium chloride (23.5 mM) 
Potassium acetate (56 mM) 
Magnesium acetate (11.2 mM) 
Dithiothreitol (1.12 mM) 
BSA (0.12 mg ml
 1) 
S adenosylmethionine (0 – 235  M) 
Oligonucleotide (0 – 35  M)   
Buffer B (pH 7.9)  Tris acetate (20 mM) 
Potassium acetate (50 mM) 
Magnesium acetate (10 mM) 
Dithiothreitol (1 mM) 
Buffer C (pH 7.4)  Tris.HCl (48 mM) 
EDTA (9.6 mM) 
2 Mercaptoethanol  (4.8 mM) 
BSA (0.4 mg ml
 1) 
Oligonucleotide (30 nM) 
Table 7.8 
 
Fluorescence changes were monitored in a microplate reader using 10 reads per well, 
0.5 s delay between movement and reading, 1 s of shaking between data collections and 
7 s of post shake settling time. Excitation and emission wavelengths were 486 nm and 
518  nm  respectively  with  bandwidths  of  5  nm.  The  gain  was  200,  the  Z position 
9300  m and the integration time 40  s. 
 
Dam activity was measured in triplicate in black, flat bottomed, 96 well microplates 
with a total assay volume of 200  l, maintained at 37 ºC unless otherwise stated. 
 
Wells of a microplate were filled with 170  l of buffer A and overlaid with 3 drops of 
mineral oil. The plate was equilibrated at 37 ºC for 15 minutes and initiated by the 
addition of a mixture containing 10  l of dilute DpnI solution and 20  l of dilute Dam 
solution to each well. Dilute DpnI solution was prepared by diluting the stock solution Chapter 7 
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to 1 U  l
 1 in buffer B. Dilute Y. pestis Dam solution was prepared by defrosting an 
aliquot of 0.2 mg ml
 1 Dam stock on ice for 10 minutes and diluting it with the required 
amount of buffer C.  
 
Following  initiation,  the  plate  was  returned  to  the  microplate  reader  and  the 
fluorescence timecourses recorded. Methylation rates were calculated from the initial 
rate of fluorescence change and a calibration plot which linked these changes to DNA 
substrate  turnover.  Background  increases  in  fluorescence  were  accounted  for  by 
subtraction of a negative control lacking Dam. Data were fitted with the programme 
‘SigmaPlot’. 
 
Method 12. High throughput format Y. pestis Dam activity assays  
 
Fluorescence changes were monitored in a microplate reader using 10 reads per well 
without orbital shaking  between sets of  reads.  Excitation and emission wavelengths 
were 486 nm and 518 nm with bandwidths of 9 nm and 20 nm respectively. The gain 
was  130,  the  Z position  9300  m  and  the  integration  time  40   s.  Preparation  and 
initiation of the assays was performed using an automated liquid handling system.  
 
Dam  activity  was  measured  in  triplicate  in  black,  flat  bottomed,  96 well  half  area 
microplates with a total assay volume of 100  l maintained at 30 °C. Three buffers were 
used for the setup of the assay: Buffer A containing 5.9  M AdoMet and 35 nM ODN 3, 
buffer B and buffer C. The composition of these buffers is shown in the table above 
(Table 7.8, general method 11). 
 
An 85  l aliquot of  Buffer A was added to  each of the wells of a microplate  and 
incubated  at  30 °C  for  15  minutes.  Assays  were  initiated,  whilst  sat  on  a  Peltier 
temperature controlled block at 30 °C, by the addition of 5  l of dilute DpnI solution 
and 10  l of dilute Dam solution to each well. Dilute DpnI solution was prepared by 
diluting the DpnI stock solution to 1 U  l
 1 in buffer B. Dilute Y. pestis Dam solution 
was prepared by dilution of the stock to 20 nM in buffer C. 
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Following  initiation,  the  plate  was  returned  to  the  microplate  reader  and  the 
fluorescence timecourses recorded. Initial rates of fluorescence increase were based on a 
linear  trend line  fitted  to  the  first  675  s  of  data.  Data  from  library  screen  1  was 
evaluated with ‘HTS Corrector’software (4). 
 
Method 13. Fluorescence Equilibrium Perturbation (FEP) assays for Dam activity 
 
Fluorescence changes were recorded in a microplate reader with excitation at 490 nm, 
an emission wavelength of 520 nm and bandwidths of 10 nm. The recorded internal 
temperature variation of the plate reader was typically < 0.1 °C during experiments. 
Equal amounts of ODN 4 and M ODN 7 (appendix C) were annealed in a hot block 
overnight to form duplex ODN 4 / M ODN 7 used in the assay. Assays were prepared in 
black, flat bottomed, 96 well, half area microplates. Spaces around the wells were filled 
with 75 % aqueous glycerol to act as a thermal buffer. 
 
Dam activity was measured in duplicate or triplicate 100  l assays, overlaid with two 
drops of mineral oil, maintained at a constant temperature.  
 
FEP assays were prepared in buffer D (20 mM potassium phosphate (pH 7.8), 200 mM 
sodium chloride, 0.1 mg ml
 1 BSA) supplemented with ODN 4 / M ODN 7, AdoMet 
and  P. horikoshii  Dam.  All  components  except  the  AdoMet  were  added  to  the 
microplate and incubated for 30 minutes to allow the temperature to equilibrate. Assays 
and negative controls were initiated by the addition of 10  l of a solution of AdoMet or 
water. Assays and negative controls were interspersed on the plate in equal number. 
 
7.2 Experimental for chapter 2: Development of an assay for Y. pestis 
Dam activity 
 
7.2.1 Cloning, expression and purification of His6 M.YpeDam 
 
7.2.1.1 His6 M.YpeDam expression studies  
 
Y.  pestis  Dam  was  expressed  in  E.  coli  strains  BL21(DE3),  JM110  and  GM215 
harbouring plasmid pRJW421307. Each 10 ml overnight starter culture, grown from a Chapter 7 
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glycerol freeze, was used as a 1 % inoculum for 100 ml of 2YT media supplemented 
with 100  g ml
 1 ampicillin. Cultures were maintained at 37 ºC with orbital shaking 
until an absorbance of 0.6 at 600 nm was reached. Cells were induced with the addition 
of arabinose and maintained at 37 ºC with orbital shaking for a further four hours. Cell 
culture aliquots of 1.5 ml were harvested every hour after induction and the crude lysate 
analysed by 15 % SDS PAGE with coomasie staining. 
 
7.2.1.2 Large scale expression of His6 M.YpeDam in GM215 
 
Y. pestis Dam was expressed in E. coli strain GM215 harbouring plasmid pRJW421307. 
All purification steps were carried out at 4 ºC to preserve methyltransferase activity. 
Overnight cultures grown from glycerol freezes were used as a 1 % inoculum for 5 L of 
2YT media supplemented with 100  g ml 
 1 ampicillin. Cultures were maintained at 
37 ºC with orbital shaking until an absorbance of 0.6 at 600 nm was reached. Protein 
expression was induced by the addition of arabinose and the culture maintained for a 
further hour at 37 °C. Cells, typically 20 g, were collected by centrifugation (Sorval 
SLC 6000 rotor, 8000 rpm, 4 ºC, 12 min) and frozen at  80 ºC.  
 
7.2.1.3 Nickel affinity purification of His6 M.YpeDam 
 
Purification buffers were prepared according to the table below (Table 7.9). Chapter 7 
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Buffers for Y. pestis Dam  purification  
Low imidazole buffer (pH 9)  Tris.HCl (50 mM) 
Sodium chloride (300 mM) 
Imidazole (50 mM) 
Glycerol (10 % w/v) 
2 Mercaptoethanol (10 mM) 
Triton X 100 (0.05 % v/v) 
High imidazole buffer (pH 9)  Tris.HCl (50 mM) 
Sodium chloride (300 mM) 
Imidazole (500 mM) 
Glycerol (10 % w/v) 
2 Mercaptoethanol (10 mM) 
Triton X 100 (0.05 % v/v) 
Dam  methyltransferase  storage 
buffer (pH 7.5) 
Tris.HCl (50 mM) 
Sodium chloride (200 mM) 
Glycerol (20 % w/v) 
DTT (2 mM) 
EDTA (0.2 mM) 
Table 7.9 
 
Cell paste, typically 10 g, was resuspended in 30 ml of low imidazole buffer at room 
temperature with stirring. A 0.3 ml aliquot of 10 mg ml 
 1 lysozyme solution was added 
and the mixture stirred for 20 min at 4 ºC. The solution was put on ice and sonicated 
twenty  five  times  with  rest  intervals  of  5  s.  The  resultant  lysate  was  cleared  by 
centrifugation for 30 minutes at 4 °C (15,000 rpm, JA 25.5 rotor, Beckmann Avanti J 
25 centrifuge). The resultant supernatant was applied to a nickel column with a bed 
volume of 5 ml. The column was washed with 150 – 200 ml of low imidazole buffer 
and Y. pestis Dam was then eluted with a gradient of 0 – 100 % high imidazole buffer. 
Fractions containing Dam were identified by SDS PAGE, pooled, dialysed for two half 
hour periods into Dam methyltransferase storage buffer and frozen at  80 ºC. Protein 
concentration was determined as 0.2 mg ml 
 1 by Bradford assay. Approximately 1.5 mg 
of Y. pestis Dam was obtained from 10 g of cell paste. 
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7.2.2 Subcloning, expression and purification of His6 DpnI 
 
7.2.2.1 PCR amplification of the dpnI gene 
 
PCR reactions with a volume of 50  l were set up in sterile PCR tubes with components 
listed in the table below (Table 7.10). 
 
Component  Quantity ( l) 
Optimax buffer* (10 x)  5 
MgCl2 (50 mM)  2 
dNTP’s (2 mM each)  1 
Primers (DpnIf and DpnIr 100  M)   0.5 each 
Template plasmid DNA
# (10 – 1000 x dilution)  1 
Sterile water  39 
BioXACT short polymerase mix  1 
Table 7.10 * For colony PCR, MangoTaq DNA polymerase and buffer were used. Template DNA was 
substituted with whole cells picked into the mixture. The temperature programme was also preceeded 
with 10 minutes at 95°C. 
# Template DNA was obtained from a Wizard
® Plus SV Miniprep of a 10 ml 
overnight culture of GM33 harbouring plasmid pLS251. 
 




30 x  1 x 
95 °C, 90 seconds  68 °C 10 minutes 
                     47 °C, 90 second  Hold 4 °C 
68 °C, 90 seconds   
Table 7.11 
 
Samples of 5  l taken from the PCR reactions were analysed by 1 % gel electrophoresis 
and  the  reactions  purified  using  a  QIAquick  gel  extraction  kit  according  to  the 
manufacturer’s instructions. Chapter 7 
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7.2.2.2 Digestion of the dpnI gene 
 
Digests with a volume of 50  l were prepared in 1.5 ml microcentrifuge tubes and 
contained the components listed in the table below (Table 7.12). 
 
Component  Quantity ( l) 
PCR product or plasmid pMK171 *  25 
Sterile water  11 
Buffer 2 (10 x)  5 
BSA (1mg ml
 1)  5 
NcoI (10 U  l
 1)  2 
XhoI (20 U  l
 1)  2 
Table 7.12 * pMK171 was harvested from a 10 ml overnight culture of E.coli TOP10 using a Wizard 
® 
Plus  SV Miniprep. 
 
Digests were incubated for 2 hours at 37 °C in a water bath. Digested DNA was run on 
a 1 % agarose gel and purified using a QIAquick gel extraction kit according to the 
manufacturer’s  instructions.  Samples  of  the  purified  digested  dpnI  gene  and  pBad 
vector from pMK171 were analysed by 1 % agarose gel electrophoresis. 
 
7.2.2.3 Ligation of the dpnI gene into a pBad vector  
 
Ligation reactions contained three different vector to insert ratios and were prepared in 
PCR tubes. DNA was used as purified after digestion. Ligation reactions contained the 
components listed in the table (Table 7.13). 
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Component  Quantity ( l) 
Digested dpnI gene  6  3  0 
Digested vector  2  2  2 
Sterile water  0  3  6 
T4 DNA ligase buffer (10 x)  1  1  1 
T4 DNA ligase (1 3 U  l
 1)  1  1  1 
Table 7.13 
 
Reactions were incubated at room temperature for two hours or overnight at 4 °C. 
 
7.2.2.4 Transformation of E. coli with the DpnI expression plasmid 
 
Ligation  reactions  were  added  to  a  100   l  aliquot  of  GM2929  competent  cells 
previously thawed on ice for 15 minutes. Cells were kept on ice for a further 30 minutes 
and heat shocked in a water bath at 42 °C for 45 seconds. The cells were returned to the 
ice for 2 minutes and 250  l of SOC media added. Following incubation at 37 °C with 
orbital  shaking  for  one  hour,  150   l  of  cell  culture  was  plated  out  onto  2YT  agar 
supplemented  with  10   g  ml
 1  chloramphenicol  and  100   g  ml
 1  ampicillin. 
Transformants yielded colonies following incubation at 37 °C overnight. The newly 
formed DpnI expression plasmid was designated pMMS495859. 
 
7.2.2.5 Analytical digestion of pMMS495859 
 
Plasmid  pMMS495859  was  harvested  from  10  ml  overnight  cultures  of  GM2929 
supplemented  with  100   g  ml
 1  ampicillin  and  10   g  ml
 1  chloramphenicol  using 
minipreps.  Double and single digests were set up containing components listed in the 
table below and incubated for 1 hour at 37 °C (Table 7.14). 
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Component  Quantity ( l) 
Plasmid DNA  5  5 
Sterile water  3.5  2.5  
Buffer 4 (10 x)  1  1 
BSA (1 mg ml
 1)  1  1 
NcoI (10 U  l
 1)  0  1   
XhoI (20 U  l
 1)  1  1 
Table 7.14 
 
Digestions were analysed by 1 % agarose gel electrophoresis. 
 
7.2.2.6 His6 DpnI expression studies 
 
Overnight cultures of GM2929 harbouring pBad or pMMS495859 were used as a 1 % 
inoculum  for  100  ml  2YT  media  supplemented  with  100   g  ml
 1  ampicillin  and 
10  g ml
 1 chloramphenicol. Cultures were maintained at 37 °C with orbital shaking 
until an absorbance of 0.6 at 600 nm was reached. Expression was induced with the 
addition of arabinose. Cultures were maintained as before and 1.5 ml samples taken 
after 1 and 2 hours. Cells from the samples were collected by microcentrifugation, re 
suspended in 100  l of 2 x SDS PAGE loading buffer and heated at 95 °C for 10 
minutes. The protein content of 5  l samples was analysed by 15 % SDS PAGE with 
coomasie staining. 
 
7.2.2.7 Large scale expression of His6 DpnI in E. coli strain GM2929 
 
An overnight culture of E.coli GM2929 harbouring plasmid pMMS495859 was grown 
from a glycerol stock in 2YT media supplemented with 100  g ml
 1 ampicillin and 
10  g ml
 1 chloramphenicol. The culture was used as a 1 % inoculum for 5 L of 2YT 
media supplemented with 100  g ml
 1 ampicillin. The culture was maintained at 37 °C 
with orbital shaking. At an absorbance of 0.6 at 600 nm, expression was induced by 
addition of arabinose. The culture was maintained for a further 3 hours at 27 °C and 
23 g of cell paste was harvested by centrifugation (Sorval Evolution, SLC 6000 rotor, 
6800 rpm, 4 °C).  Chapter 7 
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7.2.2.8 Selection of a strain for His6 DpnI expression  
 
Overnight cultures of GM33, GM48, GM124, GM161 and GM215 harbouring plasmid 
pMMS495859 were grown in 2YT media supplemented with 100  g ml
 1 ampicillin. 
Overnight  growths  were  each  used  as  a  1  %  inoculum  for  1  L  of  2YT  media 
supplemented with 100  g ml
 1 ampicillin. All 1 L cultures were maintained at 37 °C 
with orbital shaking. Cultures of GM124, GM161 and GM215 were induced by addition 
of arabinose after 2 ½ hours, when they had an absorbance of 0.6 at 600 nm. Cultures of 
GM33 and GM48 were induced after 3 ½ hours when they had reached absorbances of 
0.57 and 0.2 at 600 nm respectively. All cell cultures were harvested by centrifugation 
6 ½ hours after inoculation (Sorval Evolution, SLC 6000 rotor, 6800 rpm, 4 °C). Strain 
GM33 did not pellet efficiently and gave 23 g of mobile slurry upon centrifugation. 
Strains GM48, GM124, GM161 and GM215 yielded 2, 3.8, 6 and 1.4 g of cell paste 
respectively. 
 
7.2.2.9 Nickel affinity purification of His6 DpnI 
 
Buffers were prepared as outlined in the table below (Table 7.15). 
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Buffers for the purification of His6 DpnI 
Low imidazole buffer (pH 7.4)  Tris.HCl (50 mM) 
Sodium chloride (400 mM) 
Imidazole (50 mM) 
Glycerol (10 % w/v) 
2 Mercaptoethanol (5 mM) 
High imidazole buffer (pH 7.4)  Tris.HCl (50 mM) 
Sodium chloride (400 mM) 
Imidazole (500 mM) 
Glycerol (10 % w/v) 
2 Mercaptoethanol (5 mM) 
DpnI storage buffer (pH 7.4)  Tris.HCl (10 mM) 
Sodium chloride (400 mM) 
EDTA (0.1 mM) 
DTT (1 mM) 
Glycerol (50 % w/v) 
Table 7.15 
 
Depending on the cell strain between 1 and 6 g of cell paste was resuspended in 30 ml 
of ice cold low imidazole buffer, supplemented with 1 mM PMSF and a Roche protease 
inhibitor tablet. Lysozyme, 10 mg, was added and the mixture stirred over ice for 15 
minutes. The PMSF was replenished and the solution sonicated for ten 25 s periods 
whilst  over  ice.  The  resultant  lysate  was  centrifuged  for  25  minutes  at  4  °C  to 
precipitate cell debris (Sorvall Evolution centrifuge, SLA 1500 rotor, 14,000 rpm). The 
supernatant was applied to a nickel affinity column with a bed volume of 10 ml at a 
flow rate of 4 ml min
 1. The column was washed with 150 ml of low imidazole buffer 
after which His6 DpnI was eluted with a step from 0 100 % high imidazole buffer. 
Fractions containing protein were identified by Bradford assay and analysed by 15 % 
SDS PAGE. The remaining protein was frozen at  80 
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7.2.2.10 Large scale expression of His6 DpnI in GM48 
 
An overnight culture of GM48 harbouring pMMS495859 was used to inoculate 5 L of 
2YT media supplemented with 100  g ml
 1 ampicillin. The culture was maintained at 
37 °C  with  orbital  shaking.  Once  the  absorbance  at  600  nm  reached  0.6,  DpnI 
expression was induced with the addition of arabinose. The culture was maintained for a 
further 3 hours at 37 °C and 24 g of cells were harvested by centrifugation (Sorval 
evolution, SLC 6000 rotor, 6800 rpm, 4 °C). 
 
7.2.2.11 Nickel affinity purification of His6 DpnI from E. coli GM48 
 
Purification was carried out using 5 g of cell paste as described in section 7.2.2.9. DpnI 
was eluted from the column with a 30 ml gradient from low to high imidazole buffer 
rather than a step. Protein was pooled and dialysed into ‘DpnI storage buffer’ for two 




7.2.2.12 Digests using His6 DpnI 
 
Digests were set up in 1.5 ml microcentrifuge tubes and incubated at 37 °C for 30 
minutes. Digests contained components listed in the table below (Table 7.16). 
 
Component  Quantity ( l) 
Plasmid DNA*  5 
Sterile water  1 
Buffer 4 (10 x)  1 
BSA (1 mg ml
 1)  1 
DpnI (Commercial (2 U  l
 1) or His6 DpnI (300 nM))  2  
Table 7.16 * Unmethylated pBadHisA from GM2929 or Methylated pMK171 from E.coli TOP10 
. 
Digestions with the His6 DpnI and the commercially available restriction enzyme were 
analysed by 1 % agarose gel electrophoresis with ethidium bromide staining. 
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7.2.3 Development of an assay for Y. pestis Dam activity 
 
7.2.3.1 Assays using the first and second oligonucleotide designs 
 
Assays were not carried out as described in the general experimental methods. Dam 
used in early assay development with ODN 1 and 2 (appendix C) was of a low quality 
due to its instability. The stabilising effect of DNA on the enzyme was not discovered 
until after the initial period of assay development. 
 
Fluorescence changes were monitored in a microplate reader using 100 reads per well, 
0.5 s delay between movement and reading, 3 s of shaking between data collections and 
5 s of post shake settling time. Excitation and emission wavelengths were 486 nm and 
518  nm  respectively  with  bandwidths  of  5  nm.  The  gain  was  170,  the  Z position 
9300  m and the integration time 40  s.  
 
Dam activity was measured in black, flat bottomed, 96 well microplates with a total 
assay volume of 200  l maintained at 37 °C.  
 
Two buffers were used for the preparation of the assay: Buffer 4 (appendix H) and Dam 
methyltransferase  buffer  (50  mM  Tris HCl  (pH  7.5),  10  mM  EDTA,  5  mM  2 
mercaptoethanol and 0.4 mg ml
 1 BSA). 
 
Assays using ODN 1 were prepared as follows: Buffer 4 (180  l, 1.1 x) supplemented 
with 4 U DpnI, 0.1 mg ml
 1 BSA, 550  M AdoMet and 27.5 nM ODN 1 was added to 
the wells of a microplate, overlaid with mineral oil, and incubated at  37 °C for 30 
minutes. Assays were initiated by the addition of 20  l of 300 nM Dam diluted in Dam 
methyltransferase  buffer.  The  plate  was  returned  to  the  microplate  reader  and  the 
fluorescence timecourses were monitored. Final concentrations of assay components 
were: 500  M AdoMet, 25 nM ODN 1, 30 nM Y. pestis Dam and 0.2 U  l
 1 DpnI. 
 
Assays  using  ODN  2  were  set  up  as  described  for  ODN  1  except  that  final 
concentrations of assay  components were: 15, 25, 35, 45, 55 nM ODN 2, 250  M 
AdoMet, 20 nM Y. pestis Dam and 0.1 U  l
 1 DpnI. Chapter 7 
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7.2.3.2 Proof of principle assays using oligonucleotide design 3 
 
The principle of the real time coupled enzyme assay was demonstrated in a series of 
assays containing 33 nM ODN 3, 240  M AdoMet and 0, 0.3 or 0.6 nM Dam. Assays 
were prepared as described in the general experimental methods section (method 11).  
 
7.2.3.3 Optimisation of the sodium chloride concentration in Dam activity assays 
 
Assays were prepared as described in general experimental method 11 except that buffer 
A contained various amounts of sodium chloride to give concentrations between 0 and 
150 mM in the final assay.  
 
7.3 Experimental for chapter 3: Kinetic analysis of Y. pestis Dam and 
validation of the coupled enzyme assay 
 
7.3.1 Kinetic analysis of Y. pestis Dam 
 
7.3.1.1 Calibration of oligonucleotide fluorescence 
 
Calibration assays were carried out as described in general experimental method 11 with 
some exceptions. Assays contained the fully methylated oligonucleotide FM ODN 3 in 
place of ODN 3, at concentrations of 0, 0.5, 1, 2, 3, 3.5 nM. AdoMet was present in the 
assays at 25  M but buffer C was added instead of ‘dilute Dam solution’ at the initiation 
step. Endpoint fluorescence was measured in duplicate on three separate occasions for 
each concentration of DNA.  
 
7.3.1.2 Measurement of the stabilisation of Y. pestis Dam by its substrates 
 
Enzyme inactivation was studied under three conditions, without either substrate, in the 
presence of 30 nM ODN 3 or with 120  M AdoMet in solution. Dilute Dam solutions 
were prepared at a concentration of 24 nM in buffer C, with or without the appropriate 
substrates.  Dilute  Dam  solutions  were  mixed  2:1  with  dilute  DpnI  solution  and Chapter 7 
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incubated at 30 °C in a PCR machine. Aliquots of this enzyme mix were withdrawn 
periodically and rapidly cooled on ice. These aliquots were used to initiate Dam activity 
assays containing 120  M AdoMet and 33 nM ODN 3 in the usual manner. Resultant 
fluorescence timecourses were used to determine the relative activity of the Dam in the 
aliquots. 
 
7.3.1.3 Dependence of Y. pestis Dam activity on substrate concentrations 
 
The dependence of Y. pestis Dam activity on AdoMet concentration was determined 
with two sets of assays both containing 1 nM Dam, 33 nM ODN 3 and 2.5, 5, 10, 20, 
40, 100 and 200  M AdoMet. The first set of assays was incubated at 37 °C and the 
other at 30 °C. The dependence of Dam activity on ODN 3 concentration was measured 
in a series of assays containing 0.31 nM Dam, 120  M AdoMet and 0.5, 1.5, 2.5, 3.5, 
3.5,  4.5,  5.5  and  6.5  nM  ODN  3.  Assays  were  carried  out  as  described  in  general 
experimental method 11. 
 
7.3.1.4 Inhibition of Dam by S adenosylhomocysteine 
 
Inhibition of Dam by S adenosylhomocysteine was investigated with several sets of 
assays containing 1 nM Dam, 33 nM ODN 3 and 20, 25, 30, 40, 70, 140 and 200  M 
AdoMet.  One  set  of  assays  was  conducted  at  each  of  the  following  AdoHcy 
concentrations; 0, 5, 10, 15, 20, 30 and 40  M. The Ki AdoHcy was determined using 
two plots constructed from the assay data. Straight lines were fitted to double reciprocal 
plots of 1 / methylation rate against 1 / [AdoMet] at each AdoHcy concentration. These 
lines had a gradient = KM.app / Vmax, a y axis intercept = 1 / Vmax and were used to obtain 
values  for  the  KM.app  (the  apparent  KM 
AdoMet).  These  values  were  plotted  against 
AdoHcy concentration. A straight line fitted to this second plot had an intercept of  Ki 
AdoHcy on the x axis. 
 
7.3.2 Assay validation in high throughput format 
 
Three 96 well plates containing positive and negative control assays were prepared as 
described in general experimental method 12. Negative controls were  performed by Chapter 7 
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replacing the ‘dilute Dam solution’ with buffer C in the initiation step. Z’ values derived 
from the three plates of data were averaged to give an estimated Z’ for the assay. 
 
7.4  Experimental  for  chapter  4:  High  throughput  screening  for 
Y. pestis Dam inhibitors 
 
7.4.1. HTS of a compound library 
 
Assays were prepared as described in general experimental method 12. Buffer A was 
however  modified  by  the  addition  of  1   l  of  a  10  mM  test  compound  solution  in 
DMSO. The final concentration of the test compounds in the assays was 100  M. 
 
7.4.2 Synthesis of potential Dam inhibitors 
 














A mixture of 6,8 dibromoimidazo[1,2 a]pyrazine (300 mg, 1.08 mmol) in 40 % v/v 
aqueous  1 methylpiperazine  (3  ml)  was  stirred  under  nitrogen  at  room  temperature 
overnight.  Water  (5  ml)  was  added  to  the  reaction  and  the  product  extracted  into 
dichloromethane (2 x 20 ml). The organic phase was dried over magnesium sulphate 
and the solvent removed in vacuo to afford a brown gum. After recrystallisation from 
hot hexane the product, an off white solid, was obtained in 64 % yield (204 mg, 0.69 
mmol). R.f. (10 % MeOH : DCM) = 0.4; mp 85 87 °C. 
1H NMR (300 MHz, CDCl3) δ: 
7.59 (1H, s) H4, 7.50 (1H, d, J = 0.9 Hz) and 7.43 (1H, d, J = 0.9 Hz) H1 and H2, 4.37 
(4H, t, unresolved) H7, 2.57 (4H, t, J = 5.1 Hz) H8,  2.35 (3H, s) H9; 
13C NMR (75 
MHz, CDCl3) δ: 132.2 C4, 122.4 C3 or C5, 114.6 and 109.8 C1 and C2, 55.5 C8, 46.3 
and 46.3 C7 and C9; LRMS (ES
+)  m/z 296 / 298 ([M + H]
+). Chapter 7 
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A  mixture  of  6 bromoimidazo 8 (1 methylpiperazine)[1,2 a]pyrazine  (80  mg,  0.27 
mmol), pyridine 3 boronic acid (33.2 mg, 0.27 mmol), sodium carbonate (86 mg, 0.81 
mmol),  tetrakis(triphenylphosphine)palladium(0)  (10  mg,  8.6   M)  in  1,2 
dimethoxyethane (6 ml) and water (2 ml) was refluxed under nitrogen for 6 8 hours 
until TLC analysis showed the reaction had gone to completion. The majority of the 
solvent was removed in vacuo and the cooled concentrated reaction partitioned between 
dilute brine (30 ml) and ethyl acetate (3 x 25 ml). The organic extracts were combined, 
dried  over  magnesium  sulphate  and  evaporated  to  give  the  crude  product. 
Chromatography on a silica gel column with 10 % methanol : dichloromethane afforded 
the pure product, a pale yellow solid, in 63 % yield (49 mg, 0.17 mmol). R.f. (10 % 
MeOH : DCM) = 0.15; mp 128 – 130 °C; 
1H NMR (300 MHz, CDCl3) δ: 9.12 (1H, br 
s) H10, 8.58 (1H, br s) H11, 8.21 (1H, d, J = 7.9 Hz) H13, 7.95 (1H, s) H4, 7.56 (2H, 2 
x d) H1 and H2, 7.36 (1H, dd, J = 4.9, 7.4 Hz) H12, 4.43 (4H, t, J = 4.5 Hz) H7, 2.61 
(4H, t, J = 5.0 Hz) H8, 2.37 (3H, s) H9; 
13C NMR (75 MHz, CDCl3) δ: 149.2 C11, 
148.4, 147.3 C10, 135.1, 133.6, 133.4 C13, 133.1, 131.9 C1 or C2, 123.4 C12, 114.8 C1 
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HMQC (400 MHz, CDCl3). 
 
  2.37  2.61  4.43  7.36  7.56  7.95  8.21  8.58  9.12 
46.0  X                 
46.2      X             
55.2    X               
107.2            X       
114.8          X         
123.4        X           
131.9          X         
133.4              X     
147.3                  X 
149.2                X   
 
MS (ES
+) m/z 295 ([M + H]
+); HRMS (ES) C16H19N6
+ calcd 295.1666, found 295.1664; 
IR (neat) 2985, 2889, 2831, 2417, 2299, 2128, 2000, 1583, 1493, 1430, 1250, 1097, 
972, 819 cm
 1; UV Vis (MeOH) 242 nm (ε = 19,500 L mol
 1 cm
 1), 316 nm (ε = 9,700 L 
mol
 1 cm
 1); Fluorescence (MeOH, λ excitation = 244 nm) λ emission = 395 nm. 
 





















Tris(dibenzylideneacetone)dipalladium(0)  (7.2  mg,  7.86   mol,  2.5  mol  %  Pd),  4,5 
bis(diphenylphosphino) 9,9 dimethylxanthene  (18.2  mg,  31.52  mol,  5  mol  %), 
N (4 aminophenyl) 4 methylbenzenesulfonamide  (165.0  mg,  630.50   mol,  1  eq), 
caesium  carbonate  (287.6  mg,  882.79   mol,  1.4  eq)  and  18 crown 6  (16.6  mg, 
62.80  mol, 10 %) were stirred and heated in 1,4 dioxane (3 ml)  under a nitrogen 
atmosphere for 15 minutes at 50 °C. 2,5 dibromopyrazine (150 mg, 630.50  mol, 1 eq) 
was dissolved in 1,4 dioxane (1 ml) and added to the mixture, via a septum, which was Chapter 7 
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then heated and stirred overnight at 90 °C. The solvent was removed in vacuo and the 
residue partitioned between dilute brine (50 ml) and ethyl acetate (3 x 50 ml). The 
organic extracts were combined, dried over magnesium sulphate and evaporated to give 
the  crude  product.  Chromatography  on  a  silica  gel  column  with  1  %  methanol  : 
dichloromethane afforded the pure product, a pale solid, in 53 % yield (139 mg, 333 
 mol).  Any  product  containing  fractions,  from  the  first  column,  found  to  be 
contaminated  with  N (4 aminophenyl) 4 methylbenzenesulfonamide  were  purified  by 
RP column chromatography in 50 % MeCN : H2O. R.f. (3 % MeOH : DCM) = 0.21, 
(RP, 50 % MeCN : H2O) = 0.11; mp 173 – 175 °C; 
1H NMR (300 MHz, MeOD) δ: 8.15 
(1H , d, J = 1.7 Hz) and 7.88 (1H, d, J = 1.7 Hz) H11 and H13, 7.53 (4H, 2 x dd, J = 3.0, 
7.6 and 3.0 and 8.9 Hz) H4 and H7, 7.27 (2H, d, J = 6.2 Hz) H3, 6.99 (2H, dd, J = 3.1 
and 9.0 Hz) H8, 2.36 (3H, d, J = 2.5 Hz) H1; 
13C NMR (75 MHz, MeOD) δ: 153.1 C10, 
144.9 and 144.4 C11 and C13, 138.8, 138.1, 135.3, 133.1, 130.5, 128.3, 127.2, 124.3, 
120.6, 21.4 C1; LRMS (ES
 ) m/z 417 / 419 ([M H]
 ). 
 




























A  mixture  of  compound  5  (60.0  mg,  143.50   mol,  1  eq), 
4 (2 carboxyethyl)benzeneboronic  acid  (30.6  mg,  157.70  mol,  1.1  eq),  caesium 
carbonate  (186.0  mg,  572.30   mol,  4  eq),  tetrakis(triphenylphosphine)palladium(0) 
(16.6 mg, 14.37  mol, 10 mol %) in 1,2 dimethoxyethane (3 ml) and water (1 ml) was 
refluxed under nitrogen overnight. The solvent was removed in vacuo and the product 
purified by RP column chromatography using a 10   15 % MeCN gradient in 0.03 % 
aqueous ammonia. Removal of the MeCN in vacuo and the remaining water by freeze 
drying afforded the product, D11:6141, as a white powder in 87 % yield (60.8 mg, 
124.79  mol). R.f. (RP, 25 % MeCN : 0.03 % aqueous NH3) = 0.32; mp > 270 °C dec. 
1H NMR (300 MHz, DMSO / D2O 75 : 25) δ: 8.55 (1H, s) and 8.16 (1H, s) H11 and 
H12, 7.79 (2H, d, J = 7.7 Hz), 7.54 (4H, 2 x d, J = 8.5 and 8.5 Hz), 7.28 (4H, 2 x d, J = Chapter 7 
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7.9 and 7.7 Hz), 6.98 (2H, d, J= 8.5 Hz), 2.80 (2H, t, J = 7.2 Hz) H18, 2.45 (t, J = 7.2 
Hz) H19, 2.29 (3H, s) H1; 
13C NMR (75 MHz, MeCN / D2O) δ: 175.9 C20, 150.7 C10, 
143.9 C13, 141.6 and 141.2 C11 and C12, 137.9, 137.5, 135.6, 134.3, 133.3, 130.7, 
129.3, 128.6, 126.8, 125.3, 122.7, 119.2, 35.4 C18, 30.1 C19, 20.2 C1; LRMS (ES
 ) m/z 
487 ([M H]
 ); HRMS (ES) C26H25N4O4S
+ calcd 489.1591, found 489.1583; IR (neat) 
3387, 3279, 3034, 2926, 2895, 2359, 2325, 1716, 1614, 1530, 1508, 1316, 1153, 1088, 
838, 815, 617 cm
 1; UV Vis (MeOH) 310 nm (ε = 19,700 L mol
 1 cm
 1), 369 nm (ε = 
10,200 L mol
 1 cm
 1); Fluorescence (MeOH, λ excitation = 310 nm) λ emission = 436, 497 
nm. 
 
































A  mixture  of  compound  5  (50.0  mg,  119.60   mol,  1  eq),  [3 (2 N,N 
dimethylaminoethylaminocarbonyl)phenyl]  boronic  acid  (31.0  mg,  131.56  mol,  1.1 
eq),  caesium  carbonate  (155  mg,  478.92   mol,  4  eq), 
tetrakis(triphenylphosphine)palladium(0)  (13.8  mg,  11.94   mol,  10  mol  %)  in  1,2 
dimethoxyethane (3 ml) and water (1 ml) was refluxed under nitrogen overnight. The 
solvent was removed and the product purified by RP column chromatography using a 
10 – 50 % MeCN : H2O gradient with or without 0.1 % acetic acid. Removal of the 
MeCN in vacuo and remaining water by freeze drying afforded the product, B02:6142, 
as a pale orange powder in 65 % yield (41 mg, 77.43  mol). R.f. (RP, 50 % MeCN : 
H2O) = 0.32;  mp 123   127 °C; 
1H NMR (300 MHz, DMSO / D2O 75 : 25) δ: 8.65 (1H, 
s) and 8.36 (1H, s) H11 and H12, 8.21 (1H, s) H19, 8.09 (1H, d, J = 7.9 Hz) and 7.79 
(1H, d, J = 7.9 Hz) H15 and H17, 7.56 (5H, m (2 x d + t), J = 8.1, 8.7 Hz) includes H16, 
7.30 (2H, d, J = 8.5 Hz), 6.99 (2H, d, J = 8.9 Hz), 3.79 (0.43H, s) H21,  3.63 (1.7H, t, J 
= 5.84 Hz) H21, 3.46 (0.65H, s) H22, 3.26 (1.8H, t, J = 5.94 Hz) H22, 2.82 (5.5H, s) 
H23, 2.29 (3H, s) H1; 
13C NMR (75 MHz, MeOD) δ: 170.9 C20, 153.0 C10, 145.0 C13, 
142.0,  139.6,  139.2,  138.8,  138.0,  135.3,  135.1,  132.8,  130.6,  130.2,  130.0,  128.3, Chapter 7 
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128.0, 125.6, 124.4, 120.6, 58.8 C21, 44.0 C23, 36.5 C22,  21.5 C1; LRMS (ES
+) m/z 
531  ([M  +  H]
+),  277  ([M  +  H
  +  Na]
2+),  185  ([M  +  2H  +  Na]
3+);  HRMS  (ES) 
C28H31N6O3S
+  calcd  531.2173.  found  531.2169;  IR  (neat)  3440,  3067,  2956,  2931, 
2850,  1668,  1644,  1507,  1326,  1200,  1154,  834,  814,  799,  720,  662 cm
 1;  UV Vis 
(MeCN) 255 nm (ε = 7,500 L mol
 1 cm
 1), 316 nm (ε = 14,500 L mol
 1 cm
 1), 360 nm (ε 
= 11,400 L mol
 1 cm
 1); Fluorescence (MeCN, λ  excitation = 255 nm) λ  emission = 452, 
498 nm. 
 
7.4.3 Analysis of hit compounds 
 
7.4.3.1 Assays to determine the effect of hit compounds on Dam activity 
 
The activity of Dam, in assays containing a range of compound concentrations, was 
measured in triplicate using general experimental method 12. 
 
7.4.3.2 Assays to determine the effect of hits on DpnI activity 
 
DpnI activity was measured in duplicate assays, with a volume of 100  l maintained at 
30 °C in black 96 well half area microplates.  Assays contained buffer B (Table 7.8) 
supplemented with 20 mM sodium chloride, 0.1 mg ml
 1 BSA, 30 nM FM ODN 3 and 
0.2 nM DpnI. Rates were determined from the first 175 s of data using the same plate 
reader parameters as for the library screen. 
 
7.4.3.3 Fluorescence intercalation displacement assays 
 
DNA binding of compounds was measured in triplicate assays, with a volume of 100  l 
in  black  96 well  half area  microplates.  Assays  contained  buffer  B  (Table  7.8) 
supplemented with 20 mM sodium chloride, 0 or 1.5  M UL ODN 2 (appendix C), 0.75 
 M thiazole orange and test compounds at the specified concentrations. Fluorescence 
intensity was measured in a Tecan Safire II microplate reader with excitation at 504 nm, 
emission at 527 nm and bandwidths of 10 nm. 
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7.5  Experimental  for  chapter  5:  A  novel  and  direct  assay  for  Dam 
activity 
 
7.5.1 Cloning, expression and purification of His6 M.PhoDam 
 
7.5.1.1 Cloning of the P. horikoshii dam gene 
 
The P. horikoshii dam gene was amplified in 50  l PCR reactions. Reactions contained 
components listed in the table below (Table 7.17). 
 
Component  Quantity ( l) 
DMSO  5 
Pfu DNA polymerase reaction buffer 
# (10 x)  5 
dNTPs (2 mM each)  1 
Primers (PhoCfo and PhoCre 100  M)   0.5 each 
P. horikoshii genomic DNA (10 – 0.1 ng  l 
 1)  1 
Sterile water  32 
Pfu DNA polymerase mix*  5 
Table 7.17 *Pfu polymerase mix contained Pfu turbo polymerase (4  l), Pfu DNA polymerase reaction 
buffer  (2   l),  water  (14   l) and  was  added  to  the  reactions  at  80  °C.
#  For  colony  PCR  MangoTaq 
polymerase and buffer were used and the template DNA was substituted with whole cells picked into the 
mixture. The temperature programme was preceded with 10 minutes at 95°C and the step at 80 °C was 
removed. 
 
Reactions were cycled through the temperature programme outlined below (Table 7.18). 
 
Temperature programme 
1 x  30 x  1 x 
95 °C, 60 seconds  95 °C, 60 seconds  72 °C 10 minutes 
80 °C, 180 seconds          49 °C, 60 seconds  Hold 4 °C 
  72 °C, 150 seconds   
Table 7.18 
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Samples  of  5   l  taken  from  the  PCR  reactions  were  analysed  by  1  %  agarose  gel 
electrophoresis with ethidium bromide staining and the successful reactions purified 
using a QIAquick
® PCR clean up kit according to the manufacturer’s instructions. 
 
7.5.1.2 Digestion of the P. horikoshii dam gene 
 
Digests were prepared in 1.5 ml microcentrifuge tubes and contained components listed 
in the table below (Table 7.19). 
 
Component  Quantity ( l) 
PCR product as purified or pBad *  25 
Sterile water  12 
NEB buffer 3 (10 x)  5 
BSA (1mg ml
 1)  5 
NcoI (10 U  l
 1)  1.5 
XhoI (20 U  l
 1)  1.5 
Table 7.19 *pBad was sourced from a 10 ml overnight culture of  E. coli TOP10 and purified using 
Promega Wizard
® SV Minipreps. 
 
Digests were incubated for 2 hours at 37 °C. Products were run on a 1 % agarose gel 
and  purified  using  a  QIAquick  gel  extraction  kit  according  to  the  manufacturer’s 
instructions.  
 
7.5.1.3 Ligation of the P. horikoshii dam gene into a pBad vector 
 
Ligation reactions containing three different vector to insert ratios were prepared in 
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Component  Quantity ( l) 
Digested dam gene (as purified)  6  3  0 
Digested vector (pBad derived, as purified)  2  2  2 
Sterile water  0  3  6 
T4 DNA ligase buffer (10 x)  1  1  1 
T4 DNA ligase  1  1  1 
Table 7.20 
 
The components were gently mixed with pipetting and incubated at 4 °C overnight. 
 
7.5.1.4.  Transformation  of  E.  coli  strain  TOP10  with  the  C His6 M.PhoDam 
expression plasmid 
 
Ligation reactions were added to a 50  l aliquot of TOP10 competent cells previously 
thawed on ice for 15 minutes. Cells were kept on ice for a further 30 minutes and heat 
shocked in a water bath at 42 °C for 45 seconds. Cells were returned to the ice for 2 
minutes and 250  l of SOC media added. Following incubation with orbital shaking at 
37 °C for one hour, 150  l of culture was plated out onto 2YT agar supplemented with 
100  g ml
 1 ampicillin. Plates yielded colonies following incubation at 37 °C overnight. 
The plasmid formed was designated pMMS511811. 
 
7.5.1.5 Analytical digests of pMMS511811 harvested from E. coli strain TOP10  
 
Plasmid was harvested from 10 ml overnight cultures of E. coli TOP10 supplemented 
with 100  g ml
 1 ampicillin using minipreps. Double and single digests with NcoI, NcoI 
/ XhoI, BamHI / PciI, BamHI / Nhe and NsiI were prepared and incubated for 1 hour at 
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Component  Quantity ( l) 
  Single digest  Double digest 
Plasmid DNA  5  5 
Sterile Water  2.5  2 
NEB buffer 3 (10 x)  1  1 
BSA (1mg ml
 1)  1  1 
Restriction enzyme 1*  0.5   0.5  
Restriction enzyme 2*  0  0.5 
Table 7.21 * Restriction enzymes were used at the standard concentrations supplied by New England 
Biolabs. None of the enzyme stocks were of the high concentration (HC) enzyme. 
 
Digests were analysed using 1 % agarose gel electrophoresis with ethidium bromide 
staining. 
 
7.5.1.6 Transformation of E.coli BL21 pLysS Rosetta 2 with plasmid pMMS511811 
 
E. coli BL21 pLysS Rosetta 2 competent cells were transformed with pMMS511811 
plasmid as described in section 7.5.1.4. In addition to ampicillin the 2YT agar plates 
used were supplemented with 30  g ml
 1 chloramphenicol. 
 
7.5.1.7 Large scale expression of C His6 M.PhoDam 
 
An overnight culture of BL21 pLysS Rosetta 2 harbouring plasmid pMMS511811 was 
grown  in  2YT  media  supplemented  with  100   g  ml
 1  ampicillin  and  10   g  ml
 1 
chloramphenicol. This overnight growth was used as a 1 % inoculum for 4 L of 2YT 
media supplemented with the same antibiotics. The culture was maintained at 37 °C 
with orbital shaking to an absorbance of 0.6 at 600 nm. Expression was induced by the 
addition of arabinose. The culture was maintained for a further 2 hours at 27 °C and 
12 g of cell paste was harvested by centrifugation (Sorval Evolution, SLC 6000 rotor, 
6800 rpm, 4 °C). Cell paste was stored at  80 °C until required. 
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7.5.1.8  Small  scale  expression  of  C His6 M.PhoDam  in  GM124,  GM161  and 
JW3351 1 
 
Each strain was cultured in 1 L of 2YT media in a similar manner to the large scale 
BL21 growth (section 7.5.1.7), with some exceptions. Chloramphenicol was not used to 
supplement growth media and post induction cultures were maintained at 37 °C for 3
1/2 
hours before harvest. GM124, GM161 and JW3351 1 yielded 6.7, 7 and 2.8 g of cell 
paste respectively. 
 
7.5.1.9 Nickel affinity purification of C His6 M.PhoDam 
 
Buffers were prepared according to the table below (Table 7.22). 
 
Buffer composition for the purification of C His6 M.PhoDam 
Low imidazole buffer (pH 7.5)  Tris.HCl (50 mM) 
Sodium chloride (300 mM) 
Imidazole (50 mM) 
Glycerol (10 %) 
Triton X 100 (0.05 % v/v) 
2 Mercaptoethanol (5 mM) 
High imidazole buffer (pH 7.5)  Tris.HCl (50 mM) 
Sodium chloride (300 mM) 
Imidazole (500 mM) 
Glycerol (10 %) 
Triton X 100 (0.05 % v/v) 
2 Mercaptoethanol (5 mM) 
Dam storage buffer (pH 7.5)  Tris.HCl (50 mM) 
Sodium chloride (200 mM) 
EDTA (0.2 mM) 
Glycerol (20 %) 
DTT (1 mM) 
Table 7.22 
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Depending on the cell strain, between 2.8 and 7 g of cell paste was resuspended in 
30 ml of ice cold low imidazole buffer, supplemented with 1 mM PMSF and a roche 
protease inhibitor tablet. Lysozyme, 10 mg, was added and the mixture stirred over ice 
for 15 minutes. The PMSF was replenished and the solution sonicated for ten 25 s 
periods whilst over ice. The resultant lysate was centrifuged for 25 minutes at 4 °C to 
precipitate cell debris (Sorvall Evolution centrifuge, SLA 1500 rotor, 14,000 rpm). The 
supernatant was applied to a nickel column with a bed volume of 10 ml at a flow rate of 
4 ml min
 1. The column was washed with 150 ml of low imidazole buffer after which C 
His6 M.PhoDam  was  eluted  with  a  30  ml  gradient  from  0     100 %  high  imidazole 
buffer.  Fractions  containing  protein  were  identified  by  Bradford  assay,  analysed  by 
15 % SDS PAGE, pooled, dialysed into Dam storage buffer and frozen at  80 
oC. 
 
7.5.1.10 Electroblotting of protein onto a PVDF membrane 
 
Electroblotting was carried out in a Bio Rad Mini Trans Blot
® Electrophoretic Transfer 
Cell. Samples, each containing 200 pmoles of the protein of interest, were applied to a 
standard 15 % SDS polyacrylamide gel. A PVDF membrane and two filter papers were 
cut to the size of the gel. The PVDF membrane was soaked in methanol for 10 minutes 
after which it was, along with the gel, filter papers and fibre pads equilibrated for 15 
minutes in transfer buffer (25 mM tris pH 8.3, 192 mM glycine, 10 % MeOH, 0.025 % 
SDS). The equilibrated components were sandwiched inside a plastic cassette according 
to the manufacturer’s instructions. The cassette was inserted into the electrophoretic 
tank  along  with  ice  cold  transfer  buffer  and  a  magnetic  stirrer  bar.  Transfer  of  the 
protein sample onto the membrane was carried out at 30 V and 4 °C with stirring 
overnight. Protein bands on the membrane were visualised with coomassie staining. The 
membrane was air dried and stored between two filter papers. 
  
7.5.1.11 Site directed mutagenesis of the P. horikoshii dam gene 
 
Mutagenic PCR reactions were prepared in 200  l PCR tubes. Reactions contained the 
components listed in the table below (Table 7.23). 
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Component  Quantity ( l) 
Pfu DNA polymerase reaction buffer (10 x)  5 
dNTPs (2 mM each)  2 
Primers (PhofM98A and PhorM98A 10  M)   1 each 
Plasmid pCLW469397* (10 ng  l
 1)  1 
Sterile water  39 
Pfu Turbo DNA polymerase
#  1 
Table 7.23 * Isolated from E. coli TOP10 and so full methylated at GATC sites and susceptible to 
DpnI.
# Added at 80 °C. 
 




1 x  16 x  1 x 
95 °C, 60 seconds  95 °C, 30 seconds  4 °C, 180 seconds 
80 °C, 180 seconds          55 °C, 60 seconds   
  68 °C, 300 seconds   
Table 7.24 
 
Samples  of  5   l  taken  from  the  PCR  reactions  were  analysed  by  1  %  agarose  gel 
electrophoresis with ethidium bromide staining. PCR reactions were then incubated at 
37 °C for 1 hour following the addition of 10 U of DpnI. Samples of 5  l taken from the 
DpnI incubations were analysed by 1 % agarose gel electrophoresis. A 1  l aliquot from 
the DpnI incubations was used to transform competent E. coli TOP10 and so produce 
the plasmid designated pMMS528431. 
 
7.5.1.12 Analytical digests of plasmid pMMS528431 
 
Analytical digests were carried out on pMMS528431 isolated from E. coli TOP10 as 
described for pMMS511811. NcoI was used to linearise the plasmid and a double NcoI / 
XhoI  digest  was  used  to  excise  the  P.  horikoshii  dam  gene.  Digests  and  the  uncut 
plasmid were analysed by 1 % agarose gel electrophoresis. Chapter 7 
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7.5.1.13  Transformation  of  E.  coli  BL21  pLysS  Rosetta  2  with  plasmid 
pMMS528431 
 
E. coli BL21 pLysS Rosetta 2 competent cells were transformed with pMMS528431 
plasmid as described in section 7.5.1.4. In addition to ampicillin, the 2YT agar plates 
used were supplemented with 30  g ml
 1 chloramphenicol. 
 
7.5.1.14 Large scale expression of N His6 M.PhoDam mutant M98A 
 
An  overnight  culture  of  BL21  pLysS  Rosetta  2  supplemented  with  10  g ml
 1 
chloramphenicol and 100  g ml
 1 ampicillin was used as a 1 % inoculum for 5 L of 2YT 
media supplemented with 100  g ml
 1 ampicillin. The culture was maintained at 37 °C 
with orbital shaking until an absorbance of 0.6 at 600 nm was reached. Expression was 
induced by the addition of arabinose. The culture was maintained overnight at 16 °C 
with orbital shaking and yielded 66 g of cell paste upon centrifugation for 25 minutes at 
4 °C (Sorval Evolution, SLC 6000 rotor, 6800 rpm). Cell paste was stored at  80 °C 
until required. 
 
7.5.1.15 Nickel affinity purification of N His6 M.PhoDam 
 
Purification by nickel affinity chromatography was carried out as described for the C 
terminally His6 tagged protein (section 7.5.1.9). Typically 10 g of cell paste yielded 
3.5 mg of N His6 M.PhoDam. 
 
7.5.2 Fluorescence Equilibrium Perturbation assay development 
 
7.5.2.1 Gel based assays for Dam activity 
 
ODN 4 / M ODN 7 at a concentration of 1  M was incubated with 100 nM mutant 
M98A  N His6 M.PhoDam  and  20   M  AdoMet  in  buffer  D  at  33  °C.  At  regular 
timepoints 100  l aliquots of assay mixture were taken and heated at 90 °C for 15 
minutes  to  terminate  methylation.  Terminated  assays  were  diluted  1:1  with  DpnI 
solution (20 mM potassium phosphate pH 7.8, 0.1 mg ml
 1 BSA, 1 mM magnesium Chapter 7 
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chloride, 200 nM DpnI) and incubated for 40 minutes at 30 °C. Samples of these digests 
were taken, mixed 2:1 with formamide, heated at 90 °C for 5 minutes and kept on ice. 
The DNA content of the samples was analysed with denaturing short oligonucleotide 
gel electrophoresis. This analysis was performed on 20 % polyacrylamide gels, made as 
described in general experimental method 9, run at a constant 20 W for 3 – 4 hours. 
Fluorescently  labelled  DNA  in  the  gels  was  visualised  under  UV  light.  Relative 
intensities of the DNA bands were quantified using GeneTools software from Syngene. 
 
7.5.2.2 Measurement of thermal melting profiles 
 
Thermal melting curves for hemi and enzymatically fully methylated ODN 4 / M ODN 
7 were measured in a Lightcycler. Duplicate melting curves were recorded at 4.4, 6.6, 
9.9,  14.8,  22.2,  33.3  and  50.0  nM  ODN  4 /  M  ODN  7  in  10  l  of  buffer  D.  The 
excitation  wavelength  was  488  nm  and  fluorescence  changes  were  recorded  as  a 
function of temperature at an emission wavelength of 520 nm. Melting profiles were 
fitted to the 4 parameter sigmoid F = F0 + a / (1 + e 
  (T – T
0
) / b) using Sigmaplot 11 to 
obtain values for the melting temperatures. In the equation F0 is fluorescence of the 
solution  at  temperature  far  below  the  melting  temperature,  F  is  the  measured 
fluorescence,  a  is  the  maximum  increase  in  fluorescence  due  to  melting,  T  is  the 
temperature, T0 is the melting temperature and b is a constant. 
 
7.5.2.3 Oligonucleotide temperature jump kinetics 
 
Kinetics of oligonucleotide melting were studied by measuring the rate of change in 
ODN 4 / 7 fluorescence following a rapid increase in temperature in a Lightcycler. 
Duplicated solutions of 4.4, 6.6, 9.9, 14.8, 22.2, 33.3 and 50.0 nM ODN 4 / 7 in 10  l of 
buffer D were exposed to a rapid temperature increase from 32 to 34 °C (20 °C s
 1). 
Fluorescence timecourses were recorded for 5 minutes thereafter with excitation and 
emission wavelengths of 488 nm and 520 nm respectively. Time dependant changes in 
fluorescence were fitted to the equation Ft = Ff  x (1   e 
 bt) + F0 using Sigmaplot 11. In 
the equation F0 is initial fluorescence, Ff is the maximum increase in fluorescence and Ft 
is the fluorescence at time t. The relaxation rate constant b obtained from these fits is 
related to the rates of association (k1) and dissociation (k 1) of the two single strands by 
the equation b = k1 [ODN 4 + M ODN 7] + k 1 (5). Relaxation rates were plotted against Chapter 7 
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the  total  ssDNA  concentrations  which  were  calculated  from  the  melting  curves 
assuming an all or nothing model of DNA hybridisation. Straight lines were fitted to 
these plots using Sigmaplot 11 to yield the association and dissociation rate constants 
given by the gradients and y axis intercepts respectively. 
 
7.5.2.4 Proof of FEP assay principle 
 
Dependence  of  the  rate  of  fluorescence  increase  on  M98A  N His6 M.PhoDam 
concentration was measured at 33 °C in triplicate assays containing 50 nM ODN 4 / M 
ODN  7,  20  mM  AdoMet  and  0,  1.25,  2.5  and  5  nM  Dam.  Assays  were  set  up  as 
described in general experimental method 13. 
 
 
7.5.2.5 The effect of Dam concentration on the inherent fluorescence of ODN 4 / M 
ODN 7 
 
The influence of M98A N His6 M.PhoDam concentration, in the absence of turnover, 
on  the  equilibrium  between  single  and  double  stranded  ODN  4  /  M  ODN  7  was 
investigated in a series of 100  l duplicate solutions. Solutions contained 5 nM ODN 4 / 
M ODN 7 and 0, 5, 10, 20, 40, 60, 80 and 100 nM Dam in buffer D (general method 
13). They were equilibrated to 33 °C and the fluorescence measured as for the normal 
FEP assays. 
 
7.5.2.6 Kinetic analysis of M98A N His6 M.PhoDam 
 
The dependence of M98A N His6 M.PhoDam activity on AdoMet concentration was 
measured in a series of duplicate assays at 33 °C containing 50 nM ODN 4 / M ODN 7, 
2.5  nM  Dam  and  0,  0.05,  0.1,  0.2,  0.4,  0.8,  1.6,  3.2  and  6.4   M  AdoMet.  The 
dependence  of  Dam  activity  on  DNA  concentration  was  measured  in  a  series  of 
duplicate assays at 32 °C containing 20  M AdoMet and 0, 0.9, 1.3, 2.0, 3.0, 4.4, 6.7, 
10, 15 nM ODN 4 / M ODN 7. The Dam concentration was equal to 10 % of the DNA 
concentration. 
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Fluorescence changes were calibrated based on the endpoint fluorescence increases in 
assays,  which  were  assumed  to  be  due  to  complete  methylation.  A  two  parameter 
exponential rise to a maximum,   Fluorescence = a(1   e
 b[ODN 4 / M ODN 7]), fitted to a plot 
of ODN 4 / M ODN 7 concentration against endpoint fluorescence increase was used to 
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NcoI   317   C'CATG_G





             
pCLW 469397
5007 bp
NcoI   7   C'CATG_G






            
pMK 171
5114 bp
NcoI   104   C'CATG_G
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pMMS 495859
4782 bp
NcoI   383   C'CATG_G








NcoI   21   C'CATG_G
NsiI   264   A_TGCA'T
NheI   653   G'CTAG_C
XhoI   1034   C'TCGA_G
PciI   3268   A'CATG_T
NsiI   3715   A_TGCA'T







                     
pMMS 528431
5007 bp
NcoI   7   C'CATG_G
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pRJW 421307
4795 bp
NcoI   1   C'CATG_G
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Appendix B: Primer sequences 
 
DpnIf: 5’ CCCCCCATGGAATTACACTTTAATTTAGAATTAGTA 3’ 
 
DpnIr: 5’ CCCCCTCGAGTCATAATTTCCGATACTTTCC 3’ 
 




TGATCTC 3’  
 
PhofM98A : 
5’ GGGAGTACTACTATAGAGCGCGAAGAGAATACAATAAACTTGCCC 3’ 
 
PhorM98A:  
5’ GGGCAAGTTTATTGTATTCTCTTCGCGCTCTATAGTAGTACTCCC 3’ 
 
pBad Forward: 5’ ATGCCATAGCATTTTTATCC 3’ 
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Appendix C: Dam activity assay oligonucleotide sequences 
 
Oligonucleotide name and structure abbreviations: 
FAM – Fluorescein 
D – Dabcyl 
HEG – Hexaethyleneglycol 
m6A – N6 methyladenine 
UL – Unlabelled 
M – Methylated 
FM – Fully methylated 
Sequences: 
 
ODN 1: 5’ (FAM)CAGTTCGCGATCATGTTC(TD)C(HEG) 
GAGAACATGATCGCGAACTG 3’ 
 
ODN 2: 5’ (FAM)CCGGATCCAGTTTTCTGGATCCGG(D) 3’ 
 
UL ODN 2: 5’ CCGGATCCAGTTTTCTGGATCCGG 3’ 
 
ODN 3: 5’ (FAM)CCGG(m6A)TCCAGTTTTCTGGATCCGG(D) 3’ 
 
FM ODN 3: 5’ (FAM)CCGG(m6A)TCCAGTTTTCTGG(m6A)TCCGG(D) 3’ 
 
ODN 4: 5’ ATTTAGATCACAA(FAM) 3’  
 
ODN 5: 5’ (D)TTGTGAUCTAAAT 3’  
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Appendix D: Adjustments made to high throughput screening data 
Plate  Well  Observations  Result  replaced 
with  plate 
average 
6130  E04  High rate  No 
6130 R  E04  High rate  No 
6131  H02  High fluorescence, high rate, fewer data 
points available as above machine limit. 
No 
6131 R        No 
6132  D04  Low rate  No 
6132 R  D04  High rate  No 
6133  C02  High rate  No 
6133 R  C02  High rate  No 
6134        No 
6134 R        No 
6135  B02,  E02, 
G04,  H04, 
H05. 
B02, E02 fluorescence increased above 
machine maximum so fewer data points 
available.  G04  inherently  fluorescent, 
fewer  data  points  available.  H04  very 
fluorescent, no data. H05 high rate. 
B02,  E02,  G04 
no.  
H04 yes.  
H05 no. 
6135 R  G04,  H04, 
H05 
G04,  H04  as  above.  H05  high  rate, 
fluorescence  increased  above  machine 
maximum so fewer data points available 
As above. 
6136  F02, F07  F02 and F07 inherently fluorescent  F02 and F07 yes 
6136 R  F02, F07  F02 and F07 inherently fluorescent  F02 and F07 yes 
6137  H09  Significantly reduced rate  No 
6137 R  H09  Significantly reduced rate  No 
6138        No 
6138 R        No 
6139  E03, H03  E03  fluorescence  increased  above 
machine maximum so fewer data points 
available. H03 inherently fluorescent. 
E03 no. H03 yes 
6139 R  E03, H03  E03, H03 as above.  E03  and  H03  as 
above 
6140  E11  Fluorescence  increased  above  machine 
maximum so fewer data points available 
E11 no 
6140R  E11  As for E11 6140  E11 no 
6141  D11  Significantly reduced rate  No 




D06 / D11 
E05 / E10 
B02 / B07 
D04 / D09 
D06  and  duplicate  were  fluorescent, 
fewer  data  points  available.  E05  and 
duplicate  were  fluorescent,  fewer  data 
points were available. B02 / B07, D04 / 
D09 showed significantly reduced rates. 
No 
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Appendix E: Results of N terminal amino acid sequencing of the wild type 
P. horikoshii Dam contaminant 
 
Protein sequence report 
Cambridge Peptides Order: CPO27574 
Customer sample code: 27kDa band 
Created on: 4th August 2008 
N terminus 
Residue 
1  M 
2      
3      
4  E 
5  Y 




Notes on the presentation of the data: 
? most probable assignment. 
    nothing detected at this position 
xxx unknown component 
 
Where several sequences are observed, an attempt is made to arrange them 
in descending  order of  abundance at each  residue.  However because of 
difficulties inherent in the sequencing process, this should be treated as a 
guide only. Chapter 7 
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Appendix F: Results of the sequencing of mutant N His6 M.PhoDam genes 
in expression plasmids from E. coli TOP10 colonies 1 and 3 
 
Colony 1 plasmid: Reverse 
 
 
Consensus   
 
Identity   
 
Colony 1   
 
Wild Type   
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Consensus   
 
Identity   
 
Colony 1   
 































mutation   
(not seen  
in reverse 
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Consensus   
 
Identity   
 
Colony 3   
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Colony 3 plasmid: Forward 
 
 
Consensus   
 
Identity   
 
Colony 1   
 






























mutation   
(not seen  
in reverse 
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Sequences with high and low consensuses are shown in red and blue respectively. In the 
consensus sequence, symbols are used to show the conservation of particular sets of 
amino acids; # = D, E, N or Q, ! = I or V, $ = L or M and % = F or Y. All of the MTases 
shown recognise the sequence GATC. When aligned E.coli Dam (278 amino acids) 
shares 193 amino acids with Y. pestis Dam (271 amino acids) and 61 with T4 phage 
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Appendix H: Commonly used commercial buffers 
 
New England Biolabs buffer composition (1 x) 
Buffer 1 (pH 7.0)  10 mM Bis tris propane.HCl 
10 mM Magnesium chloride 
1 mM Dithiothreitol 
 
Buffer 2 (pH 7.9)  50 mM Sodium chloride 
10 mM Tris.HCl 
10 mM Magnesium chloride 
1 mM Dithiothreitol 
 
Buffer 3 (pH 7.9)  100 mM Sodium chloride 
50 mM Tris.HCl 
10 mM Magnesium chloride 
1 mM Dithiothreitol 
 
Buffer 4 (pH 7.9)  50 mM Potassium acetate 
20 mM Tris acetate 
10 mM Magnesium acetate 
1 mM Dithiothreitol 
 
 
 